data_1zwu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zwu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.8 m -75.55 101.37 4.87 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.239 -0.913 . . . . 0.0 108.943 155.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.39 105.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.306 1.042 . . . . 0.0 110.179 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.9 27.2 4.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.167 0.987 . . . . 0.0 111.231 -169.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.88 -4.52 81.74 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.412 1.958 . . . . 0.0 115.65 -174.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 167.29 13.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 2.004 . . . . 0.0 112.488 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.1 m -134.23 154.89 80.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.813 2.045 . . . . 0.0 110.448 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.36 176.68 9.76 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.151 2.567 . . . . 0.0 111.646 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -29.7 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 129.431 3.092 . . . . 0.0 115.416 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.12 3.57 81.78 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.047 -1.418 . . . . 0.0 116.02 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -77.0 169.16 18.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.139 1.969 . . . . 0.0 112.173 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 m -132.62 157.92 43.56 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.811 1.645 . . . . 0.0 111.192 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -112.14 116.2 30.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.673 1.189 . . . . 0.0 112.403 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.1 p -68.98 163.48 24.49 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.359 1.464 . . . . 0.0 113.624 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 . . . . . 0 N--CA 1.469 0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 113.944 174.372 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 CA-C-O 119.955 -0.358 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.48 135.62 51.79 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 110.654 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.4 t -109.68 137.62 47.22 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.434 2.294 . . . . 0.0 111.409 -169.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.8 -160.88 24.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.321 1.439 . . . . 0.0 111.478 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -133.17 126.31 31.37 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.772 0.829 . . . . 0.0 109.665 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.94 178.09 22.0 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.579 1.085 . . . . 0.0 112.754 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -48.04 -53.93 5.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.839 3.693 . . . . 0.0 114.521 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.69 -8.69 55.67 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -100.24 -51.69 3.59 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.041 0.937 . . . . 0.0 111.124 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 124.254 1.022 . . . . 0.0 113.689 -175.832 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.5 m -72.21 117.83 14.34 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.587 -1.321 . . . . 0.0 109.287 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 85.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 129.205 3.002 . . . . 0.0 110.307 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.5 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 40.39 42.75 1.33 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.194 2.198 . . . . 0.0 111.211 -161.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -13.65 66.12 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.579 2.037 . . . . 0.0 116.235 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.36 174.68 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.2 2.0 . . . . 0.0 111.01 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 m -141.12 163.9 39.2 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.536 1.134 . . . . 0.0 110.792 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.57 168.77 1.42 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 124.255 3.304 . . . . 0.0 114.668 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.8 m -44.46 100.11 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.402 2.281 . . . . 0.0 114.258 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.26 -1.62 84.58 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.722 1.153 . . . . 0.0 115.191 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -80.5 161.58 24.77 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.749 1.275 . . . . 0.0 110.966 168.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.9 m -138.2 156.12 48.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.383 1.473 . . . . 0.0 110.862 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -89.01 114.06 25.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.745 1.218 . . . . 0.0 111.379 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t -70.73 168.22 17.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 113.233 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 126.359 1.864 . . . . 0.0 115.43 -176.587 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.269 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -123.51 149.46 45.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.195 1.798 . . . . 0.0 111.538 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -94.97 149.98 20.65 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.14 -165.16 37.79 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.564 1.078 . . . . 0.0 112.081 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -135.0 167.43 20.95 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.514 1.526 . . . . 0.0 111.591 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.62 -174.65 48.56 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.807 0.718 . . . . 0.0 113.101 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.9 -36.12 26.23 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.025 3.817 . . . . 0.0 116.151 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.61 -9.35 58.48 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -139.25 -44.85 0.46 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.8 m -50.39 154.19 1.34 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.517 1.127 . . . . 0.0 113.852 -163.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.05 70.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 123.573 1.654 . . . . 0.0 108.756 172.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? 33.33 50.23 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 1 C-N-CA 132.41 4.284 . . . . 0.0 112.559 -172.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.18 -17.92 10.44 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 127.295 2.379 . . . . 0.0 114.943 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.52 164.7 12.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.274 1.537 . . . . 0.0 111.493 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.1 m -144.7 168.11 13.09 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.364 1.466 . . . . 0.0 111.34 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.69 156.8 8.41 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.966 3.111 . . . . 0.0 114.211 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -52.85 97.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.746 2.018 . . . . 0.0 113.302 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.36 39.65 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.916 1.245 . . . . 0.0 114.85 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -94.07 167.79 11.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.801 1.301 . . . . 0.0 111.506 168.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.4 143.5 48.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.453 1.501 . . . . 0.0 110.681 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -83.08 109.02 16.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.449 0.7 . . . . 0.0 110.199 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.0 p -70.6 164.32 25.14 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 125.173 1.389 . . . . 0.0 114.582 175.432 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -114.49 131.67 56.55 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.856 1.663 . . . . 0.0 110.228 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.8 m -73.57 152.67 40.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.965 1.306 . . . . 0.0 112.63 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.62 -167.18 40.23 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.098 0.856 . . . . 0.0 111.987 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.41 167.28 21.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 110.905 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.86 -172.96 54.6 Favored Glycine 0 CA--C 1.54 1.595 0 O-C-N 121.9 -0.5 . . . . 0.0 113.565 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -42.4 -48.05 7.01 Favored 'Trans proline' 0 C--N 1.351 0.689 1 C-N-CA 125.925 4.417 . . . . 0.0 116.915 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -70.94 -9.36 57.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -134.71 -60.73 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.915 0.886 . . . . 0.0 112.178 -168.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 96.8 m . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 126.313 1.845 . . . . 0.0 112.907 -172.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.55 0.979 0 CA-C-O 121.557 0.694 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.8 m -87.09 126.24 34.64 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 138.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.71 92.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.585 2.354 . . . . 0.0 110.664 -168.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 37.74 46.04 0.7 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.32 1.848 . . . . 0.0 112.266 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.08 -10.29 65.7 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.0 2.238 . . . . 0.0 115.554 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -103.19 179.14 4.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.457 1.629 . . . . 0.0 112.669 -173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 m -138.8 158.9 69.19 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.342 1.857 . . . . 0.0 110.423 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.96 163.05 39.86 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.562 2.175 . . . . 0.0 111.485 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.4 p -56.77 93.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.519 1.928 . . . . 0.0 112.78 -173.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.6 -11.91 10.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.499 1.523 . . . . 0.0 114.604 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -91.31 169.39 10.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.793 1.796 . . . . 0.0 111.883 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 p -142.8 164.56 29.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.514 1.526 . . . . 0.0 111.762 -174.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.0 t -120.36 111.12 17.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.359 1.064 . . . . 0.0 112.352 -157.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -69.73 161.95 28.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 113.917 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 . . . . . 0 N--CA 1.472 0.642 0 C-N-CA 124.209 1.004 . . . . 0.0 113.625 -173.453 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.658 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.83 114.78 17.67 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.475 1.51 . . . . 0.0 110.636 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.74 148.32 33.07 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.463 0.705 . . . . 0.0 111.682 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.61 -152.26 13.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.992 1.758 . . . . 0.0 110.641 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -138.9 160.09 40.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.833 0.853 . . . . 0.0 110.915 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.31 172.2 13.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.044 1.783 . . . . 0.0 111.515 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.56 -34.27 75.62 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.882 2.388 . . . . 0.0 112.409 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -11.11 60.66 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -106.5 -45.36 4.27 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.995 1.318 . . . . 0.0 110.997 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.0 m . . . . . 0 CA--C 1.54 0.579 0 C-N-CA 124.618 1.167 . . . . 0.0 112.886 -177.341 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 . . . . . 0 CA--C 1.551 0.997 0 CA-C-O 121.817 0.818 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.4 m -94.26 110.08 21.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.909 1.684 . . . . 0.0 106.51 136.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.79 101.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.773 1.629 . . . . 0.0 111.373 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 48.51 27.05 1.32 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.405 1.482 . . . . 0.0 112.917 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.51 -15.74 14.7 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.37 2.414 . . . . 0.0 116.644 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.46 171.22 14.44 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.074 2.437 . . . . 0.0 112.917 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -146.86 156.17 47.82 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 123.105 0.562 . . . . 0.0 112.338 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.98 177.94 8.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.041 3.161 . . . . 0.0 112.996 -172.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.8 p 59.68 24.54 13.41 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.86 96.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.489 1.043 . . . . 0.0 112.704 -169.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.6 mtt -69.47 169.95 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.224 1.012 . . . . 0.0 110.739 160.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -140.4 155.43 46.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.143 1.777 . . . . 0.0 110.744 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -94.13 121.77 35.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.11 1.364 . . . . 0.0 113.212 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p -72.14 152.39 42.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.423 -0.798 . . . . 0.0 111.504 166.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 pm0 . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 126.345 1.858 . . . . 0.0 114.187 175.605 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.98 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.318 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -121.17 122.33 39.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.154 1.781 . . . . 0.0 109.426 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.97 164.52 19.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.72 -151.11 10.08 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.8 2.143 . . . . 0.0 110.435 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -137.37 156.61 48.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.943 1.297 . . . . 0.0 110.335 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.45 -167.4 23.47 Favored Glycine 0 CA--C 1.542 1.76 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.49 4.94 2.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.857 3.705 . . . . 0.0 115.675 -164.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 4.49 9.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.697 1.999 . . . . 0.0 112.608 176.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.8 -44.03 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.122 1.769 . . . . 0.0 111.878 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 125.841 1.656 . . . . 0.0 107.927 171.328 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -60.11 101.73 0.14 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -57.28 96.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 128.281 2.632 . . . . 0.0 110.865 -164.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? 48.79 29.55 2.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -167.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.46 -2.61 67.93 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.222 2.344 . . . . 0.0 116.23 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 165.91 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.272 2.036 . . . . 0.0 111.887 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m -141.57 130.83 12.5 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.999 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -80.6 168.79 17.59 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.635 2.89 . . . . 0.0 112.779 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p 55.06 28.13 10.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.21 35.55 60.44 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.92 1.248 . . . . 0.0 113.32 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -67.99 167.11 14.44 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.387 1.093 . . . . 0.0 110.501 162.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.41 135.22 54.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.96 2.104 . . . . 0.0 108.874 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 t -75.56 137.33 40.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.04 0.536 . . . . 0.0 110.558 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -117.68 163.93 15.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 113.969 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 125.622 1.569 . . . . 0.0 113.063 178.201 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.908 0 CA-C-O 119.391 -0.672 . . . . 0.0 113.39 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -121.84 155.71 34.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.94 1.696 . . . . 0.0 110.692 -168.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -86.62 156.03 20.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.824 0.85 . . . . 0.0 111.794 170.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.01 -174.12 41.38 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.832 1.206 . . . . 0.0 110.162 159.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -124.51 149.46 46.88 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.721 1.261 . . . . 0.0 110.557 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 179.12 52.17 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 123.523 0.582 . . . . 0.0 113.422 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.44 -20.13 61.12 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 114.444 -166.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.51 -21.41 16.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.992 1.317 . . . . 0.0 113.183 170.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -133.15 -42.76 0.87 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.426 1.49 . . . . 0.0 111.451 -173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.626 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 121.277 0.561 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.7 m -100.86 109.95 21.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.759 1.624 . . . . 0.0 107.361 139.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -53.39 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.831 2.452 . . . . 0.0 110.747 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 48.85 27.08 1.47 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.815 2.046 . . . . 0.0 113.549 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.23 -11.03 33.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.946 2.212 . . . . 0.0 115.008 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 170.8 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.096 1.948 . . . . 0.0 112.657 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.6 m -136.4 167.68 20.5 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.967 1.307 . . . . 0.0 110.493 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.96 146.15 17.48 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.706 2.938 . . . . 0.0 112.568 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.7 m -66.31 82.28 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.137 1.375 . . . . 0.0 112.177 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.26 -17.57 2.7 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.326 1.917 . . . . 0.0 113.674 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mmt -80.29 177.04 9.24 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.658 1.229 . . . . 0.0 111.457 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.9 m -127.0 163.83 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.177 2.191 . . . . 0.0 110.124 169.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.51 118.88 37.81 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.73 1.212 . . . . 0.0 110.55 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.7 p -71.21 166.94 20.45 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 128.22 2.608 . . . . 0.0 115.297 162.85 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -120.59 133.97 55.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.237 2.615 . . . . 0.0 110.397 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.1 m -65.59 155.79 34.71 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.01 -160.13 29.84 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.139 1.828 . . . . 0.0 111.534 170.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.29 174.06 10.89 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.486 1.143 . . . . 0.0 111.207 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.93 169.98 42.3 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 124.656 1.122 . . . . 0.0 112.05 -166.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.37 -36.95 85.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.979 2.453 . . . . 0.0 112.358 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -55.6 -24.06 30.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.323 1.849 . . . . 0.0 114.16 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.9 -1.25 12.61 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.902 1.281 . . . . 0.0 113.502 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.5 m -65.45 90.48 0.11 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 157.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.7 t -55.49 93.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 128.457 2.703 . . . . 0.0 111.068 -160.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 46.36 36.88 3.68 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.879 1.672 . . . . 0.0 112.796 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.69 -6.83 11.28 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.212 2.339 . . . . 0.0 117.516 171.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.24 167.42 20.4 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.998 2.399 . . . . 0.0 114.793 -170.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.6 m -132.12 161.79 60.68 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.419 . . . . 0.0 110.584 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.9 154.89 15.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.731 2.954 . . . . 0.0 113.364 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -49.91 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.98 2.112 . . . . 0.0 114.032 -173.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.17 -7.77 58.74 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.049 1.309 . . . . 0.0 114.85 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.1 mtp -76.77 161.61 28.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.52 1.66 . . . . 0.0 110.383 166.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.3 m -126.43 121.01 31.22 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.898 0.879 . . . . 0.0 110.511 -161.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.71 107.13 3.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.121 0.968 . . . . 0.0 110.748 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -73.26 156.1 38.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.297 0.57 . . . . 0.0 112.247 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.0 pm0 . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 126.575 1.95 . . . . 0.0 114.329 -178.339 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.229 0 CA-C-O 119.44 -0.645 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -129.41 136.25 49.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.455 1.102 . . . . 0.0 112.124 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.9 m -71.76 157.69 37.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.915 1.686 . . . . 0.0 112.541 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.65 -163.63 33.48 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.106 0.86 . . . . 0.0 112.927 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -141.7 170.73 15.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.911 2.084 . . . . 0.0 108.445 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.83 -171.59 50.19 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 118.565 0.621 . . . . 0.0 113.879 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.49 -38.64 72.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.316 2.678 . . . . 0.0 114.825 -161.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.425 ' HE3' ' CZ ' ' A' ' 27' ' ' TYR . 3.3 ttpp -73.45 -2.57 23.02 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.425 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 72.5 m-85 -140.26 -34.56 0.53 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -171.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 m -69.87 95.04 0.88 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -62.63 89.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.863 2.065 . . . . 0.0 111.366 -161.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? 57.69 26.58 13.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.188 1.795 . . . . 0.0 113.336 -166.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.01 -13.68 5.76 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.197 1.38 . . . . 0.0 116.44 166.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.31 170.53 14.94 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.795 1.797 . . . . 0.0 113.685 -171.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.2 m -128.1 161.75 54.24 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.287 1.835 . . . . 0.0 110.991 -173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.59 159.37 53.0 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.822 2.348 . . . . 0.0 112.184 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.6 p -60.14 92.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.822 . . . . 0.0 112.104 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -15.86 4.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.44 1.495 . . . . 0.0 113.725 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -112.49 164.66 13.03 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.739 1.27 . . . . 0.0 111.293 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.2 m -132.13 148.82 52.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.919 1.688 . . . . 0.0 109.92 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -82.58 148.44 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.148 0.579 . . . . 0.0 111.654 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.3 p -118.26 163.09 17.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.718 1.207 . . . . 0.0 113.313 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 . . . . . 0 N--CA 1.47 0.545 0 C-N-CA 125.551 1.54 . . . . 0.0 113.819 176.969 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.155 0 CA-C-O 119.472 -0.626 . . . . 0.0 113.353 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -124.02 144.86 49.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.608 1.163 . . . . 0.0 112.121 -169.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -82.32 156.24 24.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.963 1.305 . . . . 0.0 112.429 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.54 -164.6 36.3 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.63 0.634 . . . . 0.0 113.349 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -136.36 172.05 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.425 1.89 . . . . 0.0 110.695 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.55 -177.67 53.46 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 123.9 0.762 . . . . 0.0 113.554 -168.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.08 -48.59 14.31 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.261 3.974 . . . . 0.0 115.096 -172.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.75 -13.68 11.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.091 1.756 . . . . 0.0 115.632 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -135.07 -37.15 0.8 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.424 1.011 . . . . 0.0 113.317 -168.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 111.44 0.163 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -72.19 93.38 1.45 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.724 -0.61 . . . . 0.0 110.905 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.0 89.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 128.346 2.658 . . . . 0.0 111.215 -168.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? 38.06 41.74 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.699 2.8 . . . . 0.0 112.21 -163.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.27 34.23 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 128.211 2.815 . . . . 0.0 116.095 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -89.74 160.03 16.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.2 2.0 . . . . 0.0 112.031 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.3 m -140.77 161.7 52.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.577 1.151 . . . . 0.0 111.164 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.44 168.36 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.373 3.382 . . . . 0.0 115.057 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.7 m -43.79 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.889 2.476 . . . . 0.0 114.059 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.38 7.41 87.9 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.049 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.8 mtt -84.22 166.13 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.059 1.429 . . . . 0.0 111.964 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.1 m -123.99 152.7 42.24 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.762 1.625 . . . . 0.0 109.823 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.42 154.37 38.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.932 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 p -133.92 174.78 10.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -154.998 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.046 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.73 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -129.17 139.77 51.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.392 1.096 . . . . 0.0 112.651 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.2 m -79.63 159.44 26.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.381 2.272 . . . . 0.0 113.629 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.62 -166.83 39.25 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 123.938 0.78 . . . . 0.0 113.977 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -129.29 165.57 21.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.32 1.848 . . . . 0.0 111.139 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.75 -178.51 53.24 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 123.536 0.589 . . . . 0.0 113.707 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.64 -33.26 58.26 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.65 3.566 . . . . 0.0 116.297 -171.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -14.89 63.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 113.406 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -137.58 -48.88 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.02 0.827 . . . . 0.0 113.222 -171.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -156.511 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.86 99.59 9.12 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 143.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -57.94 93.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.319 1.847 . . . . 0.0 111.454 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 42.73 36.98 0.92 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.148 1.779 . . . . 0.0 112.452 -164.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.11 66.22 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.407 2.432 . . . . 0.0 116.01 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.98 170.87 9.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.219 2.009 . . . . 0.0 112.685 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.99 152.47 55.14 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.414 2.286 . . . . 0.0 109.327 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.6 166.04 6.96 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.731 2.954 . . . . 0.0 113.858 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -47.35 105.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.149 2.18 . . . . 0.0 113.591 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.23 4.28 89.74 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.968 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.2 mtt -90.42 163.95 14.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.885 1.342 . . . . 0.0 111.417 170.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -133.42 133.45 42.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.139 1.375 . . . . 0.0 111.137 -165.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.52 140.67 44.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.528 . . . . 0.0 110.53 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.0 p -117.04 163.36 16.35 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.543 1.137 . . . . 0.0 113.472 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 . . . . . 0 N--CA 1.471 0.585 0 C-N-CA 126.066 1.746 . . . . 0.0 113.825 178.451 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.12 0 CA-C-O 120.051 -0.305 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -126.18 136.02 52.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.264 1.826 . . . . 0.0 111.101 -168.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.53 150.98 32.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.149 0.98 . . . . 0.0 112.481 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.48 -162.14 31.41 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.336 0.97 . . . . 0.0 113.248 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -138.35 167.26 22.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.233 1.413 . . . . 0.0 112.546 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.15 -174.89 40.11 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.428 0.537 . . . . 0.0 113.442 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.6 -32.18 27.05 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.91 3.74 . . . . 0.0 116.523 -172.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -6.98 50.35 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 116.85 -1.548 . . . . 0.0 115.118 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -144.38 -38.57 0.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -169.867 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.2 m -64.88 96.2 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 158.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.1 t -51.89 93.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.99 2.516 . . . . 0.0 111.794 -159.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 38.44 36.18 0.12 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.722 2.009 . . . . 0.0 113.156 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -4.39 31.14 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 128.531 2.967 . . . . 0.0 116.751 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 167.56 12.69 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 121.214 2.507 . . . . 0.0 113.592 176.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.35 152.0 52.65 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 126.773 2.029 . . . . 0.0 108.356 166.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.42 168.53 2.85 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.98 3.12 . . . . 0.0 114.321 169.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -47.74 99.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.454 2.302 . . . . 0.0 113.886 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.99 84.06 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.795 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -83.8 169.54 15.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.982 1.391 . . . . 0.0 110.919 163.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.11 164.12 31.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.032 1.733 . . . . 0.0 111.572 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -117.57 112.5 20.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 112.307 -162.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.5 p -68.51 160.17 30.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.384 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pm0 . . . . . 0 CA--C 1.54 0.591 0 C-N-CA 125.528 1.531 . . . . 0.0 114.264 176.291 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 CA-C-O 119.613 -0.548 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -106.06 130.91 53.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 0.0 110.007 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -78.04 159.85 28.48 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.336 1.455 . . . . 0.0 111.118 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.74 -160.91 32.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.698 1.618 . . . . 0.0 110.852 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -138.67 156.34 47.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.686 -0.891 . . . . 0.0 110.057 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.03 -175.82 41.83 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 123.522 0.582 . . . . 0.0 114.121 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.5 -47.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.046 3.831 . . . . 0.0 115.482 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -74.56 -0.27 17.19 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -125.31 -35.67 2.58 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.89 1.276 . . . . 0.0 112.706 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 m . . . . . 0 CA--C 1.543 0.681 0 C-N-CA 124.949 1.3 . . . . 0.0 111.956 178.867 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 CA--C 1.551 0.994 0 CA-C-O 121.526 0.679 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.407 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 59.4 m -95.15 107.66 19.75 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 137.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -55.63 96.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.555 1.942 . . . . 0.0 111.325 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 39.18 43.02 0.82 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 111.896 -167.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.45 56.13 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.846 2.165 . . . . 0.0 116.506 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -118.12 167.62 11.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.853 2.326 . . . . 0.0 114.047 -170.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.1 m -131.11 164.12 44.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.003 1.321 . . . . 0.0 111.595 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.16 160.37 4.59 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.167 3.245 . . . . 0.0 114.469 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.14 100.04 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.144 2.178 . . . . 0.0 113.382 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.06 2.25 66.52 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.086 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -77.95 172.6 13.25 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.433 1.617 . . . . 0.0 111.844 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.81 159.86 36.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.048 2.139 . . . . 0.0 111.154 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -108.51 114.46 28.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.615 1.566 . . . . 0.0 110.56 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.9 p -67.51 153.19 44.26 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.779 0.799 . . . . 0.0 112.841 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 113.791 168.091 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.41 126.84 47.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.684 1.994 . . . . 0.0 110.528 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 61.4 m -74.18 158.8 33.5 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.63 -160.71 31.04 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.748 2.118 . . . . 0.0 110.334 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -138.17 143.56 40.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 1.469 . . . . 0.0 111.266 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.37 177.12 20.35 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.291 1.424 . . . . 0.0 112.053 -170.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.5 -38.69 81.48 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.931 2.421 . . . . 0.0 112.628 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -59.96 -10.24 3.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.338 1.455 . . . . 0.0 114.564 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -122.31 -29.54 4.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.188 1.395 . . . . 0.0 113.009 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 36.1 m . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 124.108 0.963 . . . . 0.0 112.92 176.637 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.543 0.684 0 CA-C-O 121.518 0.675 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -66.24 117.17 8.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 152.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.07 94.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.322 2.249 . . . . 0.0 110.721 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? 42.64 35.7 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.052 0.941 . . . . 0.0 112.458 -161.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.32 -6.05 63.23 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 126.4 1.953 . . . . 0.0 116.384 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.71 170.78 9.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.418 2.109 . . . . 0.0 112.96 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.5 m -139.14 157.45 71.15 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.472 1.909 . . . . 0.0 108.701 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.5 162.87 37.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.662 2.241 . . . . 0.0 112.263 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -55.34 89.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.695 2.398 . . . . 0.0 113.522 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.96 -8.31 7.65 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.212 1.386 . . . . 0.0 114.715 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 99.2 mtp -98.97 169.6 9.32 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.152 1.476 . . . . 0.0 111.265 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.74 136.5 51.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.773 1.629 . . . . 0.0 111.606 -175.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.8 t -89.19 116.24 27.29 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.106 1.362 . . . . 0.0 109.694 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -73.32 156.09 38.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.232 1.015 . . . . 0.0 113.339 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 CA--C 1.541 0.606 0 C-N-CA 126.862 2.065 . . . . 0.0 113.474 170.253 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 CA-C-O 119.381 -0.677 . . . . 0.0 114.428 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -116.6 141.1 48.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.534 1.134 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.69 153.35 20.79 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.017 1.327 . . . . 0.0 110.877 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.58 -159.75 26.8 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.666 -0.646 . . . . 0.0 112.534 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 0.0 110.179 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.04 178.34 49.95 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.918 0.77 . . . . 0.0 112.863 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.4 -21.69 66.34 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.468 2.779 . . . . 0.0 114.359 -167.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.57 -21.55 53.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.137 0.975 . . . . 0.0 113.136 171.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -132.56 -36.64 1.08 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.132 0.973 . . . . 0.0 113.479 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 112.072 174.896 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.979 0.895 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.03 106.16 1.2 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 150.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -52.03 97.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 128.517 2.727 . . . . 0.0 109.913 -168.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 41.9 39.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.74 2.016 . . . . 0.0 112.513 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.96 -6.59 40.53 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 127.029 2.252 . . . . 0.0 115.637 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.33 176.24 5.57 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.962 1.881 . . . . 0.0 113.829 -168.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.1 m -137.51 152.33 72.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 110.742 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.7 169.32 22.52 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 112.12 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.2 t -45.97 110.49 0.27 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.862 1.665 . . . . 0.0 113.257 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 -12.0 68.09 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.57 -1.683 . . . . 0.0 115.671 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -75.4 170.93 15.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.595 2.198 . . . . 0.0 111.38 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -130.35 148.23 52.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.535 1.534 . . . . 0.0 111.106 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -92.92 114.98 27.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.777 1.231 . . . . 0.0 110.438 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.8 p -67.54 163.12 21.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.826 1.298 . . . . 0.0 114.258 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 CA--C 1.547 0.835 0 C-N-CA 128.686 2.794 . . . . 0.0 115.545 161.401 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 CA-C-O 120.091 -0.283 . . . . 0.0 113.778 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -107.0 149.99 26.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.382 1.473 . . . . 0.0 109.929 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.8 t -118.61 133.74 55.63 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.746 0.818 . . . . 0.0 112.145 -168.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.16 -154.16 10.21 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.527 1.537 . . . . 0.0 111.289 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.29 169.84 16.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.229 1.014 . . . . 0.0 111.594 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.14 169.89 44.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.093 1.33 . . . . 0.0 111.457 -167.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.62 -34.46 92.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.617 2.211 . . . . 0.0 112.121 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -52.72 -33.95 50.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 113.271 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.49 -14.16 15.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.007 1.723 . . . . 0.0 113.712 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.64 104.55 2.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.992 0.517 . . . . 0.0 110.915 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.25 91.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.557 2.343 . . . . 0.0 110.542 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.5 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 43.58 34.63 0.84 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.592 2.357 . . . . 0.0 112.341 -164.043 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 -10.27 56.68 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.324 2.392 . . . . 0.0 116.347 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 160.81 19.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.877 2.339 . . . . 0.0 111.724 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -140.1 134.24 15.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.685 1.194 . . . . 0.0 110.275 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.52 178.38 7.63 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.444 2.763 . . . . 0.0 112.634 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 m 45.42 41.36 6.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.277 2.231 . . . . 0.0 115.423 170.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.53 58.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 113.795 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 79.1 mtm -84.56 164.48 18.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.621 1.211 . . . . 0.0 111.062 168.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 m -112.34 147.31 36.63 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.486 1.914 . . . . 0.0 109.556 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -80.3 112.04 17.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.385 0.674 . . . . 0.0 110.778 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.8 p -66.26 162.64 19.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.867 1.318 . . . . 0.0 113.974 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 CA--C 1.545 0.774 0 C-N-CA 128.41 2.684 . . . . 0.0 115.558 161.797 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.254 0 CA-C-O 119.845 -0.42 . . . . 0.0 114.057 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.59 143.05 50.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.211 1.405 . . . . 0.0 111.652 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -76.46 147.16 38.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.388 1.075 . . . . 0.0 112.675 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.68 -162.15 27.72 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.532 1.063 . . . . 0.0 112.175 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -132.14 166.29 22.14 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.187 0.994 . . . . 0.0 111.51 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.53 175.28 37.23 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.527 1.061 . . . . 0.0 113.601 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -47.87 -43.5 29.35 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.298 3.332 . . . . 0.0 114.273 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -58.1 -26.22 62.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.276 1.43 . . . . 0.0 113.91 -176.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -114.31 -14.65 12.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.602 1.561 . . . . 0.0 113.528 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 122.573 1.177 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.7 m -74.44 179.74 4.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.575 -1.328 . . . . 0.0 110.491 147.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.32 79.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.208 -1.557 . . . . 0.0 107.613 164.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 45.36 47.04 10.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.246 1.418 . . . . 0.0 112.28 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.26 76.61 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.734 1.159 . . . . 0.0 115.463 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.77 172.6 11.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.659 1.984 . . . . 0.0 109.924 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -141.88 154.8 65.88 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 118.973 0.806 . . . . 0.0 112.894 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.17 173.61 11.61 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.903 3.069 . . . . 0.0 111.773 169.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m 36.0 43.18 0.19 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 129.128 2.971 . . . . 0.0 117.086 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.19 31.08 61.71 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.854 1.216 . . . . 0.0 114.253 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -73.87 165.04 25.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.701 1.75 . . . . 0.0 109.561 159.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.3 m -118.32 115.6 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.462 1.505 . . . . 0.0 109.48 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -74.15 89.16 1.98 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.15 164.79 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.776 1.63 . . . . 0.0 114.275 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 . . . . . 0 N--CA 1.468 0.471 0 C-N-CA 125.4 1.48 . . . . 0.0 113.361 176.854 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.12 0 CA-C-O 119.488 -0.618 . . . . 0.0 113.505 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.53 126.52 37.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.952 1.301 . . . . 0.0 111.252 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -67.21 135.91 54.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.252 0.478 . . . . 0.0 111.456 167.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.55 -163.33 17.39 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.622 1.106 . . . . 0.0 112.108 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -132.59 167.0 20.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.443 1.497 . . . . 0.0 110.483 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.43 179.13 34.01 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.683 0.658 . . . . 0.0 113.383 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.51 -28.66 70.57 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.993 2.462 . . . . 0.0 113.442 -171.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -12.01 20.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.842 -1.551 . . . . 0.0 114.505 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.73 -25.93 1.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 113.633 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -61.56 101.65 0.2 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.26 95.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.488 2.315 . . . . 0.0 110.0 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? 47.05 34.41 2.81 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.893 1.277 . . . . 0.0 111.729 -167.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.2 68.46 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 126.982 2.229 . . . . 0.0 116.276 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.27 163.95 15.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.448 2.124 . . . . 0.0 111.682 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -138.38 158.29 70.92 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.804 1.241 . . . . 0.0 110.772 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.66 168.24 25.27 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.872 2.382 . . . . 0.0 112.687 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -43.71 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.249 2.619 . . . . 0.0 114.586 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -7.15 59.48 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.196 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -79.0 170.4 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.791 1.795 . . . . 0.0 111.875 170.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -139.14 163.29 32.82 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.892 2.077 . . . . 0.0 110.542 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -109.54 114.96 29.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.823 1.249 . . . . 0.0 112.091 -166.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.55 157.95 34.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.002 1.321 . . . . 0.0 112.862 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pm0 . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 124.599 1.16 . . . . 0.0 113.484 169.923 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 CA-C-O 119.503 -0.61 . . . . 0.0 113.798 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -114.84 143.76 44.6 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 112.684 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.65 157.56 31.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.551 1.141 . . . . 0.0 112.066 167.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.51 -160.89 34.66 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.281 1.896 . . . . 0.0 109.77 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -142.93 163.06 33.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.514 0.657 . . . . 0.0 110.803 169.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.71 179.11 25.72 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.696 1.141 . . . . 0.0 112.928 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.87 -8.46 23.55 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.902 3.068 . . . . 0.0 114.867 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.21 -2.12 50.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.7 1.6 . . . . 0.0 113.661 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.37 -44.91 1.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.873 1.669 . . . . 0.0 111.767 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.5 m . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 125.88 1.672 . . . . 0.0 111.913 175.081 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.5 m -68.49 103.33 1.64 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.324 0.649 . . . . 0.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -54.54 89.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 128.73 2.812 . . . . 0.0 111.524 -172.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.501 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 37.66 40.09 0.23 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.726 2.81 . . . . 0.0 112.785 -162.432 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.68 -7.46 27.93 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 126.429 1.966 . . . . 0.0 116.559 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -112.45 166.55 11.21 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.573 2.187 . . . . 0.0 113.574 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -142.17 167.07 17.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.331 1.852 . . . . 0.0 110.828 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -54.04 155.53 14.88 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.729 2.953 . . . . 0.0 114.223 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.9 t -62.28 74.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.392 2.277 . . . . 0.0 113.914 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.04 -10.41 2.55 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.026 1.774 . . . . 0.0 114.533 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.0 171.76 10.06 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.261 1.425 . . . . 0.0 111.31 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -123.01 149.69 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.102 1.761 . . . . 0.0 110.101 169.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.94 118.46 21.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.846 0.859 . . . . 0.0 109.974 166.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -78.88 159.22 27.87 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.863 0.839 . . . . 0.0 112.795 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 125.791 1.637 . . . . 0.0 113.872 173.569 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.117 0 CA-C-O 119.491 -0.616 . . . . 0.0 113.743 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.7 140.03 50.58 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.439 1.096 . . . . 0.0 111.823 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m -73.17 153.15 40.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.624 1.569 . . . . 0.0 112.53 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 -170.5 43.64 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.62 0.629 . . . . 0.0 113.953 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -128.45 165.78 20.0 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.323 2.249 . . . . 0.0 110.299 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.89 179.98 52.79 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.069 0.842 . . . . 0.0 113.295 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.67 -26.8 39.35 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 124.585 3.523 . . . . 0.0 116.235 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -71.61 -10.93 60.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -143.95 -52.02 0.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 125.729 1.612 . . . . 0.0 114.142 -159.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 . . . . . 0 CA--C 1.549 0.916 0 CA-C-O 121.656 0.741 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.435 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 20.2 m -99.66 146.7 26.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.459 1.504 . . . . 0.0 110.802 141.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -69.09 91.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.47 1.508 . . . . 0.0 110.016 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.68 25.84 1.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.814 -168.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.89 39.97 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.588 1.566 . . . . 0.0 116.54 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.29 166.19 11.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.22 2.01 . . . . 0.0 112.16 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -145.49 163.56 31.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.935 -173.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.18 156.46 10.23 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.356 3.37 . . . . 0.0 115.443 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -51.68 102.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.201 2.201 . . . . 0.0 112.59 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.38 -3.75 47.23 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.682 -1.065 . . . . 0.0 114.831 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.46 -175.59 2.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.926 1.863 . . . . 0.0 112.354 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.63 137.86 52.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.081 2.152 . . . . 0.0 109.818 160.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.36 107.81 13.46 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 158.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -77.04 165.77 24.19 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -174.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 125.418 1.487 . . . . 0.0 113.525 171.03 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.05 0 CA-C-O 119.786 -0.452 . . . . 0.0 113.109 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -122.35 133.12 54.66 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.243 2.217 . . . . 0.0 110.261 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 98.5 m -65.99 146.03 55.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 165.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.5 -167.38 39.28 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.091 0.853 . . . . 0.0 113.659 165.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -131.13 169.68 15.56 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.739 2.016 . . . . 0.0 111.539 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.33 178.87 33.14 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.139 0.876 . . . . 0.0 113.76 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.31 -35.66 35.53 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.717 3.612 . . . . 0.0 116.288 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -5.67 40.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -144.01 -30.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -157.309 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 122.211 1.005 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 47.7 m -95.95 128.11 42.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.352 1.861 . . . . 0.0 109.006 145.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.2 90.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 129.163 2.985 . . . . 0.0 111.456 -171.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? 44.96 29.81 0.5 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.195 0.998 . . . . 0.0 113.42 -165.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.21 8.22 63.16 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.075 1.322 . . . . 0.0 115.437 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -105.53 174.02 6.06 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.814 2.445 . . . . 0.0 110.654 171.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.1 m -140.1 133.26 15.09 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.85 166.48 17.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.807 3.005 . . . . 0.0 111.874 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p 53.97 27.85 7.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.44 34.37 54.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.081 1.324 . . . . 0.0 113.61 -170.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.2 mtt -67.17 170.47 6.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 110.687 163.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 m -130.34 148.83 52.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.386 1.474 . . . . 0.0 110.341 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 t -91.96 109.41 20.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.35 1.06 . . . . 0.0 111.856 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.2 p -66.43 165.8 13.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.703 1.201 . . . . 0.0 113.811 177.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 127.212 2.205 . . . . 0.0 114.447 170.357 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -120.16 126.13 49.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.276 2.231 . . . . 0.0 109.93 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 86.9 m -68.06 149.4 49.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 170.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.48 -159.25 21.14 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.773 1.654 . . . . 0.0 111.846 173.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.14 157.2 40.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.842 1.257 . . . . 0.0 110.981 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.31 -175.96 49.88 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.414 0.925 . . . . 0.0 115.414 171.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.01 -22.25 38.04 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.918 3.745 . . . . 0.0 117.284 -170.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.39 1.22 57.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.776 1.23 . . . . 0.0 113.319 176.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -129.6 -44.34 1.23 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.636 1.174 . . . . 0.0 112.403 -176.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 123.591 0.756 . . . . 0.0 113.028 170.861 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 . . . . . 0 CA--C 1.543 0.676 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m -65.49 108.35 1.97 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.706 -0.621 . . . . 0.0 111.713 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.71 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.862 2.065 . . . . 0.0 110.639 -174.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.59 43.81 1.65 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.739 2.016 . . . . 0.0 111.405 -162.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.04 70.88 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.982 1.753 . . . . 0.0 116.089 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.0 20.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.441 2.121 . . . . 0.0 111.433 176.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.8 m -142.37 154.61 64.04 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.036 1.334 . . . . 0.0 111.469 174.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -77.27 174.32 12.95 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.613 2.875 . . . . 0.0 111.95 175.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m 37.34 45.66 0.55 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.191 2.596 . . . . 0.0 116.137 167.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.86 30.78 22.8 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.746 1.641 . . . . 0.0 114.125 -176.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.8 mtt -74.37 159.94 31.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.622 1.211 . . . . 0.0 111.579 177.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.4 m -87.63 120.97 29.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.445 1.498 . . . . 0.0 109.448 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.0 t -67.67 101.14 0.98 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 160.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -75.31 163.6 27.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -174.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 125.521 1.529 . . . . 0.0 113.504 173.541 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.206 0 N-CA-C 114.074 0.39 . . . . 0.0 114.074 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -128.58 146.9 50.71 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.287 1.035 . . . . 0.0 112.02 -172.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.76 147.81 37.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.882 2.073 . . . . 0.0 112.438 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.86 -169.69 42.83 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.38 0.514 . . . . 0.0 113.77 163.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -130.12 159.97 35.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.491 1.916 . . . . 0.0 108.993 170.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.87 173.67 47.85 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 123.903 0.763 . . . . 0.0 112.744 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -45.9 34.13 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.155 3.237 . . . . 0.0 115.53 -167.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 0.28 1.23 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.615 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -137.61 -38.62 0.59 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 125.281 1.432 . . . . 0.0 113.702 -176.129 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 123.134 1.445 . . . . 0.0 113.78 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.5 m -82.17 132.59 35.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 144.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.36 86.2 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.872 1.269 . . . . 0.0 111.479 -161.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.16 42.89 25.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.673 1.189 . . . . 0.0 111.22 -159.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.15 -10.04 65.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.012 1.768 . . . . 0.0 115.03 177.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -103.01 172.38 6.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.83 1.315 . . . . 0.0 113.328 -167.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.75 157.61 64.45 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.909 2.084 . . . . 0.0 110.784 176.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.64 161.09 42.79 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.877 2.385 . . . . 0.0 111.893 165.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -55.27 92.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.238 2.215 . . . . 0.0 113.48 -173.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.76 -10.83 10.3 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.219 1.39 . . . . 0.0 114.5 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.3 mtt -88.62 167.12 13.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.868 1.334 . . . . 0.0 111.228 166.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 m -137.44 142.01 41.61 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.944 1.698 . . . . 0.0 110.858 -172.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.4 t -83.93 108.18 16.76 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.467 1.107 . . . . 0.0 110.128 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.1 p -71.44 161.72 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.823 0.82 . . . . 0.0 113.034 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 125.843 1.657 . . . . 0.0 113.864 174.255 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.025 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.18 127.88 49.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.838 1.655 . . . . 0.0 110.661 -173.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.0 t -83.51 144.76 29.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.875 0.87 . . . . 0.0 112.387 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.48 -165.2 33.21 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.319 0.961 . . . . 0.0 112.644 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -136.41 162.59 32.62 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.397 1.079 . . . . 0.0 111.864 176.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.68 -173.68 42.12 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.161 0.886 . . . . 0.0 112.953 -173.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -44.31 -47.98 10.26 Favored 'Trans proline' 0 C--N 1.35 0.652 1 C-N-CA 125.407 4.072 . . . . 0.0 115.612 -172.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -65.69 -6.53 11.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.891 1.676 . . . . 0.0 115.522 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -139.64 -56.0 0.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.005 0.922 . . . . 0.0 113.033 -171.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 126.567 1.947 . . . . 0.0 113.553 -170.881 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 121.386 0.612 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.2 m -85.76 107.44 17.61 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 139.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -55.43 95.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.964 1.706 . . . . 0.0 111.524 -158.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? 45.28 36.06 2.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.085 1.754 . . . . 0.0 112.335 -169.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.92 -4.65 59.23 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 127.697 2.57 . . . . 0.0 115.873 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.76 8.5 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.264 2.032 . . . . 0.0 113.087 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.34 152.02 74.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.148 . . . . 0.0 109.661 169.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.65 165.96 4.16 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.783 2.989 . . . . 0.0 113.257 162.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.64 98.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.703 2.401 . . . . 0.0 114.07 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.53 4.61 89.11 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.466 176.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt -77.6 172.91 12.64 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.797 1.798 . . . . 0.0 112.105 171.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 m -128.61 133.96 48.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.376 1.87 . . . . 0.0 110.62 -169.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.5 t -81.99 125.97 31.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.909 -0.494 . . . . 0.0 110.672 173.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -79.2 154.32 29.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 173.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 CA--C 1.541 0.618 0 O-C-N 121.46 -0.775 . . . . 0.0 112.845 169.725 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.916 0 CA-C-O 119.204 -0.776 . . . . 0.0 114.177 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -115.41 131.08 57.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.41 1.484 . . . . 0.0 109.864 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.44 149.89 36.79 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.491 0.316 . . . . 0.0 111.791 169.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.46 -159.17 23.03 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.871 1.224 . . . . 0.0 112.001 175.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -139.31 154.48 47.92 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.991 0.916 . . . . 0.0 110.079 175.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.41 176.92 28.73 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.857 1.218 . . . . 0.0 112.799 -173.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.88 -53.06 6.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.546 3.498 . . . . 0.0 114.467 -174.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -56.62 -12.19 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.337 1.855 . . . . 0.0 114.888 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.07 -39.11 2.85 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.882 1.673 . . . . 0.0 112.943 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.7 m . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.091 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 CA--C 1.554 1.097 0 CA-C-O 121.074 0.464 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.49 107.52 15.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 130.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.01 101.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 126.693 1.997 . . . . 0.0 110.425 -170.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 48.9 33.2 4.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.586 1.155 . . . . 0.0 112.379 -170.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.78 68.33 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.898 2.189 . . . . 0.0 115.269 -178.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -121.38 164.21 17.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.774 1.787 . . . . 0.0 112.597 -174.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.35 173.83 4.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.441 2.297 . . . . 0.0 108.878 163.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.58 136.07 16.15 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.75 2.966 . . . . 0.0 113.755 173.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.8 p -58.31 97.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.107 1.763 . . . . 0.0 112.254 -174.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.31 -19.88 4.51 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.441 1.496 . . . . 0.0 112.969 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.3 mtp -82.37 158.95 23.15 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.211 1.005 . . . . 0.0 109.645 159.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.6 m -143.29 139.6 30.21 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.834 1.254 . . . . 0.0 110.156 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -70.93 155.3 40.98 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 177.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -126.83 166.38 17.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.879 1.271 . . . . 0.0 113.219 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 124.951 1.3 . . . . 0.0 114.067 174.95 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.64 137.0 50.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.45 1.5 . . . . 0.0 110.033 -171.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 151.71 30.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 166.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.5 -162.22 26.82 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.918 1.246 . . . . 0.0 112.015 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -138.25 163.98 30.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.819 1.648 . . . . 0.0 110.714 172.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.45 -175.66 46.01 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 123.609 0.623 . . . . 0.0 113.232 -176.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.53 -36.38 31.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 125.178 3.919 . . . . 0.0 116.77 -171.038 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.94 -9.65 58.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 178.742 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.74 -47.84 0.5 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -168.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -174.127 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.8 m -95.27 112.94 24.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.684 1.994 . . . . 0.0 107.268 151.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.0 103.07 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.536 1.134 . . . . 0.0 110.44 -163.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.26 30.5 4.44 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.366 1.066 . . . . 0.0 112.156 -165.124 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.26 -7.69 81.51 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.184 1.85 . . . . 0.0 115.198 -174.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.8 171.93 8.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.584 1.692 . . . . 0.0 112.016 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.0 m -143.14 149.17 47.79 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.363 1.865 . . . . 0.0 111.521 -172.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.02 -178.27 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 125.261 3.974 . . . . 0.0 114.991 165.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -38.96 92.3 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.644 3.178 . . . . 0.0 115.311 -177.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.38 30.13 61.24 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.62 1.105 . . . . 0.0 113.588 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.4 mtt -85.71 170.04 12.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 110.813 170.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.16 142.32 35.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.22 1.808 . . . . 0.0 110.734 -164.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.6 113.13 23.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.564 1.145 . . . . 0.0 110.555 -177.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.9 p -71.58 165.87 23.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.148 0.975 . . . . 0.0 113.504 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 127.347 2.259 . . . . 0.0 114.683 170.906 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -111.65 123.04 49.4 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.43 1.892 . . . . 0.0 108.906 -178.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.77 142.69 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.246 0.476 . . . . 0.0 112.02 178.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.91 -161.47 19.21 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.951 1.739 . . . . 0.0 110.33 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -132.59 150.0 52.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.769 1.285 . . . . 0.0 110.779 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 -160.64 30.33 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 115.406 0.923 . . . . 0.0 115.406 172.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.88 4.29 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 125.109 3.873 . . . . 0.0 116.151 -160.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.32 5.44 9.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.053 1.741 . . . . 0.0 112.737 174.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -129.24 -57.44 1.15 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.487 1.515 . . . . 0.0 110.378 177.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 m . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.029 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.787 -0.149 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.1 m -57.92 160.07 5.01 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -74.9 56.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.983 1.713 . . . . 0.0 109.293 168.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 52.82 38.36 26.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.915 3.286 . . . . 0.0 112.417 -179.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.39 -12.55 7.94 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.578 2.037 . . . . 0.0 115.058 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 mtm-85 -115.36 168.52 9.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.614 1.566 . . . . 0.0 111.012 177.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -144.98 167.17 15.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.367 1.067 . . . . 0.0 112.798 -172.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.07 166.13 1.71 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 124.512 3.474 . . . . 0.0 114.59 168.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -39.16 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 128.531 2.733 . . . . 0.0 114.749 -174.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.35 3.16 81.81 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.49 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.9 mmt -80.03 161.95 25.13 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.368 1.584 . . . . 0.0 110.722 173.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.54 129.51 54.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.85 1.26 . . . . 0.0 110.639 -172.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.28 107.92 8.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.305 0.642 . . . . 0.0 109.979 174.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -57.71 148.73 23.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.673 1.189 . . . . 0.0 111.123 170.161 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 127.238 2.215 . . . . 0.0 114.197 169.91 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -126.69 140.44 52.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.891 1.276 . . . . 0.0 112.897 -170.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.6 m -84.09 142.76 30.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.513 1.525 . . . . 0.0 113.257 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.57 -163.66 36.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.863 0.744 . . . . 0.0 113.269 172.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -137.47 166.7 23.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.941 1.696 . . . . 0.0 110.773 174.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.19 -176.62 51.72 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 123.704 0.668 . . . . 0.0 113.257 -174.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.06 -39.92 41.18 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.037 3.825 . . . . 0.0 116.109 -170.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -11.09 58.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.889 1.276 . . . . 0.0 113.501 179.478 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -138.85 -45.61 0.48 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -168.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -169.031 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 CA--C 1.55 0.977 0 CA-C-O 121.658 0.742 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.438 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 30.5 m -92.83 114.85 27.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.839 1.256 . . . . 0.0 108.034 133.111 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.56 95.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.733 2.013 . . . . 0.0 110.877 -166.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? 48.14 30.86 2.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.075 0.95 . . . . 0.0 112.244 -166.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -6.47 77.66 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 126.856 2.17 . . . . 0.0 116.01 -175.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 167.9 12.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.232 2.016 . . . . 0.0 111.094 175.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -139.93 141.76 28.39 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.785 0.834 . . . . 0.0 112.545 175.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.57 172.92 9.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.985 3.124 . . . . 0.0 112.171 177.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t 43.66 39.57 2.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.943 2.097 . . . . 0.0 116.245 165.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.66 31.68 60.76 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.919 1.247 . . . . 0.0 113.95 -176.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.2 mtt -76.82 163.64 26.58 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.817 1.308 . . . . 0.0 110.39 164.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.0 m -115.42 145.95 42.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.615 1.966 . . . . 0.0 109.814 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -80.32 110.93 16.22 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.284 0.634 . . . . 0.0 111.105 177.118 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.7 p -71.37 166.3 21.95 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -176.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 128.22 2.608 . . . . 0.0 115.433 163.899 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 CA-C-O 119.894 -0.392 . . . . 0.0 113.242 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.03 131.25 53.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.332 2.253 . . . . 0.0 110.274 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m -62.63 143.23 57.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.534 0.606 . . . . 0.0 112.508 168.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.67 -159.95 15.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.121 1.82 . . . . 0.0 111.538 168.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -133.89 166.3 23.0 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.167 1.483 . . . . 0.0 112.355 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.5 170.95 29.14 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.312 1.434 . . . . 0.0 113.352 -175.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -48.37 -41.17 36.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.155 3.236 . . . . 0.0 113.888 -178.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -27.06 16.85 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.991 2.116 . . . . 0.0 114.208 177.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -119.15 -8.81 10.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.317 1.447 . . . . 0.0 113.459 177.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.568 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.1 m -65.64 100.88 0.56 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.008 -0.433 . . . . 0.0 110.93 178.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.14 89.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 128.527 2.731 . . . . 0.0 110.004 -170.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.3 mmp_? 40.38 46.68 2.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.669 1.988 . . . . 0.0 111.242 -164.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.06 -10.84 71.53 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.848 2.166 . . . . 0.0 115.453 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -96.69 163.75 12.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.747 1.774 . . . . 0.0 111.432 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.4 m -144.15 162.59 39.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.045 1.338 . . . . 0.0 110.541 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -54.5 157.06 12.69 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 124.084 3.19 . . . . 0.0 114.723 175.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.17 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.034 2.134 . . . . 0.0 113.379 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.04 64.08 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.668 -1.074 . . . . 0.0 114.845 178.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 44.0 mtt -83.33 166.48 18.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.077 1.438 . . . . 0.0 111.553 165.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.73 140.33 50.1 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.481 1.512 . . . . 0.0 110.313 173.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.21 109.06 6.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 163.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.8 p -75.81 160.52 29.88 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.776 0.798 . . . . 0.0 112.944 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 125.971 1.709 . . . . 0.0 113.947 175.743 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.186 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -127.94 145.94 50.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.278 1.039 . . . . 0.0 112.485 -174.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.5 m -76.88 151.77 35.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.923 1.689 . . . . 0.0 112.536 176.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.48 -167.38 40.52 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.604 0.621 . . . . 0.0 113.544 168.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -132.4 169.0 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.897 1.679 . . . . 0.0 112.142 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.55 -179.02 34.32 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 123.849 0.738 . . . . 0.0 113.651 -178.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.45 -29.52 31.65 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.535 3.49 . . . . 0.0 116.157 -173.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.29 -8.16 54.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 116.737 -1.601 . . . . 0.0 115.157 177.117 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -147.15 -39.32 0.2 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 125.439 1.496 . . . . 0.0 114.47 -159.658 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 CA--C 1.555 1.164 0 CA-C-O 121.83 0.824 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.96 107.94 12.07 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 124.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.75 99.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.623 2.369 . . . . 0.0 110.717 -169.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 41.39 43.04 2.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.345 1.458 . . . . 0.0 112.791 -170.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.16 -3.45 60.11 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.45 2.452 . . . . 0.0 115.262 178.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -128.41 -175.53 3.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.175 1.487 . . . . 0.0 112.516 -165.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.56 169.95 8.51 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.427 1.891 . . . . 0.0 107.551 160.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.5 164.61 15.08 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.84 2.36 . . . . 0.0 114.08 173.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -54.76 104.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.217 1.807 . . . . 0.0 111.648 177.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.94 -2.85 24.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.753 1.168 . . . . 0.0 114.296 -177.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -113.43 169.41 8.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.912 1.356 . . . . 0.0 109.938 170.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -141.58 157.11 45.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 0.0 112.337 -172.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.46 112.15 24.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.619 1.568 . . . . 0.0 111.663 -172.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.5 p -67.31 164.19 18.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -173.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 129.159 2.983 . . . . 0.0 115.706 162.648 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.297 0 CA-C-O 119.528 -0.596 . . . . 0.0 113.598 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.4 130.02 53.36 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.52 1.928 . . . . 0.0 109.649 177.682 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.5 p -93.38 159.83 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -176.378 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.2 -149.33 9.78 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.368 1.937 . . . . 0.0 111.488 -167.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -135.72 159.4 41.75 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 118.971 1.385 . . . . 0.0 112.526 -176.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.44 174.86 46.67 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.592 1.091 . . . . 0.0 113.626 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -45.49 -46.53 14.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.686 3.591 . . . . 0.0 114.673 -172.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -55.56 -24.4 32.23 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.511 1.924 . . . . 0.0 114.295 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -109.6 -27.54 9.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.362 1.865 . . . . 0.0 113.089 175.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.79 1.236 . . . . 0.0 113.87 -176.155 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.67 -102.47 1.3 Allowed Glycine 0 C--O 1.221 -0.676 0 N-CA-C 105.586 -3.006 . . . . 0.0 105.586 -149.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -65.56 148.37 51.84 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.292 1.546 . . . . 0.0 112.247 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.8 m -75.55 101.37 4.87 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.239 -0.913 . . . . 0.0 108.943 155.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.39 105.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.306 1.042 . . . . 0.0 110.179 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.9 27.2 4.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.167 0.987 . . . . 0.0 111.231 -169.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.88 -4.52 81.74 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.412 1.958 . . . . 0.0 115.65 -174.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 167.29 13.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 2.004 . . . . 0.0 112.488 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.1 m -134.23 154.89 80.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.813 2.045 . . . . 0.0 110.448 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.36 176.68 9.76 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.151 2.567 . . . . 0.0 111.646 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -29.7 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 129.431 3.092 . . . . 0.0 115.416 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.12 3.57 81.78 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.047 -1.418 . . . . 0.0 116.02 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -77.0 169.16 18.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.139 1.969 . . . . 0.0 112.173 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 m -132.62 157.92 43.56 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.811 1.645 . . . . 0.0 111.192 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -112.14 116.2 30.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.673 1.189 . . . . 0.0 112.403 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.1 p -68.98 163.48 24.49 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.359 1.464 . . . . 0.0 113.624 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -57.75 -18.24 20.27 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 113.944 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.5 19.15 78.85 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 118.497 0.589 . . . . 0.0 112.663 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.48 135.62 51.79 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 110.654 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.4 t -109.68 137.62 47.22 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.434 2.294 . . . . 0.0 111.409 -169.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.8 -160.88 24.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.321 1.439 . . . . 0.0 111.478 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -133.17 126.31 31.37 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.772 0.829 . . . . 0.0 109.665 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.94 178.09 22.0 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.579 1.085 . . . . 0.0 112.754 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -48.04 -53.93 5.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.839 3.693 . . . . 0.0 114.521 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.69 -8.69 55.67 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -100.24 -51.69 3.59 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.041 0.937 . . . . 0.0 111.124 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.1 m -95.71 -22.46 17.53 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.254 1.022 . . . . 0.0 113.689 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.97 -132.38 7.66 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 158.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.741 1.616 . . . . 0.0 110.066 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.426 ' C ' ' H ' ' A' ' 3' ' ' GLU 0.268 12.3 p . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.971 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.17 35.9 0.93 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.034 1.778 . . . . 0.0 113.343 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 1' ' ' VAL . 0.0 OUTLIER 154.2 139.42 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 1 C-N-CA 133.881 4.872 . . . . 0.0 107.841 -157.442 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.5 m -72.21 117.83 14.34 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.587 -1.321 . . . . 0.0 109.287 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 85.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 129.205 3.002 . . . . 0.0 110.307 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.5 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 40.39 42.75 1.33 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.194 2.198 . . . . 0.0 111.211 -161.948 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -13.65 66.12 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.579 2.037 . . . . 0.0 116.235 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.36 174.68 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.2 2.0 . . . . 0.0 111.01 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 m -141.12 163.9 39.2 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.536 1.134 . . . . 0.0 110.792 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.57 168.77 1.42 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 124.255 3.304 . . . . 0.0 114.668 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.8 m -44.46 100.11 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.402 2.281 . . . . 0.0 114.258 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.26 -1.62 84.58 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.722 1.153 . . . . 0.0 115.191 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -80.5 161.58 24.77 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.749 1.275 . . . . 0.0 110.966 168.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.9 m -138.2 156.12 48.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.383 1.473 . . . . 0.0 110.862 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -89.01 114.06 25.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.745 1.218 . . . . 0.0 111.379 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 4.8 t -70.73 168.22 17.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 113.233 177.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.73 -4.81 2.26 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.359 1.864 . . . . 0.0 115.43 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.23 33.87 27.79 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.269 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -123.51 149.46 45.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.195 1.798 . . . . 0.0 111.538 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -94.97 149.98 20.65 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.14 -165.16 37.79 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.564 1.078 . . . . 0.0 112.081 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -135.0 167.43 20.95 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.514 1.526 . . . . 0.0 111.591 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.62 -174.65 48.56 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.807 0.718 . . . . 0.0 113.101 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.9 -36.12 26.23 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.025 3.817 . . . . 0.0 116.151 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.61 -9.35 58.48 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -139.25 -44.85 0.46 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -170.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.65 4.05 0.87 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -173.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.91 -45.06 2.67 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.628 -1.295 . . . . 0.0 112.346 -166.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.226 0 CA-C-O 115.803 -2.046 . . . . 0.0 113.907 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.456 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 9.5 p . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.51 10.41 73.6 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.464 -1.186 . . . . 0.0 114.931 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' CD ' ' H2 ' ' A' ' 1' ' ' VAL . 49.1 mp0 -48.0 106.58 0.1 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.697 1.999 . . . . 0.0 111.356 173.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.8 m -50.39 154.19 1.34 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.517 1.127 . . . . 0.0 113.852 -163.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.05 70.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 123.573 1.654 . . . . 0.0 108.756 172.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? 33.33 50.23 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 1 C-N-CA 132.41 4.284 . . . . 0.0 112.559 -172.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.18 -17.92 10.44 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 127.295 2.379 . . . . 0.0 114.943 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.52 164.7 12.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.274 1.537 . . . . 0.0 111.493 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.1 m -144.7 168.11 13.09 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.364 1.466 . . . . 0.0 111.34 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.69 156.8 8.41 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.966 3.111 . . . . 0.0 114.211 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -52.85 97.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.746 2.018 . . . . 0.0 113.302 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.36 39.65 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.916 1.245 . . . . 0.0 114.85 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -94.07 167.79 11.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.801 1.301 . . . . 0.0 111.506 168.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.4 143.5 48.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.453 1.501 . . . . 0.0 110.681 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -83.08 109.02 16.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.449 0.7 . . . . 0.0 110.199 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.0 p -70.6 164.32 25.14 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -57.56 -17.4 13.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.173 1.389 . . . . 0.0 114.582 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . 0.485 ' C7 ' ' HZ3' ' A' ' 26' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.11 17.59 80.22 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.84 0.733 . . . . 0.0 112.935 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -114.49 131.67 56.55 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.856 1.663 . . . . 0.0 110.228 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.8 m -73.57 152.67 40.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.965 1.306 . . . . 0.0 112.63 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.62 -167.18 40.23 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.098 0.856 . . . . 0.0 111.987 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.41 167.28 21.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 110.905 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.86 -172.96 54.6 Favored Glycine 0 CA--C 1.54 1.595 0 O-C-N 121.9 -0.5 . . . . 0.0 113.565 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -42.4 -48.05 7.01 Favored 'Trans proline' 0 C--N 1.351 0.689 1 C-N-CA 125.925 4.417 . . . . 0.0 116.915 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.485 ' HZ3' ' C7 ' ' A' ' 18' ' ' NAL . 29.6 mtpp -70.94 -9.36 57.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -134.71 -60.73 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.915 0.886 . . . . 0.0 112.178 -168.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 96.8 m -117.36 -1.15 11.82 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.313 1.845 . . . . 0.0 112.907 -172.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.39 -42.46 1.95 Allowed Glycine 0 CA--C 1.537 1.467 0 O-C-N 120.886 -1.134 . . . . 0.0 113.154 -170.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.197 0 C-N-CA 127.426 2.29 . . . . 0.0 111.754 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.23 -52.47 1.41 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -156.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -155.62 -176.29 5.88 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 127.665 2.386 . . . . 0.0 111.101 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.8 m -87.09 126.24 34.64 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 138.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.71 92.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.585 2.354 . . . . 0.0 110.664 -168.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 37.74 46.04 0.7 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.32 1.848 . . . . 0.0 112.266 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.08 -10.29 65.7 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.0 2.238 . . . . 0.0 115.554 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -103.19 179.14 4.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.457 1.629 . . . . 0.0 112.669 -173.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 m -138.8 158.9 69.19 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.342 1.857 . . . . 0.0 110.423 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.96 163.05 39.86 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.562 2.175 . . . . 0.0 111.485 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.4 p -56.77 93.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.519 1.928 . . . . 0.0 112.78 -173.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.6 -11.91 10.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.499 1.523 . . . . 0.0 114.604 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -91.31 169.39 10.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.793 1.796 . . . . 0.0 111.883 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 p -142.8 164.56 29.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.514 1.526 . . . . 0.0 111.762 -174.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.0 t -120.36 111.12 17.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.359 1.064 . . . . 0.0 112.352 -157.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -69.73 161.95 28.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 113.917 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -61.88 -22.11 65.28 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.209 1.004 . . . . 0.0 113.625 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.42 40.46 39.86 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.83 114.78 17.67 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.475 1.51 . . . . 0.0 110.636 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.4 t -78.74 148.32 33.07 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.463 0.705 . . . . 0.0 111.682 178.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.61 -152.26 13.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.992 1.758 . . . . 0.0 110.641 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -138.9 160.09 40.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.833 0.853 . . . . 0.0 110.915 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.31 172.2 13.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.044 1.783 . . . . 0.0 111.515 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.56 -34.27 75.62 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.882 2.388 . . . . 0.0 112.409 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.519 ' HZ3' ' C ' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -71.77 -11.11 60.66 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 175.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -106.5 -45.36 4.27 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.995 1.318 . . . . 0.0 110.997 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.0 m -91.13 -16.98 26.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.618 1.167 . . . . 0.0 112.886 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.89 165.64 17.61 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 152.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.519 ' C ' ' HZ3' ' A' ' 26' ' ' LYS . 2.7 tpm_? . . . . . 0 C--O 1.245 0.831 0 O-C-N 122.363 -0.492 . . . . 0.0 112.019 -175.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.1 -50.83 2.37 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -161.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -150.73 -176.7 5.62 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.251 1.82 . . . . 0.0 110.622 166.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.4 m -94.26 110.08 21.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.909 1.684 . . . . 0.0 106.51 136.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.79 101.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.773 1.629 . . . . 0.0 111.373 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 48.51 27.05 1.32 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.405 1.482 . . . . 0.0 112.917 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.51 -15.74 14.7 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.37 2.414 . . . . 0.0 116.644 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.46 171.22 14.44 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.074 2.437 . . . . 0.0 112.917 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -146.86 156.17 47.82 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 123.105 0.562 . . . . 0.0 112.338 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.98 177.94 8.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.041 3.161 . . . . 0.0 112.996 -172.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.8 p 59.68 24.54 13.41 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.86 96.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.489 1.043 . . . . 0.0 112.704 -169.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.6 mtt -69.47 169.95 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.224 1.012 . . . . 0.0 110.739 160.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -140.4 155.43 46.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.143 1.777 . . . . 0.0 110.744 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -94.13 121.77 35.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.11 1.364 . . . . 0.0 113.212 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p -72.14 152.39 42.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.423 -0.798 . . . . 0.0 111.504 166.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 pm0 -58.0 -14.42 6.48 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.345 1.858 . . . . 0.0 114.187 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.73 18.93 69.22 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.318 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -121.17 122.33 39.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.154 1.781 . . . . 0.0 109.426 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.97 164.52 19.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.72 -151.11 10.08 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.8 2.143 . . . . 0.0 110.435 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -137.37 156.61 48.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.943 1.297 . . . . 0.0 110.335 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.45 -167.4 23.47 Favored Glycine 0 CA--C 1.542 1.76 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.49 4.94 2.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.857 3.705 . . . . 0.0 115.675 -164.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 4.49 9.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.697 1.999 . . . . 0.0 112.608 176.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.8 -44.03 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.122 1.769 . . . . 0.0 111.878 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m -90.6 -59.44 2.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.841 1.656 . . . . 0.0 107.927 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.48 168.94 34.09 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 157.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 116.399 -1.762 . . . . 0.0 111.442 -171.656 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 81.5 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.49 114.37 2.58 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 131.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 68.52 132.28 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.594 2.357 . . . . 0.0 112.842 -160.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -60.11 101.73 0.14 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -57.28 96.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 128.281 2.632 . . . . 0.0 110.865 -164.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? 48.79 29.55 2.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -167.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.46 -2.61 67.93 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.222 2.344 . . . . 0.0 116.23 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 165.91 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.272 2.036 . . . . 0.0 111.887 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m -141.57 130.83 12.5 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.999 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -80.6 168.79 17.59 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.635 2.89 . . . . 0.0 112.779 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p 55.06 28.13 10.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.21 35.55 60.44 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.92 1.248 . . . . 0.0 113.32 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -67.99 167.11 14.44 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.387 1.093 . . . . 0.0 110.501 162.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.41 135.22 54.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.96 2.104 . . . . 0.0 108.874 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 t -75.56 137.33 40.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.04 0.536 . . . . 0.0 110.558 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -117.68 163.93 15.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 113.969 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -57.88 -23.9 55.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.622 1.569 . . . . 0.0 113.063 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . 0.496 ' C7 ' ' HZ2' ' A' ' 26' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.07 11.04 85.11 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 125.478 1.513 . . . . 0.0 113.39 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -121.84 155.71 34.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.94 1.696 . . . . 0.0 110.692 -168.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -86.62 156.03 20.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.824 0.85 . . . . 0.0 111.794 170.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.01 -174.12 41.38 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.832 1.206 . . . . 0.0 110.162 159.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -124.51 149.46 46.88 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.721 1.261 . . . . 0.0 110.557 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 179.12 52.17 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 123.523 0.582 . . . . 0.0 113.422 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.44 -20.13 61.12 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 114.444 -166.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.496 ' HZ2' ' C7 ' ' A' ' 18' ' ' NAL . 0.7 OUTLIER -55.51 -21.41 16.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.992 1.317 . . . . 0.0 113.183 170.079 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -133.15 -42.76 0.87 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.426 1.49 . . . . 0.0 111.451 -173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m -69.93 -12.38 61.57 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.04 -0.6 76.81 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 118.355 -1.247 . . . . 0.0 113.987 163.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.264 0.8 OUTLIER . . . . . 0 C--O 1.248 1.025 0 C-N-CA 129.473 3.109 . . . . 0.0 113.174 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.55 -45.89 2.73 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.156 0.884 . . . . 0.0 113.029 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -158.76 169.02 25.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.016 1.326 . . . . 0.0 111.169 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.7 m -100.86 109.95 21.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.759 1.624 . . . . 0.0 107.361 139.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -53.39 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.831 2.452 . . . . 0.0 110.747 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 48.85 27.08 1.47 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.815 2.046 . . . . 0.0 113.549 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.23 -11.03 33.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.946 2.212 . . . . 0.0 115.008 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 170.8 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.096 1.948 . . . . 0.0 112.657 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.6 m -136.4 167.68 20.5 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.967 1.307 . . . . 0.0 110.493 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.96 146.15 17.48 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.706 2.938 . . . . 0.0 112.568 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.7 m -66.31 82.28 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.137 1.375 . . . . 0.0 112.177 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.26 -17.57 2.7 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.326 1.917 . . . . 0.0 113.674 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mmt -80.29 177.04 9.24 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.658 1.229 . . . . 0.0 111.457 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.9 m -127.0 163.83 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.177 2.191 . . . . 0.0 110.124 169.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.51 118.88 37.81 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.73 1.212 . . . . 0.0 110.55 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.7 p -71.21 166.94 20.45 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -51.75 -8.82 0.07 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.22 2.608 . . . . 0.0 115.297 162.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.82 23.98 77.27 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.02 0.827 . . . . 0.0 113.235 -172.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -120.59 133.97 55.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.237 2.615 . . . . 0.0 110.397 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 71.1 m -65.59 155.79 34.71 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.01 -160.13 29.84 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.139 1.828 . . . . 0.0 111.534 170.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.29 174.06 10.89 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.486 1.143 . . . . 0.0 111.207 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.93 169.98 42.3 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 124.656 1.122 . . . . 0.0 112.05 -166.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.37 -36.95 85.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.979 2.453 . . . . 0.0 112.358 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -55.6 -24.06 30.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.323 1.849 . . . . 0.0 114.16 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.9 -1.25 12.61 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.902 1.281 . . . . 0.0 113.502 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.08 -4.42 6.25 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.57 -49.54 0.04 OUTLIER Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.68 1.032 . . . . 0.0 115.68 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.381 0 CA-C-N 119.083 1.441 . . . . 0.0 112.957 -169.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.07 113.34 0.83 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -151.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -42.04 144.59 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.818 1.647 . . . . 0.0 111.559 170.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.5 m -65.45 90.48 0.11 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 157.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.7 t -55.49 93.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 128.457 2.703 . . . . 0.0 111.068 -160.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 46.36 36.88 3.68 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.879 1.672 . . . . 0.0 112.796 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.69 -6.83 11.28 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.212 2.339 . . . . 0.0 117.516 171.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.24 167.42 20.4 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.998 2.399 . . . . 0.0 114.793 -170.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.6 m -132.12 161.79 60.68 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.419 . . . . 0.0 110.584 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.9 154.89 15.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.731 2.954 . . . . 0.0 113.364 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -49.91 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.98 2.112 . . . . 0.0 114.032 -173.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.17 -7.77 58.74 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.049 1.309 . . . . 0.0 114.85 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.1 mtp -76.77 161.61 28.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.52 1.66 . . . . 0.0 110.383 166.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.3 m -126.43 121.01 31.22 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.898 0.879 . . . . 0.0 110.511 -161.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.71 107.13 3.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.121 0.968 . . . . 0.0 110.748 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -73.26 156.1 38.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.297 0.57 . . . . 0.0 112.247 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.0 pm0 -56.89 -17.97 11.46 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.575 1.95 . . . . 0.0 114.329 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.2 16.66 53.15 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.658 1.123 . . . . 0.0 113.969 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -129.41 136.25 49.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.455 1.102 . . . . 0.0 112.124 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.9 m -71.76 157.69 37.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.915 1.686 . . . . 0.0 112.541 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.65 -163.63 33.48 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.106 0.86 . . . . 0.0 112.927 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -141.7 170.73 15.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.911 2.084 . . . . 0.0 108.445 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.83 -171.59 50.19 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 118.565 0.621 . . . . 0.0 113.879 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.49 -38.64 72.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.316 2.678 . . . . 0.0 114.825 -161.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.425 ' HE3' ' CZ ' ' A' ' 27' ' ' TYR . 3.3 ttpp -73.45 -2.57 23.02 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.425 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 72.5 m-85 -140.26 -34.56 0.53 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -171.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.85 1.77 0.79 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.91 -61.3 2.55 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 121.053 -1.029 . . . . 0.0 111.16 -164.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? . . . . . 0 C--O 1.257 1.466 0 C-N-CA 126.673 1.989 . . . . 0.0 110.948 179.128 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 117.451 -1.261 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.23 81.95 0.19 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 120.48 1.491 . . . . 0.0 113.421 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -53.26 154.84 3.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.994 1.317 . . . . 0.0 113.976 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 m -69.87 95.04 0.88 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -62.63 89.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.863 2.065 . . . . 0.0 111.366 -161.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? 57.69 26.58 13.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.188 1.795 . . . . 0.0 113.336 -166.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.01 -13.68 5.76 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.197 1.38 . . . . 0.0 116.44 166.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.31 170.53 14.94 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.795 1.797 . . . . 0.0 113.685 -171.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.2 m -128.1 161.75 54.24 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.287 1.835 . . . . 0.0 110.991 -173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.59 159.37 53.0 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.822 2.348 . . . . 0.0 112.184 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.6 p -60.14 92.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.822 . . . . 0.0 112.104 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -15.86 4.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.44 1.495 . . . . 0.0 113.725 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -112.49 164.66 13.03 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.739 1.27 . . . . 0.0 111.293 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.2 m -132.13 148.82 52.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.919 1.688 . . . . 0.0 109.92 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -82.58 148.44 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.148 0.579 . . . . 0.0 111.654 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.3 p -118.26 163.09 17.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.718 1.207 . . . . 0.0 113.313 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -59.15 -17.76 29.99 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.551 1.54 . . . . 0.0 113.819 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.71 12.68 81.19 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.415 1.007 . . . . 0.0 113.353 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -124.02 144.86 49.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.608 1.163 . . . . 0.0 112.121 -169.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -82.32 156.24 24.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.963 1.305 . . . . 0.0 112.429 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.54 -164.6 36.3 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.63 0.634 . . . . 0.0 113.349 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -136.36 172.05 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.425 1.89 . . . . 0.0 110.695 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.55 -177.67 53.46 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 123.9 0.762 . . . . 0.0 113.554 -168.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.08 -48.59 14.31 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.261 3.974 . . . . 0.0 115.096 -172.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.75 -13.68 11.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.091 1.756 . . . . 0.0 115.632 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -135.07 -37.15 0.8 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.424 1.011 . . . . 0.0 113.317 -168.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.98 9.2 0.87 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.44 -57.97 3.32 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 120.936 -1.103 . . . . 0.0 111.051 -165.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.4 tpt85 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 116.089 -1.91 . . . . 0.0 111.873 168.39 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.87 108.13 0.64 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -156.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -58.67 146.83 34.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 117.44 0.62 . . . . 0.0 111.44 173.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -72.19 93.38 1.45 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.724 -0.61 . . . . 0.0 110.905 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.0 89.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 128.346 2.658 . . . . 0.0 111.215 -168.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? 38.06 41.74 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.699 2.8 . . . . 0.0 112.21 -163.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.27 34.23 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 128.211 2.815 . . . . 0.0 116.095 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -89.74 160.03 16.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.2 2.0 . . . . 0.0 112.031 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.3 m -140.77 161.7 52.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.577 1.151 . . . . 0.0 111.164 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.44 168.36 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.373 3.382 . . . . 0.0 115.057 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.7 m -43.79 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.889 2.476 . . . . 0.0 114.059 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.38 7.41 87.9 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.049 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.8 mtt -84.22 166.13 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.059 1.429 . . . . 0.0 111.964 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.1 m -123.99 152.7 42.24 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.762 1.625 . . . . 0.0 109.823 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.42 154.37 38.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.932 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 p -133.92 174.78 10.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -64.35 -17.62 63.89 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -154.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.12 22.33 38.65 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.73 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -129.17 139.77 51.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.392 1.096 . . . . 0.0 112.651 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.2 m -79.63 159.44 26.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.381 2.272 . . . . 0.0 113.629 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.62 -166.83 39.25 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 123.938 0.78 . . . . 0.0 113.977 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -129.29 165.57 21.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.32 1.848 . . . . 0.0 111.139 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.75 -178.51 53.24 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 123.536 0.589 . . . . 0.0 113.707 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.64 -33.26 58.26 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.65 3.566 . . . . 0.0 116.297 -171.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -14.89 63.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 113.406 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -137.58 -48.88 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.02 0.827 . . . . 0.0 113.222 -171.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.4 t -138.15 -4.74 1.69 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -156.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.04 -63.07 3.59 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.563 1.078 . . . . 0.0 110.701 -166.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.261 0.0 OUTLIER . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.32 1.848 . . . . 0.0 110.999 168.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.25 -75.14 0.51 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.061 1.315 . . . . 0.0 114.686 172.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -170.03 164.12 9.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.238 2.215 . . . . 0.0 108.957 -176.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.86 99.59 9.12 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 143.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -57.94 93.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.319 1.847 . . . . 0.0 111.454 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 42.73 36.98 0.92 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.148 1.779 . . . . 0.0 112.452 -164.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.11 66.22 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.407 2.432 . . . . 0.0 116.01 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.98 170.87 9.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.219 2.009 . . . . 0.0 112.685 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.99 152.47 55.14 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.414 2.286 . . . . 0.0 109.327 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.6 166.04 6.96 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.731 2.954 . . . . 0.0 113.858 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -47.35 105.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.149 2.18 . . . . 0.0 113.591 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.23 4.28 89.74 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.968 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.2 mtt -90.42 163.95 14.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.885 1.342 . . . . 0.0 111.417 170.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -133.42 133.45 42.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.139 1.375 . . . . 0.0 111.137 -165.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.52 140.67 44.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.528 . . . . 0.0 110.53 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.0 p -117.04 163.36 16.35 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.543 1.137 . . . . 0.0 113.472 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 -58.15 -18.25 24.24 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.066 1.746 . . . . 0.0 113.825 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.88 17.84 79.43 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.11 0.862 . . . . 0.0 113.132 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -126.18 136.02 52.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.264 1.826 . . . . 0.0 111.101 -168.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.53 150.98 32.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.149 0.98 . . . . 0.0 112.481 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.48 -162.14 31.41 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.336 0.97 . . . . 0.0 113.248 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -138.35 167.26 22.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.233 1.413 . . . . 0.0 112.546 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.15 -174.89 40.11 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.428 0.537 . . . . 0.0 113.442 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.6 -32.18 27.05 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.91 3.74 . . . . 0.0 116.523 -172.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -6.98 50.35 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 116.85 -1.548 . . . . 0.0 115.118 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -144.38 -38.57 0.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.52 -24.05 0.96 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.42 6.44 48.46 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 119.331 -0.705 . . . . 0.0 113.952 -159.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.473 0 CA-C-O 116.079 -1.915 . . . . 0.0 113.347 -163.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.22 114.54 3.67 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -154.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -37.35 136.86 0.44 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.977 2.111 . . . . 0.0 113.949 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.2 m -64.88 96.2 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 158.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.1 t -51.89 93.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.99 2.516 . . . . 0.0 111.794 -159.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 38.44 36.18 0.12 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.722 2.009 . . . . 0.0 113.156 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -4.39 31.14 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 128.531 2.967 . . . . 0.0 116.751 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 167.56 12.69 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 121.214 2.507 . . . . 0.0 113.592 176.463 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.35 152.0 52.65 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 126.773 2.029 . . . . 0.0 108.356 166.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.42 168.53 2.85 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.98 3.12 . . . . 0.0 114.321 169.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -47.74 99.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.454 2.302 . . . . 0.0 113.886 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.99 84.06 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.795 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -83.8 169.54 15.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.982 1.391 . . . . 0.0 110.919 163.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.11 164.12 31.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.032 1.733 . . . . 0.0 111.572 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -117.57 112.5 20.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 112.307 -162.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.5 p -68.51 160.17 30.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.384 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pm0 -58.92 -17.0 20.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.528 1.531 . . . . 0.0 114.264 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.21 16.49 80.57 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 118.552 0.615 . . . . 0.0 112.871 -171.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -106.06 130.91 53.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 0.0 110.007 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -78.04 159.85 28.48 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.336 1.455 . . . . 0.0 111.118 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.74 -160.91 32.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.698 1.618 . . . . 0.0 110.852 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -138.67 156.34 47.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.686 -0.891 . . . . 0.0 110.057 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.03 -175.82 41.83 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 123.522 0.582 . . . . 0.0 114.121 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.5 -47.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.046 3.831 . . . . 0.0 115.482 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -74.56 -0.27 17.19 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -125.31 -35.67 2.58 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.89 1.276 . . . . 0.0 112.706 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 m -93.87 -25.68 17.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.949 1.3 . . . . 0.0 111.956 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.05 -159.75 23.47 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.638 2.066 . . . . 0.0 109.338 157.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.428 1.491 . . . . 0.0 111.411 176.415 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.429 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 11.7 m . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.93 -49.51 1.43 Allowed Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -159.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -153.07 178.68 9.44 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.641 1.976 . . . . 0.0 111.1 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.407 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 59.4 m -95.15 107.66 19.75 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 137.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -55.63 96.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.555 1.942 . . . . 0.0 111.325 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 39.18 43.02 0.82 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 111.896 -167.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.45 56.13 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.846 2.165 . . . . 0.0 116.506 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -118.12 167.62 11.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.853 2.326 . . . . 0.0 114.047 -170.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.1 m -131.11 164.12 44.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.003 1.321 . . . . 0.0 111.595 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.16 160.37 4.59 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.167 3.245 . . . . 0.0 114.469 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.14 100.04 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.144 2.178 . . . . 0.0 113.382 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.06 2.25 66.52 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.086 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -77.95 172.6 13.25 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.433 1.617 . . . . 0.0 111.844 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.81 159.86 36.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.048 2.139 . . . . 0.0 111.154 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -108.51 114.46 28.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.615 1.566 . . . . 0.0 110.56 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.9 p -67.51 153.19 44.26 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.779 0.799 . . . . 0.0 112.841 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -58.8 -14.25 8.31 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 113.791 168.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.48 17.46 66.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.082 0.848 . . . . 0.0 113.988 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.429 ' CD2' ' HA ' ' A' ' 1' ' ' VAL . 2.0 m-85 -123.41 126.84 47.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.684 1.994 . . . . 0.0 110.528 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.407 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 61.4 m -74.18 158.8 33.5 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.63 -160.71 31.04 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.748 2.118 . . . . 0.0 110.334 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -138.17 143.56 40.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 1.469 . . . . 0.0 111.266 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.37 177.12 20.35 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.291 1.424 . . . . 0.0 112.053 -170.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.5 -38.69 81.48 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.931 2.421 . . . . 0.0 112.628 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -59.96 -10.24 3.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.338 1.455 . . . . 0.0 114.564 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -122.31 -29.54 4.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.188 1.395 . . . . 0.0 113.009 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 36.1 m -87.06 -6.72 58.61 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.108 0.963 . . . . 0.0 112.92 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.84 1.19 1.18 Allowed Glycine 0 CA--C 1.537 1.453 0 N-CA-C 117.746 1.858 . . . . 0.0 117.746 153.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-N 120.316 2.058 . . . . 0.0 112.846 -168.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.37 -148.94 0.86 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 130.191 3.758 . . . . 0.0 113.574 -8.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -51.67 164.81 0.21 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.868 0.867 . . . . 0.0 112.504 168.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -66.24 117.17 8.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 152.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.07 94.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.322 2.249 . . . . 0.0 110.721 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? 42.64 35.7 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.052 0.941 . . . . 0.0 112.458 -161.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.32 -6.05 63.23 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 126.4 1.953 . . . . 0.0 116.384 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.71 170.78 9.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.418 2.109 . . . . 0.0 112.96 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.5 m -139.14 157.45 71.15 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.472 1.909 . . . . 0.0 108.701 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.5 162.87 37.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.662 2.241 . . . . 0.0 112.263 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -55.34 89.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.695 2.398 . . . . 0.0 113.522 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.96 -8.31 7.65 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.212 1.386 . . . . 0.0 114.715 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 99.2 mtp -98.97 169.6 9.32 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.152 1.476 . . . . 0.0 111.265 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.74 136.5 51.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.773 1.629 . . . . 0.0 111.606 -175.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.8 t -89.19 116.24 27.29 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.106 1.362 . . . . 0.0 109.694 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -73.32 156.09 38.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.232 1.015 . . . . 0.0 113.339 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -58.73 -16.7 17.81 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.862 2.065 . . . . 0.0 113.474 170.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . 0.41 ' C8 ' ' HZ3' ' A' ' 26' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.91 10.68 69.04 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.215 0.912 . . . . 0.0 114.428 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -116.6 141.1 48.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.534 1.134 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.69 153.35 20.79 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.017 1.327 . . . . 0.0 110.877 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.58 -159.75 26.8 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.666 -0.646 . . . . 0.0 112.534 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 0.0 110.179 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.04 178.34 49.95 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.918 0.77 . . . . 0.0 112.863 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.4 -21.69 66.34 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.468 2.779 . . . . 0.0 114.359 -167.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.41 ' HZ3' ' C8 ' ' A' ' 18' ' ' NAL . 0.6 OUTLIER -58.57 -21.55 53.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.137 0.975 . . . . 0.0 113.136 171.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -132.56 -36.64 1.08 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.132 0.973 . . . . 0.0 113.479 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m -85.77 -12.07 51.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 112.072 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.6 62.5 3.14 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.504 1.049 . . . . 0.0 110.901 169.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.363 0 C-N-CA 127.236 2.214 . . . . 0.0 110.368 -167.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.71 -119.1 9.62 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 106.512 -2.635 . . . . 0.0 106.512 -137.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.05 160.9 4.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.502 1.151 . . . . 0.0 112.965 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.03 106.16 1.2 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 150.147 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -52.03 97.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 128.517 2.727 . . . . 0.0 109.913 -168.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 41.9 39.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.74 2.016 . . . . 0.0 112.513 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.96 -6.59 40.53 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 127.029 2.252 . . . . 0.0 115.637 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.33 176.24 5.57 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.962 1.881 . . . . 0.0 113.829 -168.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.1 m -137.51 152.33 72.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 110.742 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.7 169.32 22.52 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 112.12 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.2 t -45.97 110.49 0.27 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.862 1.665 . . . . 0.0 113.257 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 -12.0 68.09 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.57 -1.683 . . . . 0.0 115.671 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -75.4 170.93 15.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.595 2.198 . . . . 0.0 111.38 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -130.35 148.23 52.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.535 1.534 . . . . 0.0 111.106 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -92.92 114.98 27.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.777 1.231 . . . . 0.0 110.438 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.8 p -67.54 163.12 21.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.826 1.298 . . . . 0.0 114.258 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -52.07 -3.04 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.686 2.794 . . . . 0.0 115.545 161.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.7 14.24 81.49 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 119.153 0.888 . . . . 0.0 113.778 -172.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -107.0 149.99 26.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.382 1.473 . . . . 0.0 109.929 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.8 t -118.61 133.74 55.63 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.746 0.818 . . . . 0.0 112.145 -168.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.16 -154.16 10.21 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.527 1.537 . . . . 0.0 111.289 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.29 169.84 16.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.229 1.014 . . . . 0.0 111.594 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.14 169.89 44.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.093 1.33 . . . . 0.0 111.457 -167.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.62 -34.46 92.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.617 2.211 . . . . 0.0 112.121 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -52.72 -33.95 50.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 113.271 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.49 -14.16 15.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.007 1.723 . . . . 0.0 113.712 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.26 -4.83 14.25 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.98 -17.39 0.09 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 163.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.273 0 CA-C-N 119.713 1.757 . . . . 0.0 114.86 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.439 HG21 ' H ' ' A' ' 2' ' ' GLY . 7.1 p . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 116.969 -1.491 . . . . 0.0 108.556 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.439 ' H ' HG21 ' A' ' 1' ' ' VAL . . . -67.36 91.39 0.2 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-N 121.307 1.867 . . . . 0.0 112.214 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -55.8 147.9 17.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.683 1.193 . . . . 0.0 113.108 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.64 104.55 2.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.992 0.517 . . . . 0.0 110.915 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.25 91.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.557 2.343 . . . . 0.0 110.542 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.5 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 43.58 34.63 0.84 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.592 2.357 . . . . 0.0 112.341 -164.043 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 -10.27 56.68 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.324 2.392 . . . . 0.0 116.347 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 160.81 19.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.877 2.339 . . . . 0.0 111.724 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -140.1 134.24 15.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.685 1.194 . . . . 0.0 110.275 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.52 178.38 7.63 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.444 2.763 . . . . 0.0 112.634 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 m 45.42 41.36 6.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.277 2.231 . . . . 0.0 115.423 170.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.53 58.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 113.795 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 79.1 mtm -84.56 164.48 18.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.621 1.211 . . . . 0.0 111.062 168.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 m -112.34 147.31 36.63 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.486 1.914 . . . . 0.0 109.556 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -80.3 112.04 17.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.385 0.674 . . . . 0.0 110.778 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.8 p -66.26 162.64 19.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.867 1.318 . . . . 0.0 113.974 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -52.49 -2.74 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 128.41 2.684 . . . . 0.0 115.558 161.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.39 14.67 79.82 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 119.124 0.874 . . . . 0.0 114.057 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.59 143.05 50.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.211 1.405 . . . . 0.0 111.652 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -76.46 147.16 38.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.388 1.075 . . . . 0.0 112.675 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.68 -162.15 27.72 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.532 1.063 . . . . 0.0 112.175 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -132.14 166.29 22.14 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.187 0.994 . . . . 0.0 111.51 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.53 175.28 37.23 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.527 1.061 . . . . 0.0 113.601 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -47.87 -43.5 29.35 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.298 3.332 . . . . 0.0 114.273 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -58.1 -26.22 62.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.276 1.43 . . . . 0.0 113.91 -176.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -114.31 -14.65 12.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.602 1.561 . . . . 0.0 113.528 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.98 -2.66 9.18 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.89 -73.21 0.02 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.299 0.954 . . . . 0.0 113.842 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 3.3 mmp_? . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.87 2.068 . . . . 0.0 112.457 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 116.86 -1.543 . . . . 0.0 106.964 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.27 93.12 0.51 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 121.46 1.936 . . . . 0.0 108.621 154.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.38 -170.05 0.19 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.333 1.453 . . . . 0.0 111.29 -166.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 40.7 m -74.44 179.74 4.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.575 -1.328 . . . . 0.0 110.491 147.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.32 79.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.208 -1.557 . . . . 0.0 107.613 164.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 45.36 47.04 10.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.246 1.418 . . . . 0.0 112.28 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.26 76.61 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.734 1.159 . . . . 0.0 115.463 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.77 172.6 11.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.659 1.984 . . . . 0.0 109.924 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -141.88 154.8 65.88 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 118.973 0.806 . . . . 0.0 112.894 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.17 173.61 11.61 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.903 3.069 . . . . 0.0 111.773 169.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m 36.0 43.18 0.19 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 129.128 2.971 . . . . 0.0 117.086 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.19 31.08 61.71 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.854 1.216 . . . . 0.0 114.253 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -73.87 165.04 25.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.701 1.75 . . . . 0.0 109.561 159.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.3 m -118.32 115.6 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.462 1.505 . . . . 0.0 109.48 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -74.15 89.16 1.98 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.15 164.79 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.776 1.63 . . . . 0.0 114.275 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -58.51 -21.67 52.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.4 1.48 . . . . 0.0 113.361 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . 0.432 ' C7 ' ' HZ1' ' A' ' 26' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.3 30.1 25.95 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.056 0.836 . . . . 0.0 113.505 -173.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.53 126.52 37.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.952 1.301 . . . . 0.0 111.252 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 69.3 m -67.21 135.91 54.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.252 0.478 . . . . 0.0 111.456 167.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.55 -163.33 17.39 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.622 1.106 . . . . 0.0 112.108 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -132.59 167.0 20.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.443 1.497 . . . . 0.0 110.483 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.43 179.13 34.01 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.683 0.658 . . . . 0.0 113.383 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.51 -28.66 70.57 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.993 2.462 . . . . 0.0 113.442 -171.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.432 ' HZ1' ' C7 ' ' A' ' 18' ' ' NAL . 0.0 OUTLIER -62.6 -12.01 20.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.842 -1.551 . . . . 0.0 114.505 173.698 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.73 -25.93 1.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.77 -11.44 23.37 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 113.633 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.04 72.11 2.32 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 166.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.236 0 CA-C-O 115.788 -2.053 . . . . 0.0 113.09 -163.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.486 1.346 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.21 107.74 3.0 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -160.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -35.31 133.03 0.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.975 2.11 . . . . 0.0 114.682 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -61.56 101.65 0.2 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.26 95.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.488 2.315 . . . . 0.0 110.0 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? 47.05 34.41 2.81 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.893 1.277 . . . . 0.0 111.729 -167.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.2 68.46 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 126.982 2.229 . . . . 0.0 116.276 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.27 163.95 15.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.448 2.124 . . . . 0.0 111.682 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -138.38 158.29 70.92 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.804 1.241 . . . . 0.0 110.772 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.66 168.24 25.27 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.872 2.382 . . . . 0.0 112.687 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -43.71 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.249 2.619 . . . . 0.0 114.586 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -7.15 59.48 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.196 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -79.0 170.4 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.791 1.795 . . . . 0.0 111.875 170.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -139.14 163.29 32.82 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.892 2.077 . . . . 0.0 110.542 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -109.54 114.96 29.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.823 1.249 . . . . 0.0 112.091 -166.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.55 157.95 34.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.002 1.321 . . . . 0.0 112.862 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pm0 -54.27 -24.69 19.87 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.599 1.16 . . . . 0.0 113.484 169.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.83 17.62 74.61 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.736 0.698 . . . . 0.0 113.798 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -114.84 143.76 44.6 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 112.684 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.65 157.56 31.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.551 1.141 . . . . 0.0 112.066 167.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.51 -160.89 34.66 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.281 1.896 . . . . 0.0 109.77 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -142.93 163.06 33.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.514 0.657 . . . . 0.0 110.803 169.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.71 179.11 25.72 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.696 1.141 . . . . 0.0 112.928 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.87 -8.46 23.55 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.902 3.068 . . . . 0.0 114.867 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.21 -2.12 50.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.7 1.6 . . . . 0.0 113.661 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.37 -44.91 1.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.873 1.669 . . . . 0.0 111.767 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.5 m -93.46 -7.17 45.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.88 1.672 . . . . 0.0 111.913 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.51 -173.71 13.4 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 127.742 2.592 . . . . 0.0 109.254 165.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.178 0 C-N-CA 124.778 1.231 . . . . 0.0 110.295 175.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.9 99.04 2.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -159.4 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -51.13 139.76 17.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.89 1.276 . . . . 0.0 114.075 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.5 m -68.49 103.33 1.64 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.324 0.649 . . . . 0.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -54.54 89.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 128.73 2.812 . . . . 0.0 111.524 -172.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.501 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 37.66 40.09 0.23 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.726 2.81 . . . . 0.0 112.785 -162.432 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.68 -7.46 27.93 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 126.429 1.966 . . . . 0.0 116.559 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -112.45 166.55 11.21 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.573 2.187 . . . . 0.0 113.574 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -142.17 167.07 17.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.331 1.852 . . . . 0.0 110.828 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -54.04 155.53 14.88 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.729 2.953 . . . . 0.0 114.223 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.9 t -62.28 74.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.392 2.277 . . . . 0.0 113.914 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.04 -10.41 2.55 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.026 1.774 . . . . 0.0 114.533 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.0 171.76 10.06 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.261 1.425 . . . . 0.0 111.31 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -123.01 149.69 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.102 1.761 . . . . 0.0 110.101 169.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.94 118.46 21.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.846 0.859 . . . . 0.0 109.974 166.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -78.88 159.22 27.87 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.863 0.839 . . . . 0.0 112.795 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 -58.83 -16.41 17.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.791 1.637 . . . . 0.0 113.872 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . 0.446 ' C6 ' ' HZ3' ' A' ' 26' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.66 9.88 82.38 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.554 1.073 . . . . 0.0 113.743 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.7 140.03 50.58 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.439 1.096 . . . . 0.0 111.823 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m -73.17 153.15 40.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.624 1.569 . . . . 0.0 112.53 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 -170.5 43.64 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.62 0.629 . . . . 0.0 113.953 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -128.45 165.78 20.0 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.323 2.249 . . . . 0.0 110.299 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.89 179.98 52.79 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.069 0.842 . . . . 0.0 113.295 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.67 -26.8 39.35 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 124.585 3.523 . . . . 0.0 116.235 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.446 ' HZ3' ' C6 ' ' A' ' 18' ' ' NAL . 1.5 mmpt? -71.61 -10.93 60.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -143.95 -52.02 0.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -142.08 7.09 1.79 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.729 1.612 . . . . 0.0 114.142 -159.135 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.94 -53.97 3.0 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.867 1.222 . . . . 0.0 112.79 -175.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.921 0 C-N-CA 126.747 2.019 . . . . 0.0 113.459 176.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.425 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 17.7 m . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.96 -48.84 1.72 Allowed Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -162.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -154.07 -177.15 6.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.259 1.824 . . . . 0.0 112.547 171.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.435 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 20.2 m -99.66 146.7 26.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.459 1.504 . . . . 0.0 110.802 141.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -69.09 91.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.47 1.508 . . . . 0.0 110.016 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.68 25.84 1.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.814 -168.276 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.89 39.97 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.588 1.566 . . . . 0.0 116.54 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.29 166.19 11.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.22 2.01 . . . . 0.0 112.16 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -145.49 163.56 31.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.935 -173.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.18 156.46 10.23 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.356 3.37 . . . . 0.0 115.443 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -51.68 102.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.201 2.201 . . . . 0.0 112.59 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.38 -3.75 47.23 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.682 -1.065 . . . . 0.0 114.831 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.46 -175.59 2.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.926 1.863 . . . . 0.0 112.354 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.63 137.86 52.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.081 2.152 . . . . 0.0 109.818 160.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.36 107.81 13.46 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 158.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -77.04 165.77 24.19 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -174.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 -58.98 -18.1 30.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.418 1.487 . . . . 0.0 113.525 171.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.27 78.82 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.056 0.836 . . . . 0.0 113.109 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.425 ' CD2' ' HA ' ' A' ' 1' ' ' VAL . 3.2 m-30 -122.35 133.12 54.66 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.243 2.217 . . . . 0.0 110.261 -173.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.435 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 98.5 m -65.99 146.03 55.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 165.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.5 -167.38 39.28 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.091 0.853 . . . . 0.0 113.659 165.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -131.13 169.68 15.56 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.739 2.016 . . . . 0.0 111.539 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.33 178.87 33.14 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.139 0.876 . . . . 0.0 113.76 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.31 -35.66 35.53 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.717 3.612 . . . . 0.0 116.288 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -5.67 40.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -144.01 -30.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t -147.64 -21.49 0.37 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -157.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.7 -56.77 0.72 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 123.944 0.783 . . . . 0.0 111.794 -159.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.317 0 C-N-CA 128.053 2.541 . . . . 0.0 113.427 -176.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -52.78 2.77 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -163.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.55 -171.7 4.01 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.013 1.725 . . . . 0.0 111.862 162.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.454 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 47.7 m -95.95 128.11 42.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.352 1.861 . . . . 0.0 109.006 145.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.2 90.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 129.163 2.985 . . . . 0.0 111.456 -171.512 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? 44.96 29.81 0.5 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.195 0.998 . . . . 0.0 113.42 -165.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.21 8.22 63.16 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.075 1.322 . . . . 0.0 115.437 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -105.53 174.02 6.06 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.814 2.445 . . . . 0.0 110.654 171.669 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.1 m -140.1 133.26 15.09 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.85 166.48 17.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.807 3.005 . . . . 0.0 111.874 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p 53.97 27.85 7.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.44 34.37 54.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.081 1.324 . . . . 0.0 113.61 -170.043 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.2 mtt -67.17 170.47 6.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 110.687 163.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 m -130.34 148.83 52.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.386 1.474 . . . . 0.0 110.341 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 t -91.96 109.41 20.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.35 1.06 . . . . 0.0 111.856 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 87.2 p -66.43 165.8 13.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.703 1.201 . . . . 0.0 113.811 177.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -52.15 -22.16 3.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.212 2.205 . . . . 0.0 114.447 170.357 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.15 29.89 73.55 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.044 -172.141 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -120.16 126.13 49.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.276 2.231 . . . . 0.0 109.93 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 86.9 m -68.06 149.4 49.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 170.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.48 -159.25 21.14 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.773 1.654 . . . . 0.0 111.846 173.423 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.14 157.2 40.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.842 1.257 . . . . 0.0 110.981 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.31 -175.96 49.88 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.414 0.925 . . . . 0.0 115.414 171.887 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.01 -22.25 38.04 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.918 3.745 . . . . 0.0 117.284 -170.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.39 1.22 57.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.776 1.23 . . . . 0.0 113.319 176.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -129.6 -44.34 1.23 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.636 1.174 . . . . 0.0 112.403 -176.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.57 -15.23 21.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.591 0.756 . . . . 0.0 113.028 170.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.93 -154.22 23.51 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 154.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.24 1.416 . . . . 0.0 109.158 175.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.02 106.2 0.96 Allowed Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -159.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -54.99 142.71 28.99 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.985 0.914 . . . . 0.0 110.44 167.596 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m -65.49 108.35 1.97 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.706 -0.621 . . . . 0.0 111.713 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.71 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.862 2.065 . . . . 0.0 110.639 -174.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 40.59 43.81 1.65 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.739 2.016 . . . . 0.0 111.405 -162.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.04 70.88 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.982 1.753 . . . . 0.0 116.089 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.0 20.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.441 2.121 . . . . 0.0 111.433 176.287 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.8 m -142.37 154.61 64.04 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.036 1.334 . . . . 0.0 111.469 174.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -77.27 174.32 12.95 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.613 2.875 . . . . 0.0 111.95 175.409 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m 37.34 45.66 0.55 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.191 2.596 . . . . 0.0 116.137 167.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.86 30.78 22.8 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.746 1.641 . . . . 0.0 114.125 -176.329 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.8 mtt -74.37 159.94 31.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.622 1.211 . . . . 0.0 111.579 177.779 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.4 m -87.63 120.97 29.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.445 1.498 . . . . 0.0 109.448 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.0 t -67.67 101.14 0.98 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 160.52 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -75.31 163.6 27.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -174.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -58.25 -17.12 16.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.521 1.529 . . . . 0.0 113.504 173.541 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . 0.472 ' C1 ' ' HZ1' ' A' ' 26' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.33 10.51 74.02 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.796 1.189 . . . . 0.0 114.074 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -128.58 146.9 50.71 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.287 1.035 . . . . 0.0 112.02 -172.155 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.76 147.81 37.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.882 2.073 . . . . 0.0 112.438 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.86 -169.69 42.83 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.38 0.514 . . . . 0.0 113.77 163.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -130.12 159.97 35.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.491 1.916 . . . . 0.0 108.993 170.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.87 173.67 47.85 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 123.903 0.763 . . . . 0.0 112.744 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -45.9 34.13 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.155 3.237 . . . . 0.0 115.53 -167.679 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.472 ' HZ1' ' C1 ' ' A' ' 18' ' ' NAL . 0.0 OUTLIER -64.81 0.28 1.23 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.615 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -137.61 -38.62 0.59 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.239 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m -115.17 -1.68 12.92 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.281 1.432 . . . . 0.0 113.702 -176.129 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.77 -48.84 1.66 Allowed Glycine 0 CA--C 1.536 1.376 0 CA-C-N 119.847 1.203 . . . . 0.0 112.861 -171.355 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? . . . . . 0 C--O 1.248 1.003 0 C-N-CA 125.519 1.528 . . . . 0.0 110.506 160.691 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.9 67.5 1.93 Allowed Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -145.173 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 59.82 -172.58 0.12 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.278 1.831 . . . . 0.0 113.78 -170.66 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.5 m -82.17 132.59 35.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 144.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.36 86.2 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.872 1.269 . . . . 0.0 111.479 -161.248 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.16 42.89 25.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.673 1.189 . . . . 0.0 111.22 -159.462 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.15 -10.04 65.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.012 1.768 . . . . 0.0 115.03 177.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -103.01 172.38 6.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.83 1.315 . . . . 0.0 113.328 -167.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.75 157.61 64.45 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.909 2.084 . . . . 0.0 110.784 176.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.64 161.09 42.79 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.877 2.385 . . . . 0.0 111.893 165.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -55.27 92.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.238 2.215 . . . . 0.0 113.48 -173.746 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.76 -10.83 10.3 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.219 1.39 . . . . 0.0 114.5 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.3 mtt -88.62 167.12 13.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.868 1.334 . . . . 0.0 111.228 166.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 m -137.44 142.01 41.61 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.944 1.698 . . . . 0.0 110.858 -172.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.4 t -83.93 108.18 16.76 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.467 1.107 . . . . 0.0 110.128 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.1 p -71.44 161.72 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.823 0.82 . . . . 0.0 113.034 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -58.59 -16.38 15.62 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.843 1.657 . . . . 0.0 113.864 174.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . 0.439 ' C6 ' ' HZ3' ' A' ' 26' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.63 18.81 79.59 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.898 0.761 . . . . 0.0 113.056 -177.469 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.18 127.88 49.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.838 1.655 . . . . 0.0 110.661 -173.401 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.0 t -83.51 144.76 29.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.875 0.87 . . . . 0.0 112.387 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.48 -165.2 33.21 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.319 0.961 . . . . 0.0 112.644 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -136.41 162.59 32.62 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.397 1.079 . . . . 0.0 111.864 176.962 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.68 -173.68 42.12 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.161 0.886 . . . . 0.0 112.953 -173.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -44.31 -47.98 10.26 Favored 'Trans proline' 0 C--N 1.35 0.652 1 C-N-CA 125.407 4.072 . . . . 0.0 115.612 -172.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.439 ' HZ3' ' C6 ' ' A' ' 18' ' ' NAL . 9.0 tptp -65.69 -6.53 11.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.891 1.676 . . . . 0.0 115.522 -179.079 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -139.64 -56.0 0.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.005 0.922 . . . . 0.0 113.033 -171.748 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m -117.86 -5.76 11.04 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.567 1.947 . . . . 0.0 113.553 -170.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.43 -49.84 3.08 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.999 -1.063 . . . . 0.0 111.894 -160.947 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.22 0 CA-C-O 115.862 -2.018 . . . . 0.0 113.248 -178.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.16 -47.23 2.58 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -161.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -152.78 176.5 11.72 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.776 1.63 . . . . 0.0 111.027 169.665 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.2 m -85.76 107.44 17.61 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 139.433 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -55.43 95.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.964 1.706 . . . . 0.0 111.524 -158.211 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? 45.28 36.06 2.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.085 1.754 . . . . 0.0 112.335 -169.545 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.92 -4.65 59.23 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 127.697 2.57 . . . . 0.0 115.873 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.76 8.5 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.264 2.032 . . . . 0.0 113.087 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.34 152.02 74.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.148 . . . . 0.0 109.661 169.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.65 165.96 4.16 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.783 2.989 . . . . 0.0 113.257 162.473 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.64 98.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.703 2.401 . . . . 0.0 114.07 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.53 4.61 89.11 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.466 176.483 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt -77.6 172.91 12.64 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.797 1.798 . . . . 0.0 112.105 171.923 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 m -128.61 133.96 48.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.376 1.87 . . . . 0.0 110.62 -169.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.5 t -81.99 125.97 31.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.909 -0.494 . . . . 0.0 110.672 173.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -79.2 154.32 29.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 173.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -59.19 -21.6 59.71 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.46 -0.775 . . . . 0.0 112.845 169.725 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . 0.423 ' C6 ' ' HZ3' ' A' ' 26' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.9 10.29 83.23 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 124.397 0.998 . . . . 0.0 114.177 172.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -115.41 131.08 57.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.41 1.484 . . . . 0.0 109.864 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.44 149.89 36.79 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.491 0.316 . . . . 0.0 111.791 169.243 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.46 -159.17 23.03 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.871 1.224 . . . . 0.0 112.001 175.47 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -139.31 154.48 47.92 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.991 0.916 . . . . 0.0 110.079 175.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.41 176.92 28.73 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.857 1.218 . . . . 0.0 112.799 -173.788 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.88 -53.06 6.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.546 3.498 . . . . 0.0 114.467 -174.042 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.423 ' HZ3' ' C6 ' ' A' ' 18' ' ' NAL . 5.0 mmpt? -56.62 -12.19 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.337 1.855 . . . . 0.0 114.888 179.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.07 -39.11 2.85 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.882 1.673 . . . . 0.0 112.943 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.7 m -110.23 -14.53 14.16 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.091 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.53 66.56 0.55 Allowed Glycine 0 N--CA 1.469 0.898 0 C-N-CA 125.695 1.617 . . . . 0.0 110.222 -176.052 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 C-N-CA 127.251 2.22 . . . . 0.0 110.954 -157.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 -45.9 2.43 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -163.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -154.45 179.84 8.64 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.776 2.03 . . . . 0.0 109.88 168.904 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.49 107.52 15.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 130.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.01 101.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 126.693 1.997 . . . . 0.0 110.425 -170.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 48.9 33.2 4.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.586 1.155 . . . . 0.0 112.379 -170.313 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.78 68.33 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.898 2.189 . . . . 0.0 115.269 -178.298 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -121.38 164.21 17.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.774 1.787 . . . . 0.0 112.597 -174.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.35 173.83 4.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.441 2.297 . . . . 0.0 108.878 163.881 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.58 136.07 16.15 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.75 2.966 . . . . 0.0 113.755 173.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.8 p -58.31 97.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.107 1.763 . . . . 0.0 112.254 -174.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.31 -19.88 4.51 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.441 1.496 . . . . 0.0 112.969 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.3 mtp -82.37 158.95 23.15 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.211 1.005 . . . . 0.0 109.645 159.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.6 m -143.29 139.6 30.21 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.834 1.254 . . . . 0.0 110.156 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -70.93 155.3 40.98 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 177.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -126.83 166.38 17.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.879 1.271 . . . . 0.0 113.219 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -57.97 -18.17 21.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.951 1.3 . . . . 0.0 114.067 174.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . 0.483 ' C7 ' ' HZ1' ' A' ' 26' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.24 9.93 84.27 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.624 1.107 . . . . 0.0 113.38 -174.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.64 137.0 50.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.45 1.5 . . . . 0.0 110.033 -171.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 151.71 30.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 166.509 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.5 -162.22 26.82 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.918 1.246 . . . . 0.0 112.015 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -138.25 163.98 30.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.819 1.648 . . . . 0.0 110.714 172.683 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.45 -175.66 46.01 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 123.609 0.623 . . . . 0.0 113.232 -176.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.53 -36.38 31.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 125.178 3.919 . . . . 0.0 116.77 -171.038 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.483 ' HZ1' ' C7 ' ' A' ' 18' ' ' NAL . 30.5 mtpp -72.94 -9.65 58.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 178.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.74 -47.84 0.5 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -168.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.55 5.17 1.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -174.127 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.18 -46.62 2.75 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 120.652 -1.28 . . . . 0.0 112.38 -167.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.546 1.938 . . . . 0.0 113.416 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.421 ' C ' ' H ' ' A' ' 3' ' ' GLU . 2.9 t . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 117.157 -1.402 . . . . 0.0 107.41 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.59 19.44 0.53 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 120.823 1.647 . . . . 0.0 114.811 169.727 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.421 ' H ' ' C ' ' A' ' 1' ' ' VAL . 8.9 tt0 -171.77 165.14 6.59 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 129.441 3.097 . . . . 0.0 108.797 -179.035 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.8 m -95.27 112.94 24.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.684 1.994 . . . . 0.0 107.268 151.109 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.0 103.07 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.536 1.134 . . . . 0.0 110.44 -163.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.26 30.5 4.44 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.366 1.066 . . . . 0.0 112.156 -165.124 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.26 -7.69 81.51 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.184 1.85 . . . . 0.0 115.198 -174.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.8 171.93 8.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.584 1.692 . . . . 0.0 112.016 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.0 m -143.14 149.17 47.79 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.363 1.865 . . . . 0.0 111.521 -172.519 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.02 -178.27 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 125.261 3.974 . . . . 0.0 114.991 165.09 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -38.96 92.3 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.644 3.178 . . . . 0.0 115.311 -177.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.38 30.13 61.24 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.62 1.105 . . . . 0.0 113.588 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.4 mtt -85.71 170.04 12.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 110.813 170.212 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.16 142.32 35.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.22 1.808 . . . . 0.0 110.734 -164.306 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.6 113.13 23.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.564 1.145 . . . . 0.0 110.555 -177.355 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.9 p -71.58 165.87 23.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.148 0.975 . . . . 0.0 113.504 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 -53.25 -17.68 1.9 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.347 2.259 . . . . 0.0 114.683 170.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.34 19.59 78.85 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.727 0.694 . . . . 0.0 112.747 -170.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -111.65 123.04 49.4 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.43 1.892 . . . . 0.0 108.906 -178.114 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.77 142.69 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.246 0.476 . . . . 0.0 112.02 178.183 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.91 -161.47 19.21 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.951 1.739 . . . . 0.0 110.33 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -132.59 150.0 52.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.769 1.285 . . . . 0.0 110.779 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 -160.64 30.33 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 115.406 0.923 . . . . 0.0 115.406 172.657 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.88 4.29 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 125.109 3.873 . . . . 0.0 116.151 -160.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.32 5.44 9.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.053 1.741 . . . . 0.0 112.737 174.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -129.24 -57.44 1.15 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.487 1.515 . . . . 0.0 110.378 177.936 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 m -73.85 -62.23 1.57 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.029 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.36 162.76 43.51 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 164.358 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 124.094 0.957 . . . . 0.0 112.321 -169.698 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.442 ' H3 ' ' CD ' ' A' ' 3' ' ' GLU . 12.0 p . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.67 7.7 68.6 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.842 -0.977 . . . . 0.0 114.71 -178.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.442 ' CD ' ' H3 ' ' A' ' 1' ' ' VAL . 52.6 mp0 -51.17 124.88 12.55 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.806 1.642 . . . . 0.0 110.819 172.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.1 m -57.92 160.07 5.01 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -74.9 56.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.983 1.713 . . . . 0.0 109.293 168.782 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 52.82 38.36 26.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.915 3.286 . . . . 0.0 112.417 -179.577 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.39 -12.55 7.94 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.578 2.037 . . . . 0.0 115.058 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 mtm-85 -115.36 168.52 9.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.614 1.566 . . . . 0.0 111.012 177.697 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -144.98 167.17 15.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.367 1.067 . . . . 0.0 112.798 -172.433 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.07 166.13 1.71 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 124.512 3.474 . . . . 0.0 114.59 168.765 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -39.16 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 128.531 2.733 . . . . 0.0 114.749 -174.149 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.35 3.16 81.81 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.49 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.9 mmt -80.03 161.95 25.13 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.368 1.584 . . . . 0.0 110.722 173.096 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.54 129.51 54.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.85 1.26 . . . . 0.0 110.639 -172.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.28 107.92 8.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.305 0.642 . . . . 0.0 109.979 174.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -57.71 148.73 23.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.673 1.189 . . . . 0.0 111.123 170.161 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -51.01 -20.75 1.48 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.238 2.215 . . . . 0.0 114.197 169.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.49 16.85 30.57 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.538 1.066 . . . . 0.0 115.405 172.316 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -126.69 140.44 52.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.891 1.276 . . . . 0.0 112.897 -170.781 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.6 m -84.09 142.76 30.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.513 1.525 . . . . 0.0 113.257 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.57 -163.66 36.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.863 0.744 . . . . 0.0 113.269 172.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -137.47 166.7 23.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.941 1.696 . . . . 0.0 110.773 174.097 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.19 -176.62 51.72 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 123.704 0.668 . . . . 0.0 113.257 -174.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.06 -39.92 41.18 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.037 3.825 . . . . 0.0 116.109 -170.236 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -11.09 58.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.889 1.276 . . . . 0.0 113.501 179.478 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -138.85 -45.61 0.48 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -168.094 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.99 6.72 1.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -169.031 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.35 -52.49 3.42 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.009 -1.057 . . . . 0.0 112.487 -169.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.932 2.093 . . . . 0.0 112.3 179.065 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . 0.459 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 42.8 t . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.13 -53.08 3.41 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -165.948 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -153.03 -177.59 6.39 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.648 1.579 . . . . 0.0 110.976 170.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.438 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 30.5 m -92.83 114.85 27.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.839 1.256 . . . . 0.0 108.034 133.111 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.56 95.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.733 2.013 . . . . 0.0 110.877 -166.723 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? 48.14 30.86 2.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.075 0.95 . . . . 0.0 112.244 -166.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -6.47 77.66 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 126.856 2.17 . . . . 0.0 116.01 -175.377 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 167.9 12.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.232 2.016 . . . . 0.0 111.094 175.187 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -139.93 141.76 28.39 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.785 0.834 . . . . 0.0 112.545 175.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.57 172.92 9.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.985 3.124 . . . . 0.0 112.171 177.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t 43.66 39.57 2.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.943 2.097 . . . . 0.0 116.245 165.041 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.66 31.68 60.76 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.919 1.247 . . . . 0.0 113.95 -176.163 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.2 mtt -76.82 163.64 26.58 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.817 1.308 . . . . 0.0 110.39 164.969 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.0 m -115.42 145.95 42.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.615 1.966 . . . . 0.0 109.814 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -80.32 110.93 16.22 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.284 0.634 . . . . 0.0 111.105 177.118 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.7 p -71.37 166.3 21.95 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -176.653 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -53.47 -5.1 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.22 2.608 . . . . 0.0 115.433 163.899 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.51 23.08 78.52 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 119.038 0.836 . . . . 0.0 113.242 -174.44 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 1' ' ' VAL . 1.7 m-85 -123.03 131.25 53.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.332 2.253 . . . . 0.0 110.274 -179.637 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.438 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m -62.63 143.23 57.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.534 0.606 . . . . 0.0 112.508 168.524 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.67 -159.95 15.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.121 1.82 . . . . 0.0 111.538 168.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -133.89 166.3 23.0 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.167 1.483 . . . . 0.0 112.355 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.5 170.95 29.14 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.312 1.434 . . . . 0.0 113.352 -175.037 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -48.37 -41.17 36.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.155 3.236 . . . . 0.0 113.888 -178.121 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -27.06 16.85 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.991 2.116 . . . . 0.0 114.208 177.903 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -119.15 -8.81 10.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.317 1.447 . . . . 0.0 113.459 177.178 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -117.78 -4.56 11.15 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.568 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.45 -63.32 0.02 OUTLIER Glycine 0 CA--C 1.534 1.247 0 CA-C-N 119.191 0.905 . . . . 0.0 114.307 179.113 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 C-N-CA 125.954 1.702 . . . . 0.0 112.767 -177.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 119.269 -0.396 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.83 107.99 0.64 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 -153.251 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -56.49 152.65 11.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.632 0.773 . . . . 0.0 112.284 177.608 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.1 m -65.64 100.88 0.56 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.008 -0.433 . . . . 0.0 110.93 178.581 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.14 89.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 128.527 2.731 . . . . 0.0 110.004 -170.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.3 mmp_? 40.38 46.68 2.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.669 1.988 . . . . 0.0 111.242 -164.37 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.06 -10.84 71.53 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.848 2.166 . . . . 0.0 115.453 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -96.69 163.75 12.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.747 1.774 . . . . 0.0 111.432 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.4 m -144.15 162.59 39.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.045 1.338 . . . . 0.0 110.541 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -54.5 157.06 12.69 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 124.084 3.19 . . . . 0.0 114.723 175.02 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.17 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.034 2.134 . . . . 0.0 113.379 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.04 64.08 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.668 -1.074 . . . . 0.0 114.845 178.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 44.0 mtt -83.33 166.48 18.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.077 1.438 . . . . 0.0 111.553 165.893 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.73 140.33 50.1 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.481 1.512 . . . . 0.0 110.313 173.485 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.21 109.06 6.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 163.177 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.8 p -75.81 160.52 29.88 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.776 0.798 . . . . 0.0 112.944 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 -58.02 -17.78 19.83 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.971 1.709 . . . . 0.0 113.947 175.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.01 14.03 61.32 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.374 0.988 . . . . 0.0 114.038 -177.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -127.94 145.94 50.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.278 1.039 . . . . 0.0 112.485 -174.175 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.5 m -76.88 151.77 35.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.923 1.689 . . . . 0.0 112.536 176.405 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.48 -167.38 40.52 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.604 0.621 . . . . 0.0 113.544 168.719 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -132.4 169.0 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.897 1.679 . . . . 0.0 112.142 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.55 -179.02 34.32 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 123.849 0.738 . . . . 0.0 113.651 -178.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.45 -29.52 31.65 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.535 3.49 . . . . 0.0 116.157 -173.46 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.29 -8.16 54.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 116.737 -1.601 . . . . 0.0 115.157 177.117 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -147.15 -39.32 0.2 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.705 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.6 t -140.81 -5.03 1.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.439 1.496 . . . . 0.0 114.47 -159.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.01 -52.89 2.13 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.225 -0.922 . . . . 0.0 112.323 -167.805 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 126.38 1.872 . . . . 0.0 112.238 -173.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.4 -52.08 2.62 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -159.776 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -141.71 177.98 7.79 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.26 2.624 . . . . 0.0 110.473 169.809 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.96 107.94 12.07 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 124.568 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.75 99.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.623 2.369 . . . . 0.0 110.717 -169.665 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 41.39 43.04 2.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.345 1.458 . . . . 0.0 112.791 -170.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.16 -3.45 60.11 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.45 2.452 . . . . 0.0 115.262 178.874 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -128.41 -175.53 3.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.175 1.487 . . . . 0.0 112.516 -165.409 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.56 169.95 8.51 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.427 1.891 . . . . 0.0 107.551 160.753 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.5 164.61 15.08 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.84 2.36 . . . . 0.0 114.08 173.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -54.76 104.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.217 1.807 . . . . 0.0 111.648 177.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.94 -2.85 24.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.753 1.168 . . . . 0.0 114.296 -177.95 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -113.43 169.41 8.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.912 1.356 . . . . 0.0 109.938 170.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -141.58 157.11 45.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 0.0 112.337 -172.417 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.46 112.15 24.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.619 1.568 . . . . 0.0 111.663 -172.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.5 p -67.31 164.19 18.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -173.777 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -51.54 -3.24 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 129.159 2.983 . . . . 0.0 115.706 162.648 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.86 19.42 78.89 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.008 0.822 . . . . 0.0 113.598 -174.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.4 130.02 53.36 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.52 1.928 . . . . 0.0 109.649 177.682 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.5 p -93.38 159.83 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -176.378 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.2 -149.33 9.78 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.368 1.937 . . . . 0.0 111.488 -167.37 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -135.72 159.4 41.75 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 118.971 1.385 . . . . 0.0 112.526 -176.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.44 174.86 46.67 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.592 1.091 . . . . 0.0 113.626 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -45.49 -46.53 14.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.686 3.591 . . . . 0.0 114.673 -172.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -55.56 -24.4 32.23 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.511 1.924 . . . . 0.0 114.295 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -109.6 -27.54 9.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.362 1.865 . . . . 0.0 113.089 175.544 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m -91.86 -8.98 44.98 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.79 1.236 . . . . 0.0 113.87 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.05 -26.14 0.12 Allowed Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.038 1.575 . . . . 0.0 117.038 166.118 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 1.7 tpm_? . . . . . 0 C--O 1.256 1.395 0 CA-C-N 119.561 1.681 . . . . 0.0 114.784 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.8 m -75.55 101.37 4.87 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.239 -0.913 . . . . 0.0 108.943 155.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.39 105.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.306 1.042 . . . . 0.0 110.179 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.9 27.2 4.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.167 0.987 . . . . 0.0 111.231 -169.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.88 -4.52 81.74 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.412 1.958 . . . . 0.0 115.65 -174.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 167.29 13.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 2.004 . . . . 0.0 112.488 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.1 m -134.23 154.89 80.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.813 2.045 . . . . 0.0 110.448 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.36 176.68 9.76 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.151 2.567 . . . . 0.0 111.646 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -29.7 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 129.431 3.092 . . . . 0.0 115.416 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.12 3.57 81.78 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.047 -1.418 . . . . 0.0 116.02 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -77.0 169.16 18.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.139 1.969 . . . . 0.0 112.173 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 m -132.62 157.92 43.56 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.811 1.645 . . . . 0.0 111.192 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -112.14 116.2 30.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.673 1.189 . . . . 0.0 112.403 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.1 p -68.98 163.48 24.49 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.359 1.464 . . . . 0.0 113.624 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 . . . . . 0 N--CA 1.469 0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 113.944 174.372 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 CA-C-O 119.955 -0.358 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.48 135.62 51.79 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 110.654 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.4 t -109.68 137.62 47.22 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.434 2.294 . . . . 0.0 111.409 -169.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.8 -160.88 24.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.321 1.439 . . . . 0.0 111.478 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -133.17 126.31 31.37 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.772 0.829 . . . . 0.0 109.665 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.94 178.09 22.0 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.579 1.085 . . . . 0.0 112.754 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -48.04 -53.93 5.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.839 3.693 . . . . 0.0 114.521 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.69 -8.69 55.67 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -100.24 -51.69 3.59 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.041 0.937 . . . . 0.0 111.124 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 124.254 1.022 . . . . 0.0 113.689 -175.832 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.5 m -72.21 117.83 14.34 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.587 -1.321 . . . . 0.0 109.287 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 85.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 129.205 3.002 . . . . 0.0 110.307 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.585 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 40.39 42.75 1.33 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.194 2.198 . . . . 0.0 111.211 -161.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -13.65 66.12 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.579 2.037 . . . . 0.0 116.235 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.36 174.68 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.2 2.0 . . . . 0.0 111.01 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 m -141.12 163.9 39.2 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.536 1.134 . . . . 0.0 110.792 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.57 168.77 1.42 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 124.255 3.304 . . . . 0.0 114.668 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.8 m -44.46 100.11 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.402 2.281 . . . . 0.0 114.258 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.26 -1.62 84.58 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.722 1.153 . . . . 0.0 115.191 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -80.5 161.58 24.77 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.749 1.275 . . . . 0.0 110.966 168.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.9 m -138.2 156.12 48.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.383 1.473 . . . . 0.0 110.862 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -89.01 114.06 25.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.745 1.218 . . . . 0.0 111.379 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 4.8 t -70.73 168.22 17.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 113.233 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 126.359 1.864 . . . . 0.0 115.43 -176.587 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.269 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -123.51 149.46 45.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.195 1.798 . . . . 0.0 111.538 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -94.97 149.98 20.65 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.14 -165.16 37.79 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.564 1.078 . . . . 0.0 112.081 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -135.0 167.43 20.95 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.514 1.526 . . . . 0.0 111.591 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.62 -174.65 48.56 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.807 0.718 . . . . 0.0 113.101 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.9 -36.12 26.23 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.025 3.817 . . . . 0.0 116.151 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.61 -9.35 58.48 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 88.3 m-85 -139.25 -44.85 0.46 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -170.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.8 m -50.39 154.19 1.34 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.517 1.127 . . . . 0.0 113.852 -163.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.05 70.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 123.573 1.654 . . . . 0.0 108.756 172.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? 33.33 50.23 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 1 C-N-CA 132.41 4.284 . . . . 0.0 112.559 -172.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.18 -17.92 10.44 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 127.295 2.379 . . . . 0.0 114.943 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.52 164.7 12.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.274 1.537 . . . . 0.0 111.493 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.1 m -144.7 168.11 13.09 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.364 1.466 . . . . 0.0 111.34 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.69 156.8 8.41 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.966 3.111 . . . . 0.0 114.211 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -52.85 97.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.746 2.018 . . . . 0.0 113.302 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.36 39.65 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.916 1.245 . . . . 0.0 114.85 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -94.07 167.79 11.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.801 1.301 . . . . 0.0 111.506 168.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.4 143.5 48.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.453 1.501 . . . . 0.0 110.681 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -83.08 109.02 16.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.449 0.7 . . . . 0.0 110.199 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.0 p -70.6 164.32 25.14 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 125.173 1.389 . . . . 0.0 114.582 175.432 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -114.49 131.67 56.55 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.856 1.663 . . . . 0.0 110.228 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.8 m -73.57 152.67 40.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.965 1.306 . . . . 0.0 112.63 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.62 -167.18 40.23 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.098 0.856 . . . . 0.0 111.987 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.41 167.28 21.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 110.905 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.86 -172.96 54.6 Favored Glycine 0 CA--C 1.54 1.595 0 O-C-N 121.9 -0.5 . . . . 0.0 113.565 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -42.4 -48.05 7.01 Favored 'Trans proline' 0 C--N 1.351 0.689 1 C-N-CA 125.925 4.417 . . . . 0.0 116.915 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -70.94 -9.36 57.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -134.71 -60.73 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.915 0.886 . . . . 0.0 112.178 -168.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 96.8 m . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 126.313 1.845 . . . . 0.0 112.907 -172.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.55 0.979 0 CA-C-O 121.557 0.694 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 58.8 m -87.09 126.24 34.64 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 138.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.71 92.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.585 2.354 . . . . 0.0 110.664 -168.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 37.74 46.04 0.7 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.32 1.848 . . . . 0.0 112.266 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.08 -10.29 65.7 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.0 2.238 . . . . 0.0 115.554 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -103.19 179.14 4.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.457 1.629 . . . . 0.0 112.669 -173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 m -138.8 158.9 69.19 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.342 1.857 . . . . 0.0 110.423 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.96 163.05 39.86 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.562 2.175 . . . . 0.0 111.485 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.4 p -56.77 93.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.519 1.928 . . . . 0.0 112.78 -173.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.6 -11.91 10.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.499 1.523 . . . . 0.0 114.604 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -91.31 169.39 10.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.793 1.796 . . . . 0.0 111.883 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 p -142.8 164.56 29.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.514 1.526 . . . . 0.0 111.762 -174.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.0 t -120.36 111.12 17.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.359 1.064 . . . . 0.0 112.352 -157.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -69.73 161.95 28.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 113.917 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 . . . . . 0 N--CA 1.472 0.642 0 C-N-CA 124.209 1.004 . . . . 0.0 113.625 -173.453 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.658 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.83 114.78 17.67 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.475 1.51 . . . . 0.0 110.636 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 4' ' ' CYS . 43.4 t -78.74 148.32 33.07 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.463 0.705 . . . . 0.0 111.682 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.61 -152.26 13.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.992 1.758 . . . . 0.0 110.641 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -138.9 160.09 40.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.833 0.853 . . . . 0.0 110.915 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.31 172.2 13.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.044 1.783 . . . . 0.0 111.515 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.56 -34.27 75.62 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.882 2.388 . . . . 0.0 112.409 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -11.11 60.66 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -106.5 -45.36 4.27 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.995 1.318 . . . . 0.0 110.997 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.0 m . . . . . 0 CA--C 1.54 0.579 0 C-N-CA 124.618 1.167 . . . . 0.0 112.886 -177.341 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 . . . . . 0 CA--C 1.551 0.997 0 CA-C-O 121.817 0.818 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.4 m -94.26 110.08 21.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.909 1.684 . . . . 0.0 106.51 136.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.79 101.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.773 1.629 . . . . 0.0 111.373 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 48.51 27.05 1.32 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.405 1.482 . . . . 0.0 112.917 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.51 -15.74 14.7 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.37 2.414 . . . . 0.0 116.644 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.46 171.22 14.44 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.074 2.437 . . . . 0.0 112.917 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -146.86 156.17 47.82 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 123.105 0.562 . . . . 0.0 112.338 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.98 177.94 8.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.041 3.161 . . . . 0.0 112.996 -172.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.8 p 59.68 24.54 13.41 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.86 96.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.489 1.043 . . . . 0.0 112.704 -169.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.6 mtt -69.47 169.95 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.224 1.012 . . . . 0.0 110.739 160.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -140.4 155.43 46.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.143 1.777 . . . . 0.0 110.744 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -94.13 121.77 35.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.11 1.364 . . . . 0.0 113.212 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p -72.14 152.39 42.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.423 -0.798 . . . . 0.0 111.504 166.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 pm0 . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 126.345 1.858 . . . . 0.0 114.187 175.605 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.98 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.318 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -121.17 122.33 39.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.154 1.781 . . . . 0.0 109.426 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.97 164.52 19.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.72 -151.11 10.08 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.8 2.143 . . . . 0.0 110.435 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -137.37 156.61 48.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.943 1.297 . . . . 0.0 110.335 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.45 -167.4 23.47 Favored Glycine 0 CA--C 1.542 1.76 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.49 4.94 2.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.857 3.705 . . . . 0.0 115.675 -164.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 4.49 9.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.697 1.999 . . . . 0.0 112.608 176.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.8 -44.03 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.122 1.769 . . . . 0.0 111.878 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 125.841 1.656 . . . . 0.0 107.927 171.328 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -60.11 101.73 0.14 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -57.28 96.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 128.281 2.632 . . . . 0.0 110.865 -164.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? 48.79 29.55 2.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -167.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.46 -2.61 67.93 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.222 2.344 . . . . 0.0 116.23 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 165.91 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.272 2.036 . . . . 0.0 111.887 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m -141.57 130.83 12.5 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.999 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -80.6 168.79 17.59 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.635 2.89 . . . . 0.0 112.779 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p 55.06 28.13 10.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.21 35.55 60.44 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.92 1.248 . . . . 0.0 113.32 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -67.99 167.11 14.44 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.387 1.093 . . . . 0.0 110.501 162.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.41 135.22 54.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.96 2.104 . . . . 0.0 108.874 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 t -75.56 137.33 40.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.04 0.536 . . . . 0.0 110.558 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -117.68 163.93 15.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 113.969 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 125.622 1.569 . . . . 0.0 113.063 178.201 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.908 0 CA-C-O 119.391 -0.672 . . . . 0.0 113.39 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -121.84 155.71 34.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.94 1.696 . . . . 0.0 110.692 -168.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -86.62 156.03 20.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.824 0.85 . . . . 0.0 111.794 170.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.01 -174.12 41.38 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.832 1.206 . . . . 0.0 110.162 159.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -124.51 149.46 46.88 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.721 1.261 . . . . 0.0 110.557 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 179.12 52.17 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 123.523 0.582 . . . . 0.0 113.422 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.44 -20.13 61.12 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 114.444 -166.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.51 -21.41 16.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.992 1.317 . . . . 0.0 113.183 170.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -133.15 -42.76 0.87 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.426 1.49 . . . . 0.0 111.451 -173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.626 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 121.277 0.561 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 61.7 m -100.86 109.95 21.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.759 1.624 . . . . 0.0 107.361 139.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -53.39 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.831 2.452 . . . . 0.0 110.747 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 48.85 27.08 1.47 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.815 2.046 . . . . 0.0 113.549 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.23 -11.03 33.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.946 2.212 . . . . 0.0 115.008 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 170.8 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.096 1.948 . . . . 0.0 112.657 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.6 m -136.4 167.68 20.5 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.967 1.307 . . . . 0.0 110.493 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.96 146.15 17.48 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.706 2.938 . . . . 0.0 112.568 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.7 m -66.31 82.28 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.137 1.375 . . . . 0.0 112.177 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.26 -17.57 2.7 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.326 1.917 . . . . 0.0 113.674 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mmt -80.29 177.04 9.24 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.658 1.229 . . . . 0.0 111.457 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.9 m -127.0 163.83 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.177 2.191 . . . . 0.0 110.124 169.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.51 118.88 37.81 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.73 1.212 . . . . 0.0 110.55 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.7 p -71.21 166.94 20.45 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 128.22 2.608 . . . . 0.0 115.297 162.85 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -120.59 133.97 55.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.237 2.615 . . . . 0.0 110.397 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 71.1 m -65.59 155.79 34.71 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.01 -160.13 29.84 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.139 1.828 . . . . 0.0 111.534 170.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.29 174.06 10.89 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.486 1.143 . . . . 0.0 111.207 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.93 169.98 42.3 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 124.656 1.122 . . . . 0.0 112.05 -166.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.37 -36.95 85.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.979 2.453 . . . . 0.0 112.358 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -55.6 -24.06 30.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.323 1.849 . . . . 0.0 114.16 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.9 -1.25 12.61 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.902 1.281 . . . . 0.0 113.502 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.5 m -65.45 90.48 0.11 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 157.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.7 t -55.49 93.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 128.457 2.703 . . . . 0.0 111.068 -160.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 46.36 36.88 3.68 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.879 1.672 . . . . 0.0 112.796 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.69 -6.83 11.28 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.212 2.339 . . . . 0.0 117.516 171.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.24 167.42 20.4 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.998 2.399 . . . . 0.0 114.793 -170.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.6 m -132.12 161.79 60.68 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.419 . . . . 0.0 110.584 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.9 154.89 15.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.731 2.954 . . . . 0.0 113.364 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -49.91 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.98 2.112 . . . . 0.0 114.032 -173.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.17 -7.77 58.74 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.049 1.309 . . . . 0.0 114.85 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.1 mtp -76.77 161.61 28.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.52 1.66 . . . . 0.0 110.383 166.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.3 m -126.43 121.01 31.22 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.898 0.879 . . . . 0.0 110.511 -161.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.71 107.13 3.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.121 0.968 . . . . 0.0 110.748 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -73.26 156.1 38.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.297 0.57 . . . . 0.0 112.247 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.0 pm0 . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 126.575 1.95 . . . . 0.0 114.329 -178.339 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.229 0 CA-C-O 119.44 -0.645 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -129.41 136.25 49.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.455 1.102 . . . . 0.0 112.124 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.9 m -71.76 157.69 37.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.915 1.686 . . . . 0.0 112.541 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.65 -163.63 33.48 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.106 0.86 . . . . 0.0 112.927 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -141.7 170.73 15.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.911 2.084 . . . . 0.0 108.445 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.83 -171.59 50.19 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 118.565 0.621 . . . . 0.0 113.879 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.49 -38.64 72.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.316 2.678 . . . . 0.0 114.825 -161.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.507 ' HE3' ' CZ ' ' A' ' 27' ' ' TYR . 3.3 ttpp -73.45 -2.57 23.02 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.507 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 72.5 m-85 -140.26 -34.56 0.53 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -171.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 m -69.87 95.04 0.88 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -62.63 89.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.863 2.065 . . . . 0.0 111.366 -161.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? 57.69 26.58 13.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.188 1.795 . . . . 0.0 113.336 -166.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.01 -13.68 5.76 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.197 1.38 . . . . 0.0 116.44 166.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.31 170.53 14.94 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.795 1.797 . . . . 0.0 113.685 -171.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.2 m -128.1 161.75 54.24 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.287 1.835 . . . . 0.0 110.991 -173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.59 159.37 53.0 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.822 2.348 . . . . 0.0 112.184 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.6 p -60.14 92.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.822 . . . . 0.0 112.104 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -15.86 4.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.44 1.495 . . . . 0.0 113.725 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -112.49 164.66 13.03 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.739 1.27 . . . . 0.0 111.293 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.2 m -132.13 148.82 52.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.919 1.688 . . . . 0.0 109.92 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -82.58 148.44 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.148 0.579 . . . . 0.0 111.654 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.3 p -118.26 163.09 17.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.718 1.207 . . . . 0.0 113.313 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 . . . . . 0 N--CA 1.47 0.545 0 C-N-CA 125.551 1.54 . . . . 0.0 113.819 176.969 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.155 0 CA-C-O 119.472 -0.626 . . . . 0.0 113.353 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -124.02 144.86 49.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.608 1.163 . . . . 0.0 112.121 -169.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -82.32 156.24 24.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.963 1.305 . . . . 0.0 112.429 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.54 -164.6 36.3 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.63 0.634 . . . . 0.0 113.349 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -136.36 172.05 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.425 1.89 . . . . 0.0 110.695 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.55 -177.67 53.46 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 123.9 0.762 . . . . 0.0 113.554 -168.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.08 -48.59 14.31 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.261 3.974 . . . . 0.0 115.096 -172.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.75 -13.68 11.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.091 1.756 . . . . 0.0 115.632 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -135.07 -37.15 0.8 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.424 1.011 . . . . 0.0 113.317 -168.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 111.44 0.163 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -72.19 93.38 1.45 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.724 -0.61 . . . . 0.0 110.905 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.0 89.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 128.346 2.658 . . . . 0.0 111.215 -168.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.504 ' H ' ' CZ ' ' A' ' 6' ' ' ARG . 7.9 mmp_? 38.06 41.74 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.699 2.8 . . . . 0.0 112.21 -163.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.27 34.23 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 128.211 2.815 . . . . 0.0 116.095 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -89.74 160.03 16.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.2 2.0 . . . . 0.0 112.031 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.3 m -140.77 161.7 52.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.577 1.151 . . . . 0.0 111.164 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.44 168.36 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.373 3.382 . . . . 0.0 115.057 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.7 m -43.79 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.889 2.476 . . . . 0.0 114.059 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.38 7.41 87.9 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.049 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.8 mtt -84.22 166.13 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.059 1.429 . . . . 0.0 111.964 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.1 m -123.99 152.7 42.24 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.762 1.625 . . . . 0.0 109.823 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.42 154.37 38.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.932 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 p -133.92 174.78 10.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -154.998 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.046 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.73 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -129.17 139.77 51.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.392 1.096 . . . . 0.0 112.651 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.2 m -79.63 159.44 26.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.381 2.272 . . . . 0.0 113.629 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.62 -166.83 39.25 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 123.938 0.78 . . . . 0.0 113.977 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -129.29 165.57 21.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.32 1.848 . . . . 0.0 111.139 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.75 -178.51 53.24 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 123.536 0.589 . . . . 0.0 113.707 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.64 -33.26 58.26 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.65 3.566 . . . . 0.0 116.297 -171.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -14.89 63.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 113.406 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -137.58 -48.88 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.02 0.827 . . . . 0.0 113.222 -171.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -156.511 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.86 99.59 9.12 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 143.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -57.94 93.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.319 1.847 . . . . 0.0 111.454 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 42.73 36.98 0.92 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.148 1.779 . . . . 0.0 112.452 -164.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.11 66.22 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.407 2.432 . . . . 0.0 116.01 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.98 170.87 9.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.219 2.009 . . . . 0.0 112.685 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.99 152.47 55.14 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.414 2.286 . . . . 0.0 109.327 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.6 166.04 6.96 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.731 2.954 . . . . 0.0 113.858 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -47.35 105.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.149 2.18 . . . . 0.0 113.591 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.23 4.28 89.74 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.968 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.2 mtt -90.42 163.95 14.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.885 1.342 . . . . 0.0 111.417 170.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -133.42 133.45 42.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.139 1.375 . . . . 0.0 111.137 -165.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.52 140.67 44.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.528 . . . . 0.0 110.53 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.0 p -117.04 163.36 16.35 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.543 1.137 . . . . 0.0 113.472 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 . . . . . 0 N--CA 1.471 0.585 0 C-N-CA 126.066 1.746 . . . . 0.0 113.825 178.451 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.12 0 CA-C-O 120.051 -0.305 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -126.18 136.02 52.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.264 1.826 . . . . 0.0 111.101 -168.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.53 150.98 32.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.149 0.98 . . . . 0.0 112.481 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.48 -162.14 31.41 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.336 0.97 . . . . 0.0 113.248 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -138.35 167.26 22.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.233 1.413 . . . . 0.0 112.546 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.15 -174.89 40.11 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.428 0.537 . . . . 0.0 113.442 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.6 -32.18 27.05 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.91 3.74 . . . . 0.0 116.523 -172.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -6.98 50.35 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 116.85 -1.548 . . . . 0.0 115.118 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -144.38 -38.57 0.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -169.867 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.2 m -64.88 96.2 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 158.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.1 t -51.89 93.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.99 2.516 . . . . 0.0 111.794 -159.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 38.44 36.18 0.12 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.722 2.009 . . . . 0.0 113.156 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -4.39 31.14 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 128.531 2.967 . . . . 0.0 116.751 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 167.56 12.69 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 121.214 2.507 . . . . 0.0 113.592 176.463 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.35 152.0 52.65 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 126.773 2.029 . . . . 0.0 108.356 166.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.42 168.53 2.85 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.98 3.12 . . . . 0.0 114.321 169.226 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -47.74 99.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.454 2.302 . . . . 0.0 113.886 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.99 84.06 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.795 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -83.8 169.54 15.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.982 1.391 . . . . 0.0 110.919 163.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.11 164.12 31.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.032 1.733 . . . . 0.0 111.572 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -117.57 112.5 20.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 112.307 -162.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.5 p -68.51 160.17 30.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.384 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pm0 . . . . . 0 CA--C 1.54 0.591 0 C-N-CA 125.528 1.531 . . . . 0.0 114.264 176.291 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 CA-C-O 119.613 -0.548 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -106.06 130.91 53.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 0.0 110.007 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -78.04 159.85 28.48 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.336 1.455 . . . . 0.0 111.118 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.74 -160.91 32.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.698 1.618 . . . . 0.0 110.852 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -138.67 156.34 47.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.686 -0.891 . . . . 0.0 110.057 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.03 -175.82 41.83 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 123.522 0.582 . . . . 0.0 114.121 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.5 -47.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.046 3.831 . . . . 0.0 115.482 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -74.56 -0.27 17.19 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -125.31 -35.67 2.58 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.89 1.276 . . . . 0.0 112.706 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 m . . . . . 0 CA--C 1.543 0.681 0 C-N-CA 124.949 1.3 . . . . 0.0 111.956 178.867 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 CA--C 1.551 0.994 0 CA-C-O 121.526 0.679 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 59.4 m -95.15 107.66 19.75 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 137.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -55.63 96.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.555 1.942 . . . . 0.0 111.325 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 39.18 43.02 0.82 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 111.896 -167.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.45 56.13 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.846 2.165 . . . . 0.0 116.506 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -118.12 167.62 11.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.853 2.326 . . . . 0.0 114.047 -170.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.1 m -131.11 164.12 44.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.003 1.321 . . . . 0.0 111.595 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.16 160.37 4.59 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.167 3.245 . . . . 0.0 114.469 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.14 100.04 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.144 2.178 . . . . 0.0 113.382 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.06 2.25 66.52 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.086 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -77.95 172.6 13.25 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.433 1.617 . . . . 0.0 111.844 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.81 159.86 36.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.048 2.139 . . . . 0.0 111.154 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -108.51 114.46 28.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.615 1.566 . . . . 0.0 110.56 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.9 p -67.51 153.19 44.26 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.779 0.799 . . . . 0.0 112.841 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 113.791 168.091 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.41 126.84 47.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.684 1.994 . . . . 0.0 110.528 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 61.4 m -74.18 158.8 33.5 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.63 -160.71 31.04 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.748 2.118 . . . . 0.0 110.334 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -138.17 143.56 40.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 1.469 . . . . 0.0 111.266 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.37 177.12 20.35 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.291 1.424 . . . . 0.0 112.053 -170.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.5 -38.69 81.48 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.931 2.421 . . . . 0.0 112.628 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -59.96 -10.24 3.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.338 1.455 . . . . 0.0 114.564 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -122.31 -29.54 4.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.188 1.395 . . . . 0.0 113.009 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 36.1 m . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 124.108 0.963 . . . . 0.0 112.92 176.637 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.543 0.684 0 CA-C-O 121.518 0.675 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -66.24 117.17 8.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 152.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.07 94.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.322 2.249 . . . . 0.0 110.721 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? 42.64 35.7 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.052 0.941 . . . . 0.0 112.458 -161.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.32 -6.05 63.23 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 126.4 1.953 . . . . 0.0 116.384 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.71 170.78 9.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.418 2.109 . . . . 0.0 112.96 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.5 m -139.14 157.45 71.15 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.472 1.909 . . . . 0.0 108.701 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.5 162.87 37.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.662 2.241 . . . . 0.0 112.263 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -55.34 89.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.695 2.398 . . . . 0.0 113.522 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.96 -8.31 7.65 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.212 1.386 . . . . 0.0 114.715 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 99.2 mtp -98.97 169.6 9.32 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.152 1.476 . . . . 0.0 111.265 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.74 136.5 51.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.773 1.629 . . . . 0.0 111.606 -175.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.8 t -89.19 116.24 27.29 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.106 1.362 . . . . 0.0 109.694 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -73.32 156.09 38.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.232 1.015 . . . . 0.0 113.339 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 CA--C 1.541 0.606 0 C-N-CA 126.862 2.065 . . . . 0.0 113.474 170.253 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 CA-C-O 119.381 -0.677 . . . . 0.0 114.428 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -116.6 141.1 48.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.534 1.134 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.69 153.35 20.79 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.017 1.327 . . . . 0.0 110.877 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.58 -159.75 26.8 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.666 -0.646 . . . . 0.0 112.534 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 0.0 110.179 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.04 178.34 49.95 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.918 0.77 . . . . 0.0 112.863 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.4 -21.69 66.34 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.468 2.779 . . . . 0.0 114.359 -167.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -58.57 -21.55 53.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.137 0.975 . . . . 0.0 113.136 171.0 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -132.56 -36.64 1.08 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.132 0.973 . . . . 0.0 113.479 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 112.072 174.896 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.979 0.895 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.03 106.16 1.2 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 150.147 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -52.03 97.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 128.517 2.727 . . . . 0.0 109.913 -168.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 41.9 39.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.74 2.016 . . . . 0.0 112.513 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.96 -6.59 40.53 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 127.029 2.252 . . . . 0.0 115.637 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.33 176.24 5.57 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.962 1.881 . . . . 0.0 113.829 -168.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.1 m -137.51 152.33 72.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 110.742 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.7 169.32 22.52 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 112.12 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.2 t -45.97 110.49 0.27 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.862 1.665 . . . . 0.0 113.257 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 -12.0 68.09 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.57 -1.683 . . . . 0.0 115.671 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -75.4 170.93 15.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.595 2.198 . . . . 0.0 111.38 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -130.35 148.23 52.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.535 1.534 . . . . 0.0 111.106 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -92.92 114.98 27.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.777 1.231 . . . . 0.0 110.438 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.8 p -67.54 163.12 21.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.826 1.298 . . . . 0.0 114.258 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 CA--C 1.547 0.835 0 C-N-CA 128.686 2.794 . . . . 0.0 115.545 161.401 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 CA-C-O 120.091 -0.283 . . . . 0.0 113.778 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -107.0 149.99 26.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.382 1.473 . . . . 0.0 109.929 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.8 t -118.61 133.74 55.63 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.746 0.818 . . . . 0.0 112.145 -168.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.16 -154.16 10.21 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.527 1.537 . . . . 0.0 111.289 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.29 169.84 16.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.229 1.014 . . . . 0.0 111.594 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.14 169.89 44.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.093 1.33 . . . . 0.0 111.457 -167.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.62 -34.46 92.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.617 2.211 . . . . 0.0 112.121 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -52.72 -33.95 50.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 113.271 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.49 -14.16 15.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.007 1.723 . . . . 0.0 113.712 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.64 104.55 2.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.992 0.517 . . . . 0.0 110.915 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.25 91.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.557 2.343 . . . . 0.0 110.542 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.579 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 43.58 34.63 0.84 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.592 2.357 . . . . 0.0 112.341 -164.043 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 -10.27 56.68 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.324 2.392 . . . . 0.0 116.347 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 160.81 19.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.877 2.339 . . . . 0.0 111.724 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -140.1 134.24 15.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.685 1.194 . . . . 0.0 110.275 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.52 178.38 7.63 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.444 2.763 . . . . 0.0 112.634 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 m 45.42 41.36 6.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.277 2.231 . . . . 0.0 115.423 170.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.53 58.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 113.795 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 79.1 mtm -84.56 164.48 18.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.621 1.211 . . . . 0.0 111.062 168.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 m -112.34 147.31 36.63 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.486 1.914 . . . . 0.0 109.556 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -80.3 112.04 17.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.385 0.674 . . . . 0.0 110.778 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.8 p -66.26 162.64 19.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.867 1.318 . . . . 0.0 113.974 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 CA--C 1.545 0.774 0 C-N-CA 128.41 2.684 . . . . 0.0 115.558 161.797 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.254 0 CA-C-O 119.845 -0.42 . . . . 0.0 114.057 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.59 143.05 50.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.211 1.405 . . . . 0.0 111.652 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -76.46 147.16 38.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.388 1.075 . . . . 0.0 112.675 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.68 -162.15 27.72 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.532 1.063 . . . . 0.0 112.175 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -132.14 166.29 22.14 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.187 0.994 . . . . 0.0 111.51 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.53 175.28 37.23 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.527 1.061 . . . . 0.0 113.601 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -47.87 -43.5 29.35 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.298 3.332 . . . . 0.0 114.273 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -58.1 -26.22 62.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.276 1.43 . . . . 0.0 113.91 -176.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -114.31 -14.65 12.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.602 1.561 . . . . 0.0 113.528 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 122.573 1.177 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.419 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 40.7 m -74.44 179.74 4.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.575 -1.328 . . . . 0.0 110.491 147.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.32 79.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.208 -1.557 . . . . 0.0 107.613 164.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 45.36 47.04 10.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.246 1.418 . . . . 0.0 112.28 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.26 76.61 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.734 1.159 . . . . 0.0 115.463 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.77 172.6 11.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.659 1.984 . . . . 0.0 109.924 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -141.88 154.8 65.88 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 118.973 0.806 . . . . 0.0 112.894 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.17 173.61 11.61 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.903 3.069 . . . . 0.0 111.773 169.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m 36.0 43.18 0.19 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 129.128 2.971 . . . . 0.0 117.086 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.19 31.08 61.71 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.854 1.216 . . . . 0.0 114.253 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -73.87 165.04 25.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.701 1.75 . . . . 0.0 109.561 159.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.3 m -118.32 115.6 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.462 1.505 . . . . 0.0 109.48 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -74.15 89.16 1.98 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.15 164.79 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.776 1.63 . . . . 0.0 114.275 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 . . . . . 0 N--CA 1.468 0.471 0 C-N-CA 125.4 1.48 . . . . 0.0 113.361 176.854 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.12 0 CA-C-O 119.488 -0.618 . . . . 0.0 113.505 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.53 126.52 37.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.952 1.301 . . . . 0.0 111.252 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 69.3 m -67.21 135.91 54.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.252 0.478 . . . . 0.0 111.456 167.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.55 -163.33 17.39 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.622 1.106 . . . . 0.0 112.108 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -132.59 167.0 20.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.443 1.497 . . . . 0.0 110.483 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.43 179.13 34.01 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.683 0.658 . . . . 0.0 113.383 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.51 -28.66 70.57 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.993 2.462 . . . . 0.0 113.442 -171.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -12.01 20.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.842 -1.551 . . . . 0.0 114.505 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.73 -25.93 1.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 113.633 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -61.56 101.65 0.2 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.26 95.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.488 2.315 . . . . 0.0 110.0 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? 47.05 34.41 2.81 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.893 1.277 . . . . 0.0 111.729 -167.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.2 68.46 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 126.982 2.229 . . . . 0.0 116.276 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.27 163.95 15.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.448 2.124 . . . . 0.0 111.682 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -138.38 158.29 70.92 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.804 1.241 . . . . 0.0 110.772 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.66 168.24 25.27 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.872 2.382 . . . . 0.0 112.687 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -43.71 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.249 2.619 . . . . 0.0 114.586 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -7.15 59.48 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.196 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -79.0 170.4 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.791 1.795 . . . . 0.0 111.875 170.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -139.14 163.29 32.82 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.892 2.077 . . . . 0.0 110.542 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -109.54 114.96 29.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.823 1.249 . . . . 0.0 112.091 -166.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.55 157.95 34.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.002 1.321 . . . . 0.0 112.862 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pm0 . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 124.599 1.16 . . . . 0.0 113.484 169.923 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 CA-C-O 119.503 -0.61 . . . . 0.0 113.798 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -114.84 143.76 44.6 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 112.684 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.65 157.56 31.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.551 1.141 . . . . 0.0 112.066 167.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.51 -160.89 34.66 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.281 1.896 . . . . 0.0 109.77 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -142.93 163.06 33.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.514 0.657 . . . . 0.0 110.803 169.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.71 179.11 25.72 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.696 1.141 . . . . 0.0 112.928 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.87 -8.46 23.55 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.902 3.068 . . . . 0.0 114.867 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.21 -2.12 50.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.7 1.6 . . . . 0.0 113.661 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.37 -44.91 1.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.873 1.669 . . . . 0.0 111.767 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.5 m . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 125.88 1.672 . . . . 0.0 111.913 175.081 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.5 m -68.49 103.33 1.64 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.324 0.649 . . . . 0.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -54.54 89.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 128.73 2.812 . . . . 0.0 111.524 -172.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.58 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 37.66 40.09 0.23 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.726 2.81 . . . . 0.0 112.785 -162.432 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.68 -7.46 27.93 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 126.429 1.966 . . . . 0.0 116.559 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -112.45 166.55 11.21 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.573 2.187 . . . . 0.0 113.574 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -142.17 167.07 17.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.331 1.852 . . . . 0.0 110.828 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -54.04 155.53 14.88 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.729 2.953 . . . . 0.0 114.223 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.9 t -62.28 74.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.392 2.277 . . . . 0.0 113.914 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.04 -10.41 2.55 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.026 1.774 . . . . 0.0 114.533 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.0 171.76 10.06 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.261 1.425 . . . . 0.0 111.31 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -123.01 149.69 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.102 1.761 . . . . 0.0 110.101 169.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.94 118.46 21.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.846 0.859 . . . . 0.0 109.974 166.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -78.88 159.22 27.87 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.863 0.839 . . . . 0.0 112.795 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 125.791 1.637 . . . . 0.0 113.872 173.569 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.117 0 CA-C-O 119.491 -0.616 . . . . 0.0 113.743 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.7 140.03 50.58 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.439 1.096 . . . . 0.0 111.823 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m -73.17 153.15 40.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.624 1.569 . . . . 0.0 112.53 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 -170.5 43.64 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.62 0.629 . . . . 0.0 113.953 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -128.45 165.78 20.0 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.323 2.249 . . . . 0.0 110.299 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.89 179.98 52.79 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.069 0.842 . . . . 0.0 113.295 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.67 -26.8 39.35 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 124.585 3.523 . . . . 0.0 116.235 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -71.61 -10.93 60.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -143.95 -52.02 0.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 125.729 1.612 . . . . 0.0 114.142 -159.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 . . . . . 0 CA--C 1.549 0.916 0 CA-C-O 121.656 0.741 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 20.2 m -99.66 146.7 26.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.459 1.504 . . . . 0.0 110.802 141.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -69.09 91.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.47 1.508 . . . . 0.0 110.016 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.421 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 48.68 25.84 1.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.814 -168.276 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.89 39.97 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.588 1.566 . . . . 0.0 116.54 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.29 166.19 11.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.22 2.01 . . . . 0.0 112.16 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -145.49 163.56 31.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.935 -173.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.18 156.46 10.23 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.356 3.37 . . . . 0.0 115.443 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -51.68 102.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.201 2.201 . . . . 0.0 112.59 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.38 -3.75 47.23 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.682 -1.065 . . . . 0.0 114.831 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.46 -175.59 2.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.926 1.863 . . . . 0.0 112.354 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.63 137.86 52.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.081 2.152 . . . . 0.0 109.818 160.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.36 107.81 13.46 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 158.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -77.04 165.77 24.19 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -174.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 125.418 1.487 . . . . 0.0 113.525 171.03 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.05 0 CA-C-O 119.786 -0.452 . . . . 0.0 113.109 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -122.35 133.12 54.66 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.243 2.217 . . . . 0.0 110.261 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 98.5 m -65.99 146.03 55.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 165.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.5 -167.38 39.28 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.091 0.853 . . . . 0.0 113.659 165.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -131.13 169.68 15.56 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.739 2.016 . . . . 0.0 111.539 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.33 178.87 33.14 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.139 0.876 . . . . 0.0 113.76 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.31 -35.66 35.53 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.717 3.612 . . . . 0.0 116.288 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -5.67 40.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -144.01 -30.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -157.309 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 122.211 1.005 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 47.7 m -95.95 128.11 42.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.352 1.861 . . . . 0.0 109.006 145.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.2 90.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 129.163 2.985 . . . . 0.0 111.456 -171.512 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? 44.96 29.81 0.5 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.195 0.998 . . . . 0.0 113.42 -165.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.21 8.22 63.16 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.075 1.322 . . . . 0.0 115.437 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -105.53 174.02 6.06 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.814 2.445 . . . . 0.0 110.654 171.669 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.1 m -140.1 133.26 15.09 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.85 166.48 17.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.807 3.005 . . . . 0.0 111.874 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p 53.97 27.85 7.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.44 34.37 54.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.081 1.324 . . . . 0.0 113.61 -170.043 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.2 mtt -67.17 170.47 6.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 110.687 163.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 m -130.34 148.83 52.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.386 1.474 . . . . 0.0 110.341 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 t -91.96 109.41 20.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.35 1.06 . . . . 0.0 111.856 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 87.2 p -66.43 165.8 13.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.703 1.201 . . . . 0.0 113.811 177.1 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 127.212 2.205 . . . . 0.0 114.447 170.357 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -120.16 126.13 49.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.276 2.231 . . . . 0.0 109.93 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 86.9 m -68.06 149.4 49.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 170.323 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.48 -159.25 21.14 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.773 1.654 . . . . 0.0 111.846 173.423 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.14 157.2 40.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.842 1.257 . . . . 0.0 110.981 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.31 -175.96 49.88 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.414 0.925 . . . . 0.0 115.414 171.887 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.01 -22.25 38.04 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.918 3.745 . . . . 0.0 117.284 -170.206 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.39 1.22 57.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.776 1.23 . . . . 0.0 113.319 176.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 86.6 m-85 -129.6 -44.34 1.23 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.636 1.174 . . . . 0.0 112.403 -176.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 123.591 0.756 . . . . 0.0 113.028 170.861 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 . . . . . 0 CA--C 1.543 0.676 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m -65.49 108.35 1.97 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.706 -0.621 . . . . 0.0 111.713 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.71 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.862 2.065 . . . . 0.0 110.639 -174.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.518 ' H ' ' CZ ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 40.59 43.81 1.65 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.739 2.016 . . . . 0.0 111.405 -162.556 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.04 70.88 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.982 1.753 . . . . 0.0 116.089 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.0 20.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.441 2.121 . . . . 0.0 111.433 176.287 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.8 m -142.37 154.61 64.04 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.036 1.334 . . . . 0.0 111.469 174.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -77.27 174.32 12.95 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.613 2.875 . . . . 0.0 111.95 175.409 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m 37.34 45.66 0.55 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.191 2.596 . . . . 0.0 116.137 167.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.86 30.78 22.8 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.746 1.641 . . . . 0.0 114.125 -176.329 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.8 mtt -74.37 159.94 31.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.622 1.211 . . . . 0.0 111.579 177.779 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.4 m -87.63 120.97 29.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.445 1.498 . . . . 0.0 109.448 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.0 t -67.67 101.14 0.98 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 160.52 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -75.31 163.6 27.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -174.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 125.521 1.529 . . . . 0.0 113.504 173.541 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.206 0 N-CA-C 114.074 0.39 . . . . 0.0 114.074 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -128.58 146.9 50.71 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.287 1.035 . . . . 0.0 112.02 -172.155 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.76 147.81 37.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.882 2.073 . . . . 0.0 112.438 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.86 -169.69 42.83 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.38 0.514 . . . . 0.0 113.77 163.704 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -130.12 159.97 35.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.491 1.916 . . . . 0.0 108.993 170.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.87 173.67 47.85 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 123.903 0.763 . . . . 0.0 112.744 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -45.9 34.13 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.155 3.237 . . . . 0.0 115.53 -167.679 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 0.28 1.23 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.615 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -137.61 -38.62 0.59 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.239 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 125.281 1.432 . . . . 0.0 113.702 -176.129 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 123.134 1.445 . . . . 0.0 113.78 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.5 m -82.17 132.59 35.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 144.158 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.36 86.2 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.872 1.269 . . . . 0.0 111.479 -161.248 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.16 42.89 25.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.673 1.189 . . . . 0.0 111.22 -159.462 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.15 -10.04 65.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.012 1.768 . . . . 0.0 115.03 177.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -103.01 172.38 6.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.83 1.315 . . . . 0.0 113.328 -167.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.75 157.61 64.45 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.909 2.084 . . . . 0.0 110.784 176.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.64 161.09 42.79 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.877 2.385 . . . . 0.0 111.893 165.531 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -55.27 92.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.238 2.215 . . . . 0.0 113.48 -173.746 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.76 -10.83 10.3 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.219 1.39 . . . . 0.0 114.5 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.3 mtt -88.62 167.12 13.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.868 1.334 . . . . 0.0 111.228 166.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 m -137.44 142.01 41.61 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.944 1.698 . . . . 0.0 110.858 -172.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.4 t -83.93 108.18 16.76 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.467 1.107 . . . . 0.0 110.128 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.1 p -71.44 161.72 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.823 0.82 . . . . 0.0 113.034 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 125.843 1.657 . . . . 0.0 113.864 174.255 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.025 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.18 127.88 49.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.838 1.655 . . . . 0.0 110.661 -173.401 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.0 t -83.51 144.76 29.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.875 0.87 . . . . 0.0 112.387 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.48 -165.2 33.21 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.319 0.961 . . . . 0.0 112.644 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -136.41 162.59 32.62 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.397 1.079 . . . . 0.0 111.864 176.962 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.68 -173.68 42.12 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.161 0.886 . . . . 0.0 112.953 -173.815 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -44.31 -47.98 10.26 Favored 'Trans proline' 0 C--N 1.35 0.652 1 C-N-CA 125.407 4.072 . . . . 0.0 115.612 -172.605 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -65.69 -6.53 11.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.891 1.676 . . . . 0.0 115.522 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -139.64 -56.0 0.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.005 0.922 . . . . 0.0 113.033 -171.748 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 126.567 1.947 . . . . 0.0 113.553 -170.881 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 121.386 0.612 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.2 m -85.76 107.44 17.61 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 139.433 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -55.43 95.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.964 1.706 . . . . 0.0 111.524 -158.211 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? 45.28 36.06 2.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.085 1.754 . . . . 0.0 112.335 -169.545 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.92 -4.65 59.23 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 127.697 2.57 . . . . 0.0 115.873 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.76 8.5 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.264 2.032 . . . . 0.0 113.087 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.34 152.02 74.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.148 . . . . 0.0 109.661 169.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.65 165.96 4.16 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.783 2.989 . . . . 0.0 113.257 162.473 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.64 98.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.703 2.401 . . . . 0.0 114.07 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.53 4.61 89.11 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.466 176.483 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt -77.6 172.91 12.64 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.797 1.798 . . . . 0.0 112.105 171.923 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 m -128.61 133.96 48.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.376 1.87 . . . . 0.0 110.62 -169.931 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.5 t -81.99 125.97 31.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.909 -0.494 . . . . 0.0 110.672 173.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -79.2 154.32 29.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 173.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 CA--C 1.541 0.618 0 O-C-N 121.46 -0.775 . . . . 0.0 112.845 169.725 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.916 0 CA-C-O 119.204 -0.776 . . . . 0.0 114.177 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -115.41 131.08 57.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.41 1.484 . . . . 0.0 109.864 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.44 149.89 36.79 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.491 0.316 . . . . 0.0 111.791 169.243 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.46 -159.17 23.03 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.871 1.224 . . . . 0.0 112.001 175.47 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -139.31 154.48 47.92 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.991 0.916 . . . . 0.0 110.079 175.089 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.41 176.92 28.73 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.857 1.218 . . . . 0.0 112.799 -173.788 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.88 -53.06 6.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.546 3.498 . . . . 0.0 114.467 -174.042 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -56.62 -12.19 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.337 1.855 . . . . 0.0 114.888 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.07 -39.11 2.85 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.882 1.673 . . . . 0.0 112.943 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.7 m . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.091 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 CA--C 1.554 1.097 0 CA-C-O 121.074 0.464 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.49 107.52 15.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 130.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.01 101.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 126.693 1.997 . . . . 0.0 110.425 -170.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 48.9 33.2 4.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.586 1.155 . . . . 0.0 112.379 -170.313 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.78 68.33 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.898 2.189 . . . . 0.0 115.269 -178.298 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -121.38 164.21 17.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.774 1.787 . . . . 0.0 112.597 -174.622 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.35 173.83 4.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.441 2.297 . . . . 0.0 108.878 163.881 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.58 136.07 16.15 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.75 2.966 . . . . 0.0 113.755 173.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.8 p -58.31 97.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.107 1.763 . . . . 0.0 112.254 -174.81 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.31 -19.88 4.51 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.441 1.496 . . . . 0.0 112.969 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.3 mtp -82.37 158.95 23.15 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.211 1.005 . . . . 0.0 109.645 159.206 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.6 m -143.29 139.6 30.21 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.834 1.254 . . . . 0.0 110.156 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -70.93 155.3 40.98 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 177.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -126.83 166.38 17.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.879 1.271 . . . . 0.0 113.219 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 124.951 1.3 . . . . 0.0 114.067 174.95 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.64 137.0 50.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.45 1.5 . . . . 0.0 110.033 -171.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 151.71 30.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 166.509 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.5 -162.22 26.82 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.918 1.246 . . . . 0.0 112.015 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -138.25 163.98 30.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.819 1.648 . . . . 0.0 110.714 172.683 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.45 -175.66 46.01 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 123.609 0.623 . . . . 0.0 113.232 -176.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.53 -36.38 31.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 125.178 3.919 . . . . 0.0 116.77 -171.038 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.94 -9.65 58.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 178.742 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.74 -47.84 0.5 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -168.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -174.127 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.8 m -95.27 112.94 24.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.684 1.994 . . . . 0.0 107.268 151.109 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.0 103.07 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.536 1.134 . . . . 0.0 110.44 -163.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.26 30.5 4.44 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.366 1.066 . . . . 0.0 112.156 -165.124 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.26 -7.69 81.51 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.184 1.85 . . . . 0.0 115.198 -174.389 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.8 171.93 8.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.584 1.692 . . . . 0.0 112.016 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.0 m -143.14 149.17 47.79 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.363 1.865 . . . . 0.0 111.521 -172.519 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.02 -178.27 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 125.261 3.974 . . . . 0.0 114.991 165.09 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -38.96 92.3 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.644 3.178 . . . . 0.0 115.311 -177.47 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.38 30.13 61.24 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.62 1.105 . . . . 0.0 113.588 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.4 mtt -85.71 170.04 12.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 110.813 170.212 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.16 142.32 35.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.22 1.808 . . . . 0.0 110.734 -164.306 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.6 113.13 23.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.564 1.145 . . . . 0.0 110.555 -177.355 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.9 p -71.58 165.87 23.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.148 0.975 . . . . 0.0 113.504 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 127.347 2.259 . . . . 0.0 114.683 170.906 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -111.65 123.04 49.4 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.43 1.892 . . . . 0.0 108.906 -178.114 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.77 142.69 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.246 0.476 . . . . 0.0 112.02 178.183 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.91 -161.47 19.21 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.951 1.739 . . . . 0.0 110.33 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -132.59 150.0 52.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.769 1.285 . . . . 0.0 110.779 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 -160.64 30.33 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 115.406 0.923 . . . . 0.0 115.406 172.657 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.88 4.29 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 125.109 3.873 . . . . 0.0 116.151 -160.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.32 5.44 9.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.053 1.741 . . . . 0.0 112.737 174.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -129.24 -57.44 1.15 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.487 1.515 . . . . 0.0 110.378 177.936 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 m . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.029 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.787 -0.149 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.1 m -57.92 160.07 5.01 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.654 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -74.9 56.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.983 1.713 . . . . 0.0 109.293 168.782 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 52.82 38.36 26.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.915 3.286 . . . . 0.0 112.417 -179.577 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.39 -12.55 7.94 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.578 2.037 . . . . 0.0 115.058 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 mtm-85 -115.36 168.52 9.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.614 1.566 . . . . 0.0 111.012 177.697 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -144.98 167.17 15.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.367 1.067 . . . . 0.0 112.798 -172.433 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.07 166.13 1.71 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 124.512 3.474 . . . . 0.0 114.59 168.765 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -39.16 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 128.531 2.733 . . . . 0.0 114.749 -174.149 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.35 3.16 81.81 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.49 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.9 mmt -80.03 161.95 25.13 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.368 1.584 . . . . 0.0 110.722 173.096 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.54 129.51 54.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.85 1.26 . . . . 0.0 110.639 -172.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.28 107.92 8.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.305 0.642 . . . . 0.0 109.979 174.081 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -57.71 148.73 23.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.673 1.189 . . . . 0.0 111.123 170.161 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 127.238 2.215 . . . . 0.0 114.197 169.91 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -126.69 140.44 52.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.891 1.276 . . . . 0.0 112.897 -170.781 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.6 m -84.09 142.76 30.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.513 1.525 . . . . 0.0 113.257 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.57 -163.66 36.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.863 0.744 . . . . 0.0 113.269 172.589 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -137.47 166.7 23.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.941 1.696 . . . . 0.0 110.773 174.097 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.19 -176.62 51.72 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 123.704 0.668 . . . . 0.0 113.257 -174.455 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.06 -39.92 41.18 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.037 3.825 . . . . 0.0 116.109 -170.236 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -11.09 58.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.889 1.276 . . . . 0.0 113.501 179.478 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -138.85 -45.61 0.48 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -168.094 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -169.031 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 CA--C 1.55 0.977 0 CA-C-O 121.658 0.742 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.459 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 30.5 m -92.83 114.85 27.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.839 1.256 . . . . 0.0 108.034 133.111 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.56 95.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.733 2.013 . . . . 0.0 110.877 -166.723 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? 48.14 30.86 2.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.075 0.95 . . . . 0.0 112.244 -166.377 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -6.47 77.66 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 126.856 2.17 . . . . 0.0 116.01 -175.377 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 167.9 12.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.232 2.016 . . . . 0.0 111.094 175.187 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -139.93 141.76 28.39 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.785 0.834 . . . . 0.0 112.545 175.856 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.57 172.92 9.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.985 3.124 . . . . 0.0 112.171 177.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t 43.66 39.57 2.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.943 2.097 . . . . 0.0 116.245 165.041 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.66 31.68 60.76 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.919 1.247 . . . . 0.0 113.95 -176.163 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.2 mtt -76.82 163.64 26.58 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.817 1.308 . . . . 0.0 110.39 164.969 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.0 m -115.42 145.95 42.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.615 1.966 . . . . 0.0 109.814 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -80.32 110.93 16.22 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.284 0.634 . . . . 0.0 111.105 177.118 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.7 p -71.37 166.3 21.95 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -176.653 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 128.22 2.608 . . . . 0.0 115.433 163.899 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 CA-C-O 119.894 -0.392 . . . . 0.0 113.242 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.03 131.25 53.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.332 2.253 . . . . 0.0 110.274 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m -62.63 143.23 57.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.534 0.606 . . . . 0.0 112.508 168.524 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.67 -159.95 15.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.121 1.82 . . . . 0.0 111.538 168.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -133.89 166.3 23.0 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.167 1.483 . . . . 0.0 112.355 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.5 170.95 29.14 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.312 1.434 . . . . 0.0 113.352 -175.037 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -48.37 -41.17 36.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.155 3.236 . . . . 0.0 113.888 -178.121 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -27.06 16.85 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.991 2.116 . . . . 0.0 114.208 177.903 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -119.15 -8.81 10.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.317 1.447 . . . . 0.0 113.459 177.178 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.568 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.1 m -65.64 100.88 0.56 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.008 -0.433 . . . . 0.0 110.93 178.581 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.14 89.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 128.527 2.731 . . . . 0.0 110.004 -170.821 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.448 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 7.3 mmp_? 40.38 46.68 2.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.669 1.988 . . . . 0.0 111.242 -164.37 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.06 -10.84 71.53 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.848 2.166 . . . . 0.0 115.453 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -96.69 163.75 12.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.747 1.774 . . . . 0.0 111.432 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.4 m -144.15 162.59 39.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.045 1.338 . . . . 0.0 110.541 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -54.5 157.06 12.69 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 124.084 3.19 . . . . 0.0 114.723 175.02 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.17 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.034 2.134 . . . . 0.0 113.379 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.04 64.08 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.668 -1.074 . . . . 0.0 114.845 178.588 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 44.0 mtt -83.33 166.48 18.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.077 1.438 . . . . 0.0 111.553 165.893 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.73 140.33 50.1 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.481 1.512 . . . . 0.0 110.313 173.485 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.21 109.06 6.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 163.177 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.8 p -75.81 160.52 29.88 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.776 0.798 . . . . 0.0 112.944 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 125.971 1.709 . . . . 0.0 113.947 175.743 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.186 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -127.94 145.94 50.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.278 1.039 . . . . 0.0 112.485 -174.175 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.5 m -76.88 151.77 35.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.923 1.689 . . . . 0.0 112.536 176.405 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.48 -167.38 40.52 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.604 0.621 . . . . 0.0 113.544 168.719 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -132.4 169.0 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.897 1.679 . . . . 0.0 112.142 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.55 -179.02 34.32 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 123.849 0.738 . . . . 0.0 113.651 -178.827 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.45 -29.52 31.65 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.535 3.49 . . . . 0.0 116.157 -173.46 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.29 -8.16 54.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 116.737 -1.601 . . . . 0.0 115.157 177.117 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -147.15 -39.32 0.2 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.705 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 125.439 1.496 . . . . 0.0 114.47 -159.658 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 CA--C 1.555 1.164 0 CA-C-O 121.83 0.824 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.96 107.94 12.07 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 124.568 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.75 99.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.623 2.369 . . . . 0.0 110.717 -169.665 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 41.39 43.04 2.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.345 1.458 . . . . 0.0 112.791 -170.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.16 -3.45 60.11 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.45 2.452 . . . . 0.0 115.262 178.874 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -128.41 -175.53 3.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.175 1.487 . . . . 0.0 112.516 -165.409 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.56 169.95 8.51 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.427 1.891 . . . . 0.0 107.551 160.753 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.5 164.61 15.08 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.84 2.36 . . . . 0.0 114.08 173.289 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -54.76 104.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.217 1.807 . . . . 0.0 111.648 177.487 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.94 -2.85 24.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.753 1.168 . . . . 0.0 114.296 -177.95 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -113.43 169.41 8.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.912 1.356 . . . . 0.0 109.938 170.604 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -141.58 157.11 45.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 0.0 112.337 -172.417 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.46 112.15 24.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.619 1.568 . . . . 0.0 111.663 -172.631 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.5 p -67.31 164.19 18.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -173.777 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 129.159 2.983 . . . . 0.0 115.706 162.648 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.297 0 CA-C-O 119.528 -0.596 . . . . 0.0 113.598 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.4 130.02 53.36 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.52 1.928 . . . . 0.0 109.649 177.682 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.5 p -93.38 159.83 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -176.378 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.2 -149.33 9.78 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.368 1.937 . . . . 0.0 111.488 -167.37 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -135.72 159.4 41.75 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 118.971 1.385 . . . . 0.0 112.526 -176.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.44 174.86 46.67 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.592 1.091 . . . . 0.0 113.626 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -45.49 -46.53 14.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.686 3.591 . . . . 0.0 114.673 -172.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -55.56 -24.4 32.23 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.511 1.924 . . . . 0.0 114.295 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -109.6 -27.54 9.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.362 1.865 . . . . 0.0 113.089 175.544 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.79 1.236 . . . . 0.0 113.87 -176.155 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.67 -102.47 1.3 Allowed Glycine 0 C--O 1.221 -0.676 0 N-CA-C 105.586 -3.006 . . . . 0.0 105.586 -149.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -65.56 148.37 51.84 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.292 1.546 . . . . 0.0 112.247 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.8 m -75.55 101.37 4.87 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.239 -0.913 . . . . 0.0 108.943 155.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.39 105.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.306 1.042 . . . . 0.0 110.179 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.9 27.2 4.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.167 0.987 . . . . 0.0 111.231 -169.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.88 -4.52 81.74 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.412 1.958 . . . . 0.0 115.65 -174.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 167.29 13.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 2.004 . . . . 0.0 112.488 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.1 m -134.23 154.89 80.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.813 2.045 . . . . 0.0 110.448 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.36 176.68 9.76 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.151 2.567 . . . . 0.0 111.646 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -29.7 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 129.431 3.092 . . . . 0.0 115.416 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.12 3.57 81.78 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.047 -1.418 . . . . 0.0 116.02 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -77.0 169.16 18.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.139 1.969 . . . . 0.0 112.173 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 m -132.62 157.92 43.56 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.811 1.645 . . . . 0.0 111.192 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -112.14 116.2 30.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.673 1.189 . . . . 0.0 112.403 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.1 p -68.98 163.48 24.49 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.359 1.464 . . . . 0.0 113.624 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -57.75 -18.24 20.27 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 113.944 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.5 19.15 78.85 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 118.497 0.589 . . . . 0.0 112.663 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.48 135.62 51.79 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 110.654 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.4 t -109.68 137.62 47.22 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.434 2.294 . . . . 0.0 111.409 -169.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.8 -160.88 24.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.321 1.439 . . . . 0.0 111.478 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -133.17 126.31 31.37 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.772 0.829 . . . . 0.0 109.665 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.94 178.09 22.0 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.579 1.085 . . . . 0.0 112.754 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -48.04 -53.93 5.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.839 3.693 . . . . 0.0 114.521 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.69 -8.69 55.67 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -100.24 -51.69 3.59 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.041 0.937 . . . . 0.0 111.124 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.1 m -95.71 -22.46 17.53 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.254 1.022 . . . . 0.0 113.689 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.97 -132.38 7.66 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 158.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.741 1.616 . . . . 0.0 110.066 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.268 12.3 p . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.971 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.17 35.9 0.93 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.034 1.778 . . . . 0.0 113.343 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 154.2 139.42 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 1 C-N-CA 133.881 4.872 . . . . 0.0 107.841 -157.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.5 m -72.21 117.83 14.34 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.587 -1.321 . . . . 0.0 109.287 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 85.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 129.205 3.002 . . . . 0.0 110.307 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.585 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 40.39 42.75 1.33 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.194 2.198 . . . . 0.0 111.211 -161.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -13.65 66.12 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.579 2.037 . . . . 0.0 116.235 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.36 174.68 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.2 2.0 . . . . 0.0 111.01 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 m -141.12 163.9 39.2 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.536 1.134 . . . . 0.0 110.792 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.57 168.77 1.42 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 124.255 3.304 . . . . 0.0 114.668 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.8 m -44.46 100.11 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.402 2.281 . . . . 0.0 114.258 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.26 -1.62 84.58 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.722 1.153 . . . . 0.0 115.191 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -80.5 161.58 24.77 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.749 1.275 . . . . 0.0 110.966 168.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.9 m -138.2 156.12 48.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.383 1.473 . . . . 0.0 110.862 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -89.01 114.06 25.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.745 1.218 . . . . 0.0 111.379 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 4.8 t -70.73 168.22 17.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 113.233 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.73 -4.81 2.26 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.359 1.864 . . . . 0.0 115.43 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.23 33.87 27.79 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.269 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -123.51 149.46 45.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.195 1.798 . . . . 0.0 111.538 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -94.97 149.98 20.65 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.14 -165.16 37.79 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.564 1.078 . . . . 0.0 112.081 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -135.0 167.43 20.95 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.514 1.526 . . . . 0.0 111.591 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.62 -174.65 48.56 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.807 0.718 . . . . 0.0 113.101 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.9 -36.12 26.23 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.025 3.817 . . . . 0.0 116.151 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.61 -9.35 58.48 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 88.3 m-85 -139.25 -44.85 0.46 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -170.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.65 4.05 0.87 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -173.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.91 -45.06 2.67 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.628 -1.295 . . . . 0.0 112.346 -166.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.226 0 CA-C-O 115.803 -2.046 . . . . 0.0 113.907 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.51 10.41 73.6 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.464 -1.186 . . . . 0.0 114.931 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -48.0 106.58 0.1 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.697 1.999 . . . . 0.0 111.356 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.8 m -50.39 154.19 1.34 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.517 1.127 . . . . 0.0 113.852 -163.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.05 70.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 123.573 1.654 . . . . 0.0 108.756 172.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? 33.33 50.23 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 1 C-N-CA 132.41 4.284 . . . . 0.0 112.559 -172.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.18 -17.92 10.44 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 127.295 2.379 . . . . 0.0 114.943 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.52 164.7 12.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.274 1.537 . . . . 0.0 111.493 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.1 m -144.7 168.11 13.09 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.364 1.466 . . . . 0.0 111.34 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.69 156.8 8.41 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.966 3.111 . . . . 0.0 114.211 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -52.85 97.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.746 2.018 . . . . 0.0 113.302 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.36 39.65 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.916 1.245 . . . . 0.0 114.85 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -94.07 167.79 11.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.801 1.301 . . . . 0.0 111.506 168.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.4 143.5 48.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.453 1.501 . . . . 0.0 110.681 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -83.08 109.02 16.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.449 0.7 . . . . 0.0 110.199 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.0 p -70.6 164.32 25.14 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -57.56 -17.4 13.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.173 1.389 . . . . 0.0 114.582 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.11 17.59 80.22 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.84 0.733 . . . . 0.0 112.935 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -114.49 131.67 56.55 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.856 1.663 . . . . 0.0 110.228 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.8 m -73.57 152.67 40.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.965 1.306 . . . . 0.0 112.63 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.62 -167.18 40.23 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.098 0.856 . . . . 0.0 111.987 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.41 167.28 21.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 110.905 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.86 -172.96 54.6 Favored Glycine 0 CA--C 1.54 1.595 0 O-C-N 121.9 -0.5 . . . . 0.0 113.565 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -42.4 -48.05 7.01 Favored 'Trans proline' 0 C--N 1.351 0.689 1 C-N-CA 125.925 4.417 . . . . 0.0 116.915 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -70.94 -9.36 57.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -134.71 -60.73 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.915 0.886 . . . . 0.0 112.178 -168.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 96.8 m -117.36 -1.15 11.82 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.313 1.845 . . . . 0.0 112.907 -172.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.39 -42.46 1.95 Allowed Glycine 0 CA--C 1.537 1.467 0 O-C-N 120.886 -1.134 . . . . 0.0 113.154 -170.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.197 0 C-N-CA 127.426 2.29 . . . . 0.0 111.754 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.23 -52.47 1.41 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -156.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -155.62 -176.29 5.88 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 127.665 2.386 . . . . 0.0 111.101 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 58.8 m -87.09 126.24 34.64 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 138.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.71 92.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.585 2.354 . . . . 0.0 110.664 -168.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 37.74 46.04 0.7 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.32 1.848 . . . . 0.0 112.266 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.08 -10.29 65.7 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.0 2.238 . . . . 0.0 115.554 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -103.19 179.14 4.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.457 1.629 . . . . 0.0 112.669 -173.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 m -138.8 158.9 69.19 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.342 1.857 . . . . 0.0 110.423 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.96 163.05 39.86 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.562 2.175 . . . . 0.0 111.485 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.4 p -56.77 93.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.519 1.928 . . . . 0.0 112.78 -173.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.6 -11.91 10.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.499 1.523 . . . . 0.0 114.604 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -91.31 169.39 10.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.793 1.796 . . . . 0.0 111.883 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 p -142.8 164.56 29.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.514 1.526 . . . . 0.0 111.762 -174.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.0 t -120.36 111.12 17.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.359 1.064 . . . . 0.0 112.352 -157.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -69.73 161.95 28.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 113.917 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -61.88 -22.11 65.28 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.209 1.004 . . . . 0.0 113.625 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.42 40.46 39.86 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.83 114.78 17.67 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.475 1.51 . . . . 0.0 110.636 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 4' ' ' CYS . 43.4 t -78.74 148.32 33.07 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.463 0.705 . . . . 0.0 111.682 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.61 -152.26 13.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.992 1.758 . . . . 0.0 110.641 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -138.9 160.09 40.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.833 0.853 . . . . 0.0 110.915 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.31 172.2 13.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.044 1.783 . . . . 0.0 111.515 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.56 -34.27 75.62 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.882 2.388 . . . . 0.0 112.409 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -11.11 60.66 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -106.5 -45.36 4.27 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.995 1.318 . . . . 0.0 110.997 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.0 m -91.13 -16.98 26.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.618 1.167 . . . . 0.0 112.886 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.89 165.64 17.61 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 152.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? . . . . . 0 C--O 1.245 0.831 0 O-C-N 122.363 -0.492 . . . . 0.0 112.019 -175.378 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.1 -50.83 2.37 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -161.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -150.73 -176.7 5.62 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.251 1.82 . . . . 0.0 110.622 166.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.4 m -94.26 110.08 21.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.909 1.684 . . . . 0.0 106.51 136.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.79 101.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.773 1.629 . . . . 0.0 111.373 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 48.51 27.05 1.32 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.405 1.482 . . . . 0.0 112.917 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.51 -15.74 14.7 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.37 2.414 . . . . 0.0 116.644 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.46 171.22 14.44 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.074 2.437 . . . . 0.0 112.917 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -146.86 156.17 47.82 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 123.105 0.562 . . . . 0.0 112.338 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.98 177.94 8.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.041 3.161 . . . . 0.0 112.996 -172.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.8 p 59.68 24.54 13.41 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.86 96.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.489 1.043 . . . . 0.0 112.704 -169.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.6 mtt -69.47 169.95 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.224 1.012 . . . . 0.0 110.739 160.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -140.4 155.43 46.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.143 1.777 . . . . 0.0 110.744 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -94.13 121.77 35.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.11 1.364 . . . . 0.0 113.212 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p -72.14 152.39 42.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.423 -0.798 . . . . 0.0 111.504 166.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 pm0 -58.0 -14.42 6.48 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.345 1.858 . . . . 0.0 114.187 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.73 18.93 69.22 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.318 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -121.17 122.33 39.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.154 1.781 . . . . 0.0 109.426 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.97 164.52 19.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.72 -151.11 10.08 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.8 2.143 . . . . 0.0 110.435 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -137.37 156.61 48.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.943 1.297 . . . . 0.0 110.335 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.45 -167.4 23.47 Favored Glycine 0 CA--C 1.542 1.76 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.49 4.94 2.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.857 3.705 . . . . 0.0 115.675 -164.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 4.49 9.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.697 1.999 . . . . 0.0 112.608 176.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.8 -44.03 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.122 1.769 . . . . 0.0 111.878 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m -90.6 -59.44 2.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.841 1.656 . . . . 0.0 107.927 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.48 168.94 34.09 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 157.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 116.399 -1.762 . . . . 0.0 111.442 -171.656 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 81.5 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.49 114.37 2.58 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 131.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 68.52 132.28 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.594 2.357 . . . . 0.0 112.842 -160.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -60.11 101.73 0.14 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -57.28 96.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 128.281 2.632 . . . . 0.0 110.865 -164.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? 48.79 29.55 2.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -167.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.46 -2.61 67.93 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.222 2.344 . . . . 0.0 116.23 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 165.91 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.272 2.036 . . . . 0.0 111.887 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m -141.57 130.83 12.5 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.999 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -80.6 168.79 17.59 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.635 2.89 . . . . 0.0 112.779 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p 55.06 28.13 10.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.21 35.55 60.44 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.92 1.248 . . . . 0.0 113.32 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -67.99 167.11 14.44 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.387 1.093 . . . . 0.0 110.501 162.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.41 135.22 54.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.96 2.104 . . . . 0.0 108.874 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 t -75.56 137.33 40.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.04 0.536 . . . . 0.0 110.558 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -117.68 163.93 15.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 113.969 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -57.88 -23.9 55.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.622 1.569 . . . . 0.0 113.063 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.07 11.04 85.11 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 125.478 1.513 . . . . 0.0 113.39 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -121.84 155.71 34.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.94 1.696 . . . . 0.0 110.692 -168.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -86.62 156.03 20.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.824 0.85 . . . . 0.0 111.794 170.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.01 -174.12 41.38 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.832 1.206 . . . . 0.0 110.162 159.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -124.51 149.46 46.88 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.721 1.261 . . . . 0.0 110.557 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 179.12 52.17 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 123.523 0.582 . . . . 0.0 113.422 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.44 -20.13 61.12 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 114.444 -166.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.51 -21.41 16.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.992 1.317 . . . . 0.0 113.183 170.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -133.15 -42.76 0.87 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.426 1.49 . . . . 0.0 111.451 -173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m -69.93 -12.38 61.57 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.04 -0.6 76.81 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 118.355 -1.247 . . . . 0.0 113.987 163.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.264 0.8 OUTLIER . . . . . 0 C--O 1.248 1.025 0 C-N-CA 129.473 3.109 . . . . 0.0 113.174 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.55 -45.89 2.73 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.156 0.884 . . . . 0.0 113.029 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -158.76 169.02 25.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.016 1.326 . . . . 0.0 111.169 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 61.7 m -100.86 109.95 21.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.759 1.624 . . . . 0.0 107.361 139.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -53.39 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.831 2.452 . . . . 0.0 110.747 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 48.85 27.08 1.47 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.815 2.046 . . . . 0.0 113.549 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.23 -11.03 33.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.946 2.212 . . . . 0.0 115.008 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 170.8 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.096 1.948 . . . . 0.0 112.657 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.6 m -136.4 167.68 20.5 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.967 1.307 . . . . 0.0 110.493 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.96 146.15 17.48 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.706 2.938 . . . . 0.0 112.568 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.7 m -66.31 82.28 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.137 1.375 . . . . 0.0 112.177 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.26 -17.57 2.7 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.326 1.917 . . . . 0.0 113.674 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mmt -80.29 177.04 9.24 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.658 1.229 . . . . 0.0 111.457 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.9 m -127.0 163.83 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.177 2.191 . . . . 0.0 110.124 169.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.51 118.88 37.81 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.73 1.212 . . . . 0.0 110.55 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.7 p -71.21 166.94 20.45 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -51.75 -8.82 0.07 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.22 2.608 . . . . 0.0 115.297 162.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.82 23.98 77.27 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.02 0.827 . . . . 0.0 113.235 -172.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -120.59 133.97 55.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.237 2.615 . . . . 0.0 110.397 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 71.1 m -65.59 155.79 34.71 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.01 -160.13 29.84 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.139 1.828 . . . . 0.0 111.534 170.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.29 174.06 10.89 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.486 1.143 . . . . 0.0 111.207 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.93 169.98 42.3 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 124.656 1.122 . . . . 0.0 112.05 -166.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.37 -36.95 85.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.979 2.453 . . . . 0.0 112.358 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -55.6 -24.06 30.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.323 1.849 . . . . 0.0 114.16 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.9 -1.25 12.61 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.902 1.281 . . . . 0.0 113.502 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.08 -4.42 6.25 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.57 -49.54 0.04 OUTLIER Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.68 1.032 . . . . 0.0 115.68 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.381 0 CA-C-N 119.083 1.441 . . . . 0.0 112.957 -169.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.07 113.34 0.83 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -151.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -42.04 144.59 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.818 1.647 . . . . 0.0 111.559 170.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.5 m -65.45 90.48 0.11 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 157.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.7 t -55.49 93.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 128.457 2.703 . . . . 0.0 111.068 -160.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 46.36 36.88 3.68 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.879 1.672 . . . . 0.0 112.796 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.69 -6.83 11.28 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.212 2.339 . . . . 0.0 117.516 171.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.24 167.42 20.4 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.998 2.399 . . . . 0.0 114.793 -170.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.6 m -132.12 161.79 60.68 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.419 . . . . 0.0 110.584 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.9 154.89 15.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.731 2.954 . . . . 0.0 113.364 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -49.91 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.98 2.112 . . . . 0.0 114.032 -173.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.17 -7.77 58.74 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.049 1.309 . . . . 0.0 114.85 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.1 mtp -76.77 161.61 28.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.52 1.66 . . . . 0.0 110.383 166.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.3 m -126.43 121.01 31.22 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.898 0.879 . . . . 0.0 110.511 -161.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.71 107.13 3.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.121 0.968 . . . . 0.0 110.748 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -73.26 156.1 38.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.297 0.57 . . . . 0.0 112.247 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.0 pm0 -56.89 -17.97 11.46 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.575 1.95 . . . . 0.0 114.329 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.2 16.66 53.15 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.658 1.123 . . . . 0.0 113.969 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -129.41 136.25 49.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.455 1.102 . . . . 0.0 112.124 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.9 m -71.76 157.69 37.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.915 1.686 . . . . 0.0 112.541 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.65 -163.63 33.48 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.106 0.86 . . . . 0.0 112.927 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -141.7 170.73 15.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.911 2.084 . . . . 0.0 108.445 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.83 -171.59 50.19 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 118.565 0.621 . . . . 0.0 113.879 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.49 -38.64 72.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.316 2.678 . . . . 0.0 114.825 -161.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.507 ' HE3' ' CZ ' ' A' ' 27' ' ' TYR . 3.3 ttpp -73.45 -2.57 23.02 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.507 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 72.5 m-85 -140.26 -34.56 0.53 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -171.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.85 1.77 0.79 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.91 -61.3 2.55 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 121.053 -1.029 . . . . 0.0 111.16 -164.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? . . . . . 0 C--O 1.257 1.466 0 C-N-CA 126.673 1.989 . . . . 0.0 110.948 179.128 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 117.451 -1.261 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.23 81.95 0.19 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 120.48 1.491 . . . . 0.0 113.421 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -53.26 154.84 3.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.994 1.317 . . . . 0.0 113.976 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 m -69.87 95.04 0.88 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -62.63 89.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.863 2.065 . . . . 0.0 111.366 -161.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? 57.69 26.58 13.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.188 1.795 . . . . 0.0 113.336 -166.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.01 -13.68 5.76 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.197 1.38 . . . . 0.0 116.44 166.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.31 170.53 14.94 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.795 1.797 . . . . 0.0 113.685 -171.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.2 m -128.1 161.75 54.24 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.287 1.835 . . . . 0.0 110.991 -173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.59 159.37 53.0 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.822 2.348 . . . . 0.0 112.184 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.6 p -60.14 92.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.822 . . . . 0.0 112.104 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -15.86 4.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.44 1.495 . . . . 0.0 113.725 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -112.49 164.66 13.03 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.739 1.27 . . . . 0.0 111.293 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.2 m -132.13 148.82 52.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.919 1.688 . . . . 0.0 109.92 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -82.58 148.44 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.148 0.579 . . . . 0.0 111.654 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.3 p -118.26 163.09 17.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.718 1.207 . . . . 0.0 113.313 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -59.15 -17.76 29.99 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.551 1.54 . . . . 0.0 113.819 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.71 12.68 81.19 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.415 1.007 . . . . 0.0 113.353 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -124.02 144.86 49.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.608 1.163 . . . . 0.0 112.121 -169.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -82.32 156.24 24.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.963 1.305 . . . . 0.0 112.429 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.54 -164.6 36.3 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.63 0.634 . . . . 0.0 113.349 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -136.36 172.05 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.425 1.89 . . . . 0.0 110.695 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.55 -177.67 53.46 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 123.9 0.762 . . . . 0.0 113.554 -168.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.08 -48.59 14.31 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.261 3.974 . . . . 0.0 115.096 -172.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.75 -13.68 11.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.091 1.756 . . . . 0.0 115.632 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -135.07 -37.15 0.8 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.424 1.011 . . . . 0.0 113.317 -168.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.98 9.2 0.87 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.44 -57.97 3.32 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 120.936 -1.103 . . . . 0.0 111.051 -165.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.4 tpt85 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 116.089 -1.91 . . . . 0.0 111.873 168.39 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.87 108.13 0.64 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -156.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -58.67 146.83 34.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 117.44 0.62 . . . . 0.0 111.44 173.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -72.19 93.38 1.45 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.724 -0.61 . . . . 0.0 110.905 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.0 89.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 128.346 2.658 . . . . 0.0 111.215 -168.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.504 ' H ' ' CZ ' ' A' ' 6' ' ' ARG . 7.9 mmp_? 38.06 41.74 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.699 2.8 . . . . 0.0 112.21 -163.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.27 34.23 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 128.211 2.815 . . . . 0.0 116.095 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -89.74 160.03 16.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.2 2.0 . . . . 0.0 112.031 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.3 m -140.77 161.7 52.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.577 1.151 . . . . 0.0 111.164 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.44 168.36 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.373 3.382 . . . . 0.0 115.057 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.7 m -43.79 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.889 2.476 . . . . 0.0 114.059 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.38 7.41 87.9 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.049 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.8 mtt -84.22 166.13 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.059 1.429 . . . . 0.0 111.964 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.1 m -123.99 152.7 42.24 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.762 1.625 . . . . 0.0 109.823 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.42 154.37 38.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.932 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 p -133.92 174.78 10.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -64.35 -17.62 63.89 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -154.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.12 22.33 38.65 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.73 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -129.17 139.77 51.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.392 1.096 . . . . 0.0 112.651 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.2 m -79.63 159.44 26.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.381 2.272 . . . . 0.0 113.629 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.62 -166.83 39.25 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 123.938 0.78 . . . . 0.0 113.977 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -129.29 165.57 21.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.32 1.848 . . . . 0.0 111.139 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.75 -178.51 53.24 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 123.536 0.589 . . . . 0.0 113.707 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.64 -33.26 58.26 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.65 3.566 . . . . 0.0 116.297 -171.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -14.89 63.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 113.406 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -137.58 -48.88 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.02 0.827 . . . . 0.0 113.222 -171.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.4 t -138.15 -4.74 1.69 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -156.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.04 -63.07 3.59 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.563 1.078 . . . . 0.0 110.701 -166.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.261 0.0 OUTLIER . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.32 1.848 . . . . 0.0 110.999 168.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.25 -75.14 0.51 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.061 1.315 . . . . 0.0 114.686 172.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -170.03 164.12 9.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.238 2.215 . . . . 0.0 108.957 -176.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.86 99.59 9.12 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 143.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -57.94 93.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.319 1.847 . . . . 0.0 111.454 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 42.73 36.98 0.92 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.148 1.779 . . . . 0.0 112.452 -164.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.11 66.22 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.407 2.432 . . . . 0.0 116.01 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.98 170.87 9.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.219 2.009 . . . . 0.0 112.685 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.99 152.47 55.14 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.414 2.286 . . . . 0.0 109.327 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.6 166.04 6.96 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.731 2.954 . . . . 0.0 113.858 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -47.35 105.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.149 2.18 . . . . 0.0 113.591 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.23 4.28 89.74 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.968 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.2 mtt -90.42 163.95 14.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.885 1.342 . . . . 0.0 111.417 170.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -133.42 133.45 42.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.139 1.375 . . . . 0.0 111.137 -165.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.52 140.67 44.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.528 . . . . 0.0 110.53 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.0 p -117.04 163.36 16.35 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.543 1.137 . . . . 0.0 113.472 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 -58.15 -18.25 24.24 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.066 1.746 . . . . 0.0 113.825 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.88 17.84 79.43 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.11 0.862 . . . . 0.0 113.132 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -126.18 136.02 52.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.264 1.826 . . . . 0.0 111.101 -168.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.53 150.98 32.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.149 0.98 . . . . 0.0 112.481 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.48 -162.14 31.41 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.336 0.97 . . . . 0.0 113.248 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -138.35 167.26 22.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.233 1.413 . . . . 0.0 112.546 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.15 -174.89 40.11 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.428 0.537 . . . . 0.0 113.442 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.6 -32.18 27.05 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.91 3.74 . . . . 0.0 116.523 -172.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -6.98 50.35 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 116.85 -1.548 . . . . 0.0 115.118 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -144.38 -38.57 0.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.52 -24.05 0.96 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.42 6.44 48.46 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 119.331 -0.705 . . . . 0.0 113.952 -159.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.473 0 CA-C-O 116.079 -1.915 . . . . 0.0 113.347 -163.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.22 114.54 3.67 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -154.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -37.35 136.86 0.44 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.977 2.111 . . . . 0.0 113.949 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.2 m -64.88 96.2 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 158.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.1 t -51.89 93.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.99 2.516 . . . . 0.0 111.794 -159.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 38.44 36.18 0.12 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.722 2.009 . . . . 0.0 113.156 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -4.39 31.14 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 128.531 2.967 . . . . 0.0 116.751 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 167.56 12.69 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 121.214 2.507 . . . . 0.0 113.592 176.463 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.35 152.0 52.65 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 126.773 2.029 . . . . 0.0 108.356 166.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.42 168.53 2.85 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.98 3.12 . . . . 0.0 114.321 169.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -47.74 99.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.454 2.302 . . . . 0.0 113.886 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.99 84.06 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.795 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -83.8 169.54 15.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.982 1.391 . . . . 0.0 110.919 163.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.11 164.12 31.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.032 1.733 . . . . 0.0 111.572 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -117.57 112.5 20.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 112.307 -162.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.5 p -68.51 160.17 30.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.384 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pm0 -58.92 -17.0 20.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.528 1.531 . . . . 0.0 114.264 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.21 16.49 80.57 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 118.552 0.615 . . . . 0.0 112.871 -171.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -106.06 130.91 53.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 0.0 110.007 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -78.04 159.85 28.48 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.336 1.455 . . . . 0.0 111.118 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.74 -160.91 32.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.698 1.618 . . . . 0.0 110.852 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -138.67 156.34 47.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.686 -0.891 . . . . 0.0 110.057 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.03 -175.82 41.83 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 123.522 0.582 . . . . 0.0 114.121 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.5 -47.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.046 3.831 . . . . 0.0 115.482 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -74.56 -0.27 17.19 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -125.31 -35.67 2.58 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.89 1.276 . . . . 0.0 112.706 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 m -93.87 -25.68 17.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.949 1.3 . . . . 0.0 111.956 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.05 -159.75 23.47 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.638 2.066 . . . . 0.0 109.338 157.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.428 1.491 . . . . 0.0 111.411 176.415 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.416 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 11.7 m . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.93 -49.51 1.43 Allowed Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -159.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -153.07 178.68 9.44 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.641 1.976 . . . . 0.0 111.1 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 59.4 m -95.15 107.66 19.75 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 137.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -55.63 96.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.555 1.942 . . . . 0.0 111.325 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 39.18 43.02 0.82 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 111.896 -167.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.45 56.13 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.846 2.165 . . . . 0.0 116.506 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -118.12 167.62 11.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.853 2.326 . . . . 0.0 114.047 -170.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.1 m -131.11 164.12 44.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.003 1.321 . . . . 0.0 111.595 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.16 160.37 4.59 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.167 3.245 . . . . 0.0 114.469 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.14 100.04 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.144 2.178 . . . . 0.0 113.382 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.06 2.25 66.52 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.086 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -77.95 172.6 13.25 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.433 1.617 . . . . 0.0 111.844 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.81 159.86 36.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.048 2.139 . . . . 0.0 111.154 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -108.51 114.46 28.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.615 1.566 . . . . 0.0 110.56 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.9 p -67.51 153.19 44.26 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.779 0.799 . . . . 0.0 112.841 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -58.8 -14.25 8.31 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 113.791 168.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.48 17.46 66.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.082 0.848 . . . . 0.0 113.988 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 1' ' ' VAL . 2.0 m-85 -123.41 126.84 47.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.684 1.994 . . . . 0.0 110.528 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 61.4 m -74.18 158.8 33.5 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.63 -160.71 31.04 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.748 2.118 . . . . 0.0 110.334 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -138.17 143.56 40.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 1.469 . . . . 0.0 111.266 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.37 177.12 20.35 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.291 1.424 . . . . 0.0 112.053 -170.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.5 -38.69 81.48 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.931 2.421 . . . . 0.0 112.628 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -59.96 -10.24 3.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.338 1.455 . . . . 0.0 114.564 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -122.31 -29.54 4.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.188 1.395 . . . . 0.0 113.009 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 36.1 m -87.06 -6.72 58.61 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.108 0.963 . . . . 0.0 112.92 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.84 1.19 1.18 Allowed Glycine 0 CA--C 1.537 1.453 0 N-CA-C 117.746 1.858 . . . . 0.0 117.746 153.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-N 120.316 2.058 . . . . 0.0 112.846 -168.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.37 -148.94 0.86 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 130.191 3.758 . . . . 0.0 113.574 -8.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -51.67 164.81 0.21 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.868 0.867 . . . . 0.0 112.504 168.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -66.24 117.17 8.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 152.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.07 94.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.322 2.249 . . . . 0.0 110.721 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? 42.64 35.7 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.052 0.941 . . . . 0.0 112.458 -161.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.32 -6.05 63.23 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 126.4 1.953 . . . . 0.0 116.384 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.71 170.78 9.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.418 2.109 . . . . 0.0 112.96 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.5 m -139.14 157.45 71.15 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.472 1.909 . . . . 0.0 108.701 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.5 162.87 37.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.662 2.241 . . . . 0.0 112.263 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -55.34 89.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.695 2.398 . . . . 0.0 113.522 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.96 -8.31 7.65 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.212 1.386 . . . . 0.0 114.715 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 99.2 mtp -98.97 169.6 9.32 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.152 1.476 . . . . 0.0 111.265 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.74 136.5 51.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.773 1.629 . . . . 0.0 111.606 -175.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.8 t -89.19 116.24 27.29 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.106 1.362 . . . . 0.0 109.694 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -73.32 156.09 38.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.232 1.015 . . . . 0.0 113.339 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -58.73 -16.7 17.81 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.862 2.065 . . . . 0.0 113.474 170.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.91 10.68 69.04 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.215 0.912 . . . . 0.0 114.428 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -116.6 141.1 48.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.534 1.134 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.69 153.35 20.79 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.017 1.327 . . . . 0.0 110.877 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.58 -159.75 26.8 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.666 -0.646 . . . . 0.0 112.534 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 0.0 110.179 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.04 178.34 49.95 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.918 0.77 . . . . 0.0 112.863 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.4 -21.69 66.34 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.468 2.779 . . . . 0.0 114.359 -167.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -58.57 -21.55 53.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.137 0.975 . . . . 0.0 113.136 171.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -132.56 -36.64 1.08 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.132 0.973 . . . . 0.0 113.479 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m -85.77 -12.07 51.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 112.072 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.6 62.5 3.14 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.504 1.049 . . . . 0.0 110.901 169.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.363 0 C-N-CA 127.236 2.214 . . . . 0.0 110.368 -167.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.71 -119.1 9.62 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 106.512 -2.635 . . . . 0.0 106.512 -137.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.05 160.9 4.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.502 1.151 . . . . 0.0 112.965 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.03 106.16 1.2 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 150.147 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -52.03 97.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 128.517 2.727 . . . . 0.0 109.913 -168.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 41.9 39.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.74 2.016 . . . . 0.0 112.513 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.96 -6.59 40.53 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 127.029 2.252 . . . . 0.0 115.637 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.33 176.24 5.57 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.962 1.881 . . . . 0.0 113.829 -168.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.1 m -137.51 152.33 72.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 110.742 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.7 169.32 22.52 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 112.12 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.2 t -45.97 110.49 0.27 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.862 1.665 . . . . 0.0 113.257 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 -12.0 68.09 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.57 -1.683 . . . . 0.0 115.671 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -75.4 170.93 15.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.595 2.198 . . . . 0.0 111.38 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -130.35 148.23 52.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.535 1.534 . . . . 0.0 111.106 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -92.92 114.98 27.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.777 1.231 . . . . 0.0 110.438 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.8 p -67.54 163.12 21.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.826 1.298 . . . . 0.0 114.258 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -52.07 -3.04 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.686 2.794 . . . . 0.0 115.545 161.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.7 14.24 81.49 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 119.153 0.888 . . . . 0.0 113.778 -172.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -107.0 149.99 26.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.382 1.473 . . . . 0.0 109.929 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.8 t -118.61 133.74 55.63 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.746 0.818 . . . . 0.0 112.145 -168.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.16 -154.16 10.21 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.527 1.537 . . . . 0.0 111.289 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.29 169.84 16.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.229 1.014 . . . . 0.0 111.594 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.14 169.89 44.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.093 1.33 . . . . 0.0 111.457 -167.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.62 -34.46 92.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.617 2.211 . . . . 0.0 112.121 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -52.72 -33.95 50.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 113.271 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.49 -14.16 15.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.007 1.723 . . . . 0.0 113.712 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.26 -4.83 14.25 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.98 -17.39 0.09 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 163.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.273 0 CA-C-N 119.713 1.757 . . . . 0.0 114.86 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.533 HG22 ' H ' ' A' ' 2' ' ' GLY . 7.1 p . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 116.969 -1.491 . . . . 0.0 108.556 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.533 ' H ' HG22 ' A' ' 1' ' ' VAL . . . -67.36 91.39 0.2 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-N 121.307 1.867 . . . . 0.0 112.214 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -55.8 147.9 17.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.683 1.193 . . . . 0.0 113.108 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.64 104.55 2.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.992 0.517 . . . . 0.0 110.915 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.25 91.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.557 2.343 . . . . 0.0 110.542 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.579 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 43.58 34.63 0.84 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.592 2.357 . . . . 0.0 112.341 -164.043 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 -10.27 56.68 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.324 2.392 . . . . 0.0 116.347 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 160.81 19.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.877 2.339 . . . . 0.0 111.724 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -140.1 134.24 15.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.685 1.194 . . . . 0.0 110.275 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.52 178.38 7.63 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.444 2.763 . . . . 0.0 112.634 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 m 45.42 41.36 6.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.277 2.231 . . . . 0.0 115.423 170.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.53 58.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 113.795 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 79.1 mtm -84.56 164.48 18.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.621 1.211 . . . . 0.0 111.062 168.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 m -112.34 147.31 36.63 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.486 1.914 . . . . 0.0 109.556 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -80.3 112.04 17.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.385 0.674 . . . . 0.0 110.778 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.8 p -66.26 162.64 19.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.867 1.318 . . . . 0.0 113.974 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -52.49 -2.74 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 128.41 2.684 . . . . 0.0 115.558 161.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.39 14.67 79.82 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 119.124 0.874 . . . . 0.0 114.057 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.59 143.05 50.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.211 1.405 . . . . 0.0 111.652 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -76.46 147.16 38.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.388 1.075 . . . . 0.0 112.675 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.68 -162.15 27.72 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.532 1.063 . . . . 0.0 112.175 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -132.14 166.29 22.14 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.187 0.994 . . . . 0.0 111.51 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.53 175.28 37.23 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.527 1.061 . . . . 0.0 113.601 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -47.87 -43.5 29.35 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.298 3.332 . . . . 0.0 114.273 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -58.1 -26.22 62.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.276 1.43 . . . . 0.0 113.91 -176.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -114.31 -14.65 12.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.602 1.561 . . . . 0.0 113.528 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.98 -2.66 9.18 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.89 -73.21 0.02 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.299 0.954 . . . . 0.0 113.842 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.454 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 3.3 mmp_? . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.87 2.068 . . . . 0.0 112.457 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 116.86 -1.543 . . . . 0.0 106.964 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.27 93.12 0.51 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 121.46 1.936 . . . . 0.0 108.621 154.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.38 -170.05 0.19 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.333 1.453 . . . . 0.0 111.29 -166.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.419 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 40.7 m -74.44 179.74 4.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.575 -1.328 . . . . 0.0 110.491 147.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.32 79.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.208 -1.557 . . . . 0.0 107.613 164.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 45.36 47.04 10.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.246 1.418 . . . . 0.0 112.28 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.26 76.61 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.734 1.159 . . . . 0.0 115.463 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.77 172.6 11.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.659 1.984 . . . . 0.0 109.924 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -141.88 154.8 65.88 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 118.973 0.806 . . . . 0.0 112.894 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.17 173.61 11.61 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.903 3.069 . . . . 0.0 111.773 169.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m 36.0 43.18 0.19 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 129.128 2.971 . . . . 0.0 117.086 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.19 31.08 61.71 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.854 1.216 . . . . 0.0 114.253 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -73.87 165.04 25.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.701 1.75 . . . . 0.0 109.561 159.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.3 m -118.32 115.6 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.462 1.505 . . . . 0.0 109.48 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -74.15 89.16 1.98 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.15 164.79 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.776 1.63 . . . . 0.0 114.275 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -58.51 -21.67 52.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.4 1.48 . . . . 0.0 113.361 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.3 30.1 25.95 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.056 0.836 . . . . 0.0 113.505 -173.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.53 126.52 37.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.952 1.301 . . . . 0.0 111.252 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 69.3 m -67.21 135.91 54.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.252 0.478 . . . . 0.0 111.456 167.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.55 -163.33 17.39 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.622 1.106 . . . . 0.0 112.108 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -132.59 167.0 20.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.443 1.497 . . . . 0.0 110.483 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.43 179.13 34.01 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.683 0.658 . . . . 0.0 113.383 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.51 -28.66 70.57 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.993 2.462 . . . . 0.0 113.442 -171.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -12.01 20.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.842 -1.551 . . . . 0.0 114.505 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.73 -25.93 1.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.77 -11.44 23.37 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 113.633 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.04 72.11 2.32 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 166.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.236 0 CA-C-O 115.788 -2.053 . . . . 0.0 113.09 -163.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.486 1.346 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.21 107.74 3.0 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -160.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -35.31 133.03 0.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.975 2.11 . . . . 0.0 114.682 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -61.56 101.65 0.2 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.26 95.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.488 2.315 . . . . 0.0 110.0 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? 47.05 34.41 2.81 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.893 1.277 . . . . 0.0 111.729 -167.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.2 68.46 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 126.982 2.229 . . . . 0.0 116.276 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.27 163.95 15.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.448 2.124 . . . . 0.0 111.682 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -138.38 158.29 70.92 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.804 1.241 . . . . 0.0 110.772 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.66 168.24 25.27 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.872 2.382 . . . . 0.0 112.687 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -43.71 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.249 2.619 . . . . 0.0 114.586 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -7.15 59.48 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.196 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -79.0 170.4 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.791 1.795 . . . . 0.0 111.875 170.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -139.14 163.29 32.82 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.892 2.077 . . . . 0.0 110.542 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -109.54 114.96 29.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.823 1.249 . . . . 0.0 112.091 -166.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.55 157.95 34.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.002 1.321 . . . . 0.0 112.862 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pm0 -54.27 -24.69 19.87 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.599 1.16 . . . . 0.0 113.484 169.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.83 17.62 74.61 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.736 0.698 . . . . 0.0 113.798 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -114.84 143.76 44.6 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 112.684 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.65 157.56 31.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.551 1.141 . . . . 0.0 112.066 167.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.51 -160.89 34.66 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.281 1.896 . . . . 0.0 109.77 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -142.93 163.06 33.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.514 0.657 . . . . 0.0 110.803 169.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.71 179.11 25.72 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.696 1.141 . . . . 0.0 112.928 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.87 -8.46 23.55 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.902 3.068 . . . . 0.0 114.867 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.21 -2.12 50.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.7 1.6 . . . . 0.0 113.661 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.37 -44.91 1.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.873 1.669 . . . . 0.0 111.767 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.5 m -93.46 -7.17 45.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.88 1.672 . . . . 0.0 111.913 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.51 -173.71 13.4 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 127.742 2.592 . . . . 0.0 109.254 165.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.178 0 C-N-CA 124.778 1.231 . . . . 0.0 110.295 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.9 99.04 2.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -159.4 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -51.13 139.76 17.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.89 1.276 . . . . 0.0 114.075 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.5 m -68.49 103.33 1.64 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.324 0.649 . . . . 0.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -54.54 89.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 128.73 2.812 . . . . 0.0 111.524 -172.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.58 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 37.66 40.09 0.23 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.726 2.81 . . . . 0.0 112.785 -162.432 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.68 -7.46 27.93 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 126.429 1.966 . . . . 0.0 116.559 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -112.45 166.55 11.21 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.573 2.187 . . . . 0.0 113.574 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -142.17 167.07 17.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.331 1.852 . . . . 0.0 110.828 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -54.04 155.53 14.88 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.729 2.953 . . . . 0.0 114.223 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.9 t -62.28 74.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.392 2.277 . . . . 0.0 113.914 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.04 -10.41 2.55 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.026 1.774 . . . . 0.0 114.533 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.0 171.76 10.06 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.261 1.425 . . . . 0.0 111.31 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -123.01 149.69 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.102 1.761 . . . . 0.0 110.101 169.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.94 118.46 21.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.846 0.859 . . . . 0.0 109.974 166.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -78.88 159.22 27.87 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.863 0.839 . . . . 0.0 112.795 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 -58.83 -16.41 17.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.791 1.637 . . . . 0.0 113.872 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.66 9.88 82.38 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.554 1.073 . . . . 0.0 113.743 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.7 140.03 50.58 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.439 1.096 . . . . 0.0 111.823 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m -73.17 153.15 40.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.624 1.569 . . . . 0.0 112.53 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 -170.5 43.64 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.62 0.629 . . . . 0.0 113.953 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -128.45 165.78 20.0 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.323 2.249 . . . . 0.0 110.299 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.89 179.98 52.79 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.069 0.842 . . . . 0.0 113.295 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.67 -26.8 39.35 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 124.585 3.523 . . . . 0.0 116.235 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -71.61 -10.93 60.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -143.95 -52.02 0.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -142.08 7.09 1.79 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.729 1.612 . . . . 0.0 114.142 -159.135 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.94 -53.97 3.0 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.867 1.222 . . . . 0.0 112.79 -175.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.921 0 C-N-CA 126.747 2.019 . . . . 0.0 113.459 176.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.411 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 17.7 m . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.96 -48.84 1.72 Allowed Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -162.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -154.07 -177.15 6.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.259 1.824 . . . . 0.0 112.547 171.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 20.2 m -99.66 146.7 26.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.459 1.504 . . . . 0.0 110.802 141.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -69.09 91.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.47 1.508 . . . . 0.0 110.016 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.421 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 48.68 25.84 1.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.814 -168.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.89 39.97 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.588 1.566 . . . . 0.0 116.54 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.29 166.19 11.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.22 2.01 . . . . 0.0 112.16 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -145.49 163.56 31.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.935 -173.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.18 156.46 10.23 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.356 3.37 . . . . 0.0 115.443 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -51.68 102.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.201 2.201 . . . . 0.0 112.59 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.38 -3.75 47.23 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.682 -1.065 . . . . 0.0 114.831 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.46 -175.59 2.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.926 1.863 . . . . 0.0 112.354 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.63 137.86 52.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.081 2.152 . . . . 0.0 109.818 160.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.36 107.81 13.46 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 158.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -77.04 165.77 24.19 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -174.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 -58.98 -18.1 30.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.418 1.487 . . . . 0.0 113.525 171.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.27 78.82 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.056 0.836 . . . . 0.0 113.109 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.411 ' CD2' ' HA ' ' A' ' 1' ' ' VAL . 3.2 m-30 -122.35 133.12 54.66 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.243 2.217 . . . . 0.0 110.261 -173.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 98.5 m -65.99 146.03 55.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 165.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.5 -167.38 39.28 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.091 0.853 . . . . 0.0 113.659 165.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -131.13 169.68 15.56 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.739 2.016 . . . . 0.0 111.539 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.33 178.87 33.14 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.139 0.876 . . . . 0.0 113.76 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.31 -35.66 35.53 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.717 3.612 . . . . 0.0 116.288 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -5.67 40.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -144.01 -30.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t -147.64 -21.49 0.37 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -157.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.7 -56.77 0.72 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 123.944 0.783 . . . . 0.0 111.794 -159.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.317 0 C-N-CA 128.053 2.541 . . . . 0.0 113.427 -176.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -52.78 2.77 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -163.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.55 -171.7 4.01 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.013 1.725 . . . . 0.0 111.862 162.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 47.7 m -95.95 128.11 42.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.352 1.861 . . . . 0.0 109.006 145.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.2 90.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 129.163 2.985 . . . . 0.0 111.456 -171.512 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? 44.96 29.81 0.5 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.195 0.998 . . . . 0.0 113.42 -165.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.21 8.22 63.16 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.075 1.322 . . . . 0.0 115.437 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -105.53 174.02 6.06 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.814 2.445 . . . . 0.0 110.654 171.669 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.1 m -140.1 133.26 15.09 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.85 166.48 17.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.807 3.005 . . . . 0.0 111.874 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p 53.97 27.85 7.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.44 34.37 54.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.081 1.324 . . . . 0.0 113.61 -170.043 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.2 mtt -67.17 170.47 6.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 110.687 163.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 m -130.34 148.83 52.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.386 1.474 . . . . 0.0 110.341 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 t -91.96 109.41 20.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.35 1.06 . . . . 0.0 111.856 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 87.2 p -66.43 165.8 13.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.703 1.201 . . . . 0.0 113.811 177.1 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -52.15 -22.16 3.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.212 2.205 . . . . 0.0 114.447 170.357 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.15 29.89 73.55 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.044 -172.141 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -120.16 126.13 49.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.276 2.231 . . . . 0.0 109.93 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 86.9 m -68.06 149.4 49.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 170.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.48 -159.25 21.14 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.773 1.654 . . . . 0.0 111.846 173.423 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.14 157.2 40.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.842 1.257 . . . . 0.0 110.981 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.31 -175.96 49.88 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.414 0.925 . . . . 0.0 115.414 171.887 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.01 -22.25 38.04 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.918 3.745 . . . . 0.0 117.284 -170.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.39 1.22 57.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.776 1.23 . . . . 0.0 113.319 176.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 86.6 m-85 -129.6 -44.34 1.23 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.636 1.174 . . . . 0.0 112.403 -176.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.57 -15.23 21.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.591 0.756 . . . . 0.0 113.028 170.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.93 -154.22 23.51 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 154.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.24 1.416 . . . . 0.0 109.158 175.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.02 106.2 0.96 Allowed Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -159.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -54.99 142.71 28.99 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.985 0.914 . . . . 0.0 110.44 167.596 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m -65.49 108.35 1.97 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.706 -0.621 . . . . 0.0 111.713 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.71 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.862 2.065 . . . . 0.0 110.639 -174.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.518 ' H ' ' CZ ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 40.59 43.81 1.65 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.739 2.016 . . . . 0.0 111.405 -162.556 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.04 70.88 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.982 1.753 . . . . 0.0 116.089 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.0 20.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.441 2.121 . . . . 0.0 111.433 176.287 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.8 m -142.37 154.61 64.04 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.036 1.334 . . . . 0.0 111.469 174.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -77.27 174.32 12.95 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.613 2.875 . . . . 0.0 111.95 175.409 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m 37.34 45.66 0.55 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.191 2.596 . . . . 0.0 116.137 167.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.86 30.78 22.8 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.746 1.641 . . . . 0.0 114.125 -176.329 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.8 mtt -74.37 159.94 31.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.622 1.211 . . . . 0.0 111.579 177.779 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.4 m -87.63 120.97 29.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.445 1.498 . . . . 0.0 109.448 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.0 t -67.67 101.14 0.98 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 160.52 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -75.31 163.6 27.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -174.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -58.25 -17.12 16.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.521 1.529 . . . . 0.0 113.504 173.541 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.33 10.51 74.02 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.796 1.189 . . . . 0.0 114.074 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -128.58 146.9 50.71 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.287 1.035 . . . . 0.0 112.02 -172.155 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.76 147.81 37.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.882 2.073 . . . . 0.0 112.438 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.86 -169.69 42.83 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.38 0.514 . . . . 0.0 113.77 163.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -130.12 159.97 35.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.491 1.916 . . . . 0.0 108.993 170.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.87 173.67 47.85 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 123.903 0.763 . . . . 0.0 112.744 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -45.9 34.13 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.155 3.237 . . . . 0.0 115.53 -167.679 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 0.28 1.23 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.615 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -137.61 -38.62 0.59 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.239 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m -115.17 -1.68 12.92 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.281 1.432 . . . . 0.0 113.702 -176.129 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.77 -48.84 1.66 Allowed Glycine 0 CA--C 1.536 1.376 0 CA-C-N 119.847 1.203 . . . . 0.0 112.861 -171.355 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? . . . . . 0 C--O 1.248 1.003 0 C-N-CA 125.519 1.528 . . . . 0.0 110.506 160.691 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.9 67.5 1.93 Allowed Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -145.173 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 59.82 -172.58 0.12 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.278 1.831 . . . . 0.0 113.78 -170.66 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.5 m -82.17 132.59 35.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 144.158 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.36 86.2 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.872 1.269 . . . . 0.0 111.479 -161.248 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.16 42.89 25.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.673 1.189 . . . . 0.0 111.22 -159.462 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.15 -10.04 65.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.012 1.768 . . . . 0.0 115.03 177.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -103.01 172.38 6.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.83 1.315 . . . . 0.0 113.328 -167.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.75 157.61 64.45 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.909 2.084 . . . . 0.0 110.784 176.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.64 161.09 42.79 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.877 2.385 . . . . 0.0 111.893 165.531 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -55.27 92.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.238 2.215 . . . . 0.0 113.48 -173.746 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.76 -10.83 10.3 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.219 1.39 . . . . 0.0 114.5 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.3 mtt -88.62 167.12 13.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.868 1.334 . . . . 0.0 111.228 166.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 m -137.44 142.01 41.61 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.944 1.698 . . . . 0.0 110.858 -172.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.4 t -83.93 108.18 16.76 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.467 1.107 . . . . 0.0 110.128 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.1 p -71.44 161.72 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.823 0.82 . . . . 0.0 113.034 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -58.59 -16.38 15.62 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.843 1.657 . . . . 0.0 113.864 174.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.63 18.81 79.59 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.898 0.761 . . . . 0.0 113.056 -177.469 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.18 127.88 49.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.838 1.655 . . . . 0.0 110.661 -173.401 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.0 t -83.51 144.76 29.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.875 0.87 . . . . 0.0 112.387 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.48 -165.2 33.21 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.319 0.961 . . . . 0.0 112.644 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -136.41 162.59 32.62 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.397 1.079 . . . . 0.0 111.864 176.962 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.68 -173.68 42.12 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.161 0.886 . . . . 0.0 112.953 -173.815 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -44.31 -47.98 10.26 Favored 'Trans proline' 0 C--N 1.35 0.652 1 C-N-CA 125.407 4.072 . . . . 0.0 115.612 -172.605 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -65.69 -6.53 11.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.891 1.676 . . . . 0.0 115.522 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -139.64 -56.0 0.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.005 0.922 . . . . 0.0 113.033 -171.748 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m -117.86 -5.76 11.04 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.567 1.947 . . . . 0.0 113.553 -170.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.43 -49.84 3.08 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.999 -1.063 . . . . 0.0 111.894 -160.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.22 0 CA-C-O 115.862 -2.018 . . . . 0.0 113.248 -178.752 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.16 -47.23 2.58 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -161.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -152.78 176.5 11.72 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.776 1.63 . . . . 0.0 111.027 169.665 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.2 m -85.76 107.44 17.61 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 139.433 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -55.43 95.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.964 1.706 . . . . 0.0 111.524 -158.211 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? 45.28 36.06 2.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.085 1.754 . . . . 0.0 112.335 -169.545 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.92 -4.65 59.23 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 127.697 2.57 . . . . 0.0 115.873 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.76 8.5 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.264 2.032 . . . . 0.0 113.087 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.34 152.02 74.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.148 . . . . 0.0 109.661 169.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.65 165.96 4.16 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.783 2.989 . . . . 0.0 113.257 162.473 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.64 98.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.703 2.401 . . . . 0.0 114.07 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.53 4.61 89.11 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.466 176.483 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt -77.6 172.91 12.64 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.797 1.798 . . . . 0.0 112.105 171.923 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 m -128.61 133.96 48.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.376 1.87 . . . . 0.0 110.62 -169.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.5 t -81.99 125.97 31.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.909 -0.494 . . . . 0.0 110.672 173.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -79.2 154.32 29.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 173.591 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.49 ' H ' ' HD3' ' A' ' 30' ' ' ARG . 9.5 pt20 -59.19 -21.6 59.71 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.46 -0.775 . . . . 0.0 112.845 169.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.9 10.29 83.23 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 124.397 0.998 . . . . 0.0 114.177 172.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -115.41 131.08 57.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.41 1.484 . . . . 0.0 109.864 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.44 149.89 36.79 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.491 0.316 . . . . 0.0 111.791 169.243 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.46 -159.17 23.03 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.871 1.224 . . . . 0.0 112.001 175.47 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -139.31 154.48 47.92 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.991 0.916 . . . . 0.0 110.079 175.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.41 176.92 28.73 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.857 1.218 . . . . 0.0 112.799 -173.788 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.88 -53.06 6.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.546 3.498 . . . . 0.0 114.467 -174.042 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -56.62 -12.19 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.337 1.855 . . . . 0.0 114.888 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.07 -39.11 2.85 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.882 1.673 . . . . 0.0 112.943 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.7 m -110.23 -14.53 14.16 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.091 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.53 66.56 0.55 Allowed Glycine 0 N--CA 1.469 0.898 0 C-N-CA 125.695 1.617 . . . . 0.0 110.222 -176.052 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HD3' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 C-N-CA 127.251 2.22 . . . . 0.0 110.954 -157.588 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 -45.9 2.43 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -163.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -154.45 179.84 8.64 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.776 2.03 . . . . 0.0 109.88 168.904 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.49 107.52 15.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 130.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.01 101.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 126.693 1.997 . . . . 0.0 110.425 -170.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 48.9 33.2 4.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.586 1.155 . . . . 0.0 112.379 -170.313 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.78 68.33 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.898 2.189 . . . . 0.0 115.269 -178.298 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -121.38 164.21 17.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.774 1.787 . . . . 0.0 112.597 -174.622 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.35 173.83 4.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.441 2.297 . . . . 0.0 108.878 163.881 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.58 136.07 16.15 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.75 2.966 . . . . 0.0 113.755 173.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.8 p -58.31 97.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.107 1.763 . . . . 0.0 112.254 -174.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.31 -19.88 4.51 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.441 1.496 . . . . 0.0 112.969 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.3 mtp -82.37 158.95 23.15 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.211 1.005 . . . . 0.0 109.645 159.206 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.6 m -143.29 139.6 30.21 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.834 1.254 . . . . 0.0 110.156 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -70.93 155.3 40.98 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 177.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -126.83 166.38 17.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.879 1.271 . . . . 0.0 113.219 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -57.97 -18.17 21.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.951 1.3 . . . . 0.0 114.067 174.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.24 9.93 84.27 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.624 1.107 . . . . 0.0 113.38 -174.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.64 137.0 50.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.45 1.5 . . . . 0.0 110.033 -171.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 151.71 30.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 166.509 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.5 -162.22 26.82 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.918 1.246 . . . . 0.0 112.015 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -138.25 163.98 30.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.819 1.648 . . . . 0.0 110.714 172.683 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.45 -175.66 46.01 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 123.609 0.623 . . . . 0.0 113.232 -176.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.53 -36.38 31.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 125.178 3.919 . . . . 0.0 116.77 -171.038 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.94 -9.65 58.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 178.742 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.74 -47.84 0.5 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -168.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.55 5.17 1.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -174.127 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.18 -46.62 2.75 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 120.652 -1.28 . . . . 0.0 112.38 -167.231 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.546 1.938 . . . . 0.0 113.416 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 117.157 -1.402 . . . . 0.0 107.41 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.59 19.44 0.53 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 120.823 1.647 . . . . 0.0 114.811 169.727 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -171.77 165.14 6.59 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 129.441 3.097 . . . . 0.0 108.797 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.8 m -95.27 112.94 24.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.684 1.994 . . . . 0.0 107.268 151.109 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.0 103.07 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.536 1.134 . . . . 0.0 110.44 -163.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.26 30.5 4.44 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.366 1.066 . . . . 0.0 112.156 -165.124 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.26 -7.69 81.51 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.184 1.85 . . . . 0.0 115.198 -174.389 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.8 171.93 8.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.584 1.692 . . . . 0.0 112.016 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.0 m -143.14 149.17 47.79 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.363 1.865 . . . . 0.0 111.521 -172.519 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.02 -178.27 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 125.261 3.974 . . . . 0.0 114.991 165.09 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -38.96 92.3 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.644 3.178 . . . . 0.0 115.311 -177.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.38 30.13 61.24 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.62 1.105 . . . . 0.0 113.588 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.4 mtt -85.71 170.04 12.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 110.813 170.212 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.16 142.32 35.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.22 1.808 . . . . 0.0 110.734 -164.306 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.6 113.13 23.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.564 1.145 . . . . 0.0 110.555 -177.355 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.9 p -71.58 165.87 23.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.148 0.975 . . . . 0.0 113.504 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 -53.25 -17.68 1.9 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.347 2.259 . . . . 0.0 114.683 170.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.34 19.59 78.85 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.727 0.694 . . . . 0.0 112.747 -170.47 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -111.65 123.04 49.4 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.43 1.892 . . . . 0.0 108.906 -178.114 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.77 142.69 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.246 0.476 . . . . 0.0 112.02 178.183 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.91 -161.47 19.21 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.951 1.739 . . . . 0.0 110.33 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -132.59 150.0 52.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.769 1.285 . . . . 0.0 110.779 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 -160.64 30.33 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 115.406 0.923 . . . . 0.0 115.406 172.657 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.88 4.29 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 125.109 3.873 . . . . 0.0 116.151 -160.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.32 5.44 9.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.053 1.741 . . . . 0.0 112.737 174.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -129.24 -57.44 1.15 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.487 1.515 . . . . 0.0 110.378 177.936 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 m -73.85 -62.23 1.57 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.029 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.36 162.76 43.51 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 164.358 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 124.094 0.957 . . . . 0.0 112.321 -169.698 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.412 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 12.0 p . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.67 7.7 68.6 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.842 -0.977 . . . . 0.0 114.71 -178.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.412 ' CD ' ' H2 ' ' A' ' 1' ' ' VAL . 52.6 mp0 -51.17 124.88 12.55 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.806 1.642 . . . . 0.0 110.819 172.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.1 m -57.92 160.07 5.01 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -74.9 56.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.983 1.713 . . . . 0.0 109.293 168.782 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 52.82 38.36 26.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.915 3.286 . . . . 0.0 112.417 -179.577 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.39 -12.55 7.94 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.578 2.037 . . . . 0.0 115.058 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 mtm-85 -115.36 168.52 9.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.614 1.566 . . . . 0.0 111.012 177.697 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -144.98 167.17 15.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.367 1.067 . . . . 0.0 112.798 -172.433 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.07 166.13 1.71 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 124.512 3.474 . . . . 0.0 114.59 168.765 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -39.16 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 128.531 2.733 . . . . 0.0 114.749 -174.149 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.35 3.16 81.81 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.49 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.9 mmt -80.03 161.95 25.13 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.368 1.584 . . . . 0.0 110.722 173.096 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.54 129.51 54.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.85 1.26 . . . . 0.0 110.639 -172.735 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.28 107.92 8.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.305 0.642 . . . . 0.0 109.979 174.081 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -57.71 148.73 23.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.673 1.189 . . . . 0.0 111.123 170.161 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -51.01 -20.75 1.48 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.238 2.215 . . . . 0.0 114.197 169.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.49 16.85 30.57 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.538 1.066 . . . . 0.0 115.405 172.316 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -126.69 140.44 52.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.891 1.276 . . . . 0.0 112.897 -170.781 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.6 m -84.09 142.76 30.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.513 1.525 . . . . 0.0 113.257 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.57 -163.66 36.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.863 0.744 . . . . 0.0 113.269 172.589 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -137.47 166.7 23.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.941 1.696 . . . . 0.0 110.773 174.097 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.19 -176.62 51.72 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 123.704 0.668 . . . . 0.0 113.257 -174.455 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.06 -39.92 41.18 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.037 3.825 . . . . 0.0 116.109 -170.236 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -11.09 58.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.889 1.276 . . . . 0.0 113.501 179.478 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -138.85 -45.61 0.48 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -168.094 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.99 6.72 1.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -169.031 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.35 -52.49 3.42 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.009 -1.057 . . . . 0.0 112.487 -169.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.932 2.093 . . . . 0.0 112.3 179.065 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' VAL . . . . . 0.446 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 42.8 t . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.13 -53.08 3.41 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -165.948 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -153.03 -177.59 6.39 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.648 1.579 . . . . 0.0 110.976 170.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.459 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 30.5 m -92.83 114.85 27.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.839 1.256 . . . . 0.0 108.034 133.111 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.56 95.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.733 2.013 . . . . 0.0 110.877 -166.723 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? 48.14 30.86 2.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.075 0.95 . . . . 0.0 112.244 -166.377 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -6.47 77.66 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 126.856 2.17 . . . . 0.0 116.01 -175.377 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 167.9 12.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.232 2.016 . . . . 0.0 111.094 175.187 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -139.93 141.76 28.39 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.785 0.834 . . . . 0.0 112.545 175.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.57 172.92 9.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.985 3.124 . . . . 0.0 112.171 177.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t 43.66 39.57 2.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.943 2.097 . . . . 0.0 116.245 165.041 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.66 31.68 60.76 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.919 1.247 . . . . 0.0 113.95 -176.163 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.2 mtt -76.82 163.64 26.58 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.817 1.308 . . . . 0.0 110.39 164.969 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.0 m -115.42 145.95 42.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.615 1.966 . . . . 0.0 109.814 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -80.32 110.93 16.22 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.284 0.634 . . . . 0.0 111.105 177.118 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.7 p -71.37 166.3 21.95 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -176.653 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -53.47 -5.1 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.22 2.608 . . . . 0.0 115.433 163.899 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.51 23.08 78.52 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 119.038 0.836 . . . . 0.0 113.242 -174.44 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' CD2' ' HA ' ' A' ' 1' ' ' VAL . 1.7 m-85 -123.03 131.25 53.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.332 2.253 . . . . 0.0 110.274 -179.637 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m -62.63 143.23 57.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.534 0.606 . . . . 0.0 112.508 168.524 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.67 -159.95 15.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.121 1.82 . . . . 0.0 111.538 168.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -133.89 166.3 23.0 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.167 1.483 . . . . 0.0 112.355 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.5 170.95 29.14 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.312 1.434 . . . . 0.0 113.352 -175.037 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -48.37 -41.17 36.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.155 3.236 . . . . 0.0 113.888 -178.121 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -27.06 16.85 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.991 2.116 . . . . 0.0 114.208 177.903 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -119.15 -8.81 10.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.317 1.447 . . . . 0.0 113.459 177.178 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -117.78 -4.56 11.15 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.568 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.45 -63.32 0.02 OUTLIER Glycine 0 CA--C 1.534 1.247 0 CA-C-N 119.191 0.905 . . . . 0.0 114.307 179.113 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 C-N-CA 125.954 1.702 . . . . 0.0 112.767 -177.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 119.269 -0.396 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.83 107.99 0.64 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 -153.251 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -56.49 152.65 11.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.632 0.773 . . . . 0.0 112.284 177.608 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.1 m -65.64 100.88 0.56 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.008 -0.433 . . . . 0.0 110.93 178.581 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.14 89.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 128.527 2.731 . . . . 0.0 110.004 -170.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.448 ' NH1' ' H ' ' A' ' 6' ' ' ARG . 7.3 mmp_? 40.38 46.68 2.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.669 1.988 . . . . 0.0 111.242 -164.37 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.06 -10.84 71.53 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.848 2.166 . . . . 0.0 115.453 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -96.69 163.75 12.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.747 1.774 . . . . 0.0 111.432 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.4 m -144.15 162.59 39.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.045 1.338 . . . . 0.0 110.541 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -54.5 157.06 12.69 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 124.084 3.19 . . . . 0.0 114.723 175.02 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.17 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.034 2.134 . . . . 0.0 113.379 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.04 64.08 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.668 -1.074 . . . . 0.0 114.845 178.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 44.0 mtt -83.33 166.48 18.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.077 1.438 . . . . 0.0 111.553 165.893 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.73 140.33 50.1 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.481 1.512 . . . . 0.0 110.313 173.485 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.21 109.06 6.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 163.177 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.8 p -75.81 160.52 29.88 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.776 0.798 . . . . 0.0 112.944 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 -58.02 -17.78 19.83 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.971 1.709 . . . . 0.0 113.947 175.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.01 14.03 61.32 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.374 0.988 . . . . 0.0 114.038 -177.398 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -127.94 145.94 50.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.278 1.039 . . . . 0.0 112.485 -174.175 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.5 m -76.88 151.77 35.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.923 1.689 . . . . 0.0 112.536 176.405 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.48 -167.38 40.52 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.604 0.621 . . . . 0.0 113.544 168.719 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -132.4 169.0 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.897 1.679 . . . . 0.0 112.142 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.55 -179.02 34.32 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 123.849 0.738 . . . . 0.0 113.651 -178.827 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.45 -29.52 31.65 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.535 3.49 . . . . 0.0 116.157 -173.46 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.29 -8.16 54.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 116.737 -1.601 . . . . 0.0 115.157 177.117 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -147.15 -39.32 0.2 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.705 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.6 t -140.81 -5.03 1.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.439 1.496 . . . . 0.0 114.47 -159.658 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.01 -52.89 2.13 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.225 -0.922 . . . . 0.0 112.323 -167.805 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 126.38 1.872 . . . . 0.0 112.238 -173.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.4 -52.08 2.62 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -159.776 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -141.71 177.98 7.79 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.26 2.624 . . . . 0.0 110.473 169.809 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.96 107.94 12.07 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 124.568 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.75 99.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.623 2.369 . . . . 0.0 110.717 -169.665 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 41.39 43.04 2.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.345 1.458 . . . . 0.0 112.791 -170.968 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.16 -3.45 60.11 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.45 2.452 . . . . 0.0 115.262 178.874 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -128.41 -175.53 3.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.175 1.487 . . . . 0.0 112.516 -165.409 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.56 169.95 8.51 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.427 1.891 . . . . 0.0 107.551 160.753 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.5 164.61 15.08 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.84 2.36 . . . . 0.0 114.08 173.289 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -54.76 104.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.217 1.807 . . . . 0.0 111.648 177.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.94 -2.85 24.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.753 1.168 . . . . 0.0 114.296 -177.95 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -113.43 169.41 8.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.912 1.356 . . . . 0.0 109.938 170.604 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -141.58 157.11 45.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 0.0 112.337 -172.417 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.46 112.15 24.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.619 1.568 . . . . 0.0 111.663 -172.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.5 p -67.31 164.19 18.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -173.777 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -51.54 -3.24 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 129.159 2.983 . . . . 0.0 115.706 162.648 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.86 19.42 78.89 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.008 0.822 . . . . 0.0 113.598 -174.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.4 130.02 53.36 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.52 1.928 . . . . 0.0 109.649 177.682 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.5 p -93.38 159.83 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -176.378 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.2 -149.33 9.78 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.368 1.937 . . . . 0.0 111.488 -167.37 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -135.72 159.4 41.75 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 118.971 1.385 . . . . 0.0 112.526 -176.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.44 174.86 46.67 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.592 1.091 . . . . 0.0 113.626 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -45.49 -46.53 14.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.686 3.591 . . . . 0.0 114.673 -172.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -55.56 -24.4 32.23 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.511 1.924 . . . . 0.0 114.295 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -109.6 -27.54 9.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.362 1.865 . . . . 0.0 113.089 175.544 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m -91.86 -8.98 44.98 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.79 1.236 . . . . 0.0 113.87 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.05 -26.14 0.12 Allowed Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.038 1.575 . . . . 0.0 117.038 166.118 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.432 ' HA ' ' CZ ' ' A' ' 30' ' ' ARG . 1.7 tpm_? . . . . . 0 C--O 1.256 1.395 0 CA-C-N 119.561 1.681 . . . . 0.0 114.784 -178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.8 m -75.55 101.37 4.87 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.239 -0.913 . . . . 0.0 108.943 155.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.39 105.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.306 1.042 . . . . 0.0 110.179 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.9 27.2 4.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.167 0.987 . . . . 0.0 111.231 -169.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.88 -4.52 81.74 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.412 1.958 . . . . 0.0 115.65 -174.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 167.29 13.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 2.004 . . . . 0.0 112.488 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.1 m -134.23 154.89 80.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.813 2.045 . . . . 0.0 110.448 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.36 176.68 9.76 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.151 2.567 . . . . 0.0 111.646 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -29.7 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 129.431 3.092 . . . . 0.0 115.416 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.12 3.57 81.78 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.047 -1.418 . . . . 0.0 116.02 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -77.0 169.16 18.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.139 1.969 . . . . 0.0 112.173 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 m -132.62 157.92 43.56 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.811 1.645 . . . . 0.0 111.192 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -112.14 116.2 30.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.673 1.189 . . . . 0.0 112.403 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.1 p -68.98 163.48 24.49 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.359 1.464 . . . . 0.0 113.624 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 . . . . . 0 N--CA 1.469 0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 113.944 174.372 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.001 0 CA-C-O 119.955 -0.358 . . . . 0.0 112.663 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.48 135.62 51.79 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 110.654 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.4 t -109.68 137.62 47.22 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.434 2.294 . . . . 0.0 111.409 -169.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.8 -160.88 24.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.321 1.439 . . . . 0.0 111.478 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -133.17 126.31 31.37 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.772 0.829 . . . . 0.0 109.665 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.94 178.09 22.0 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.579 1.085 . . . . 0.0 112.754 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -48.04 -53.93 5.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.839 3.693 . . . . 0.0 114.521 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.69 -8.69 55.67 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -100.24 -51.69 3.59 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.041 0.937 . . . . 0.0 111.124 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.54 0.567 0 C-N-CA 124.254 1.022 . . . . 0.0 113.689 -175.832 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.631 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.5 m -72.21 117.83 14.34 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.587 -1.321 . . . . 0.0 109.287 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 85.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 129.205 3.002 . . . . 0.0 110.307 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.585 ' H ' ' NH1' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 40.39 42.75 1.33 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.194 2.198 . . . . 0.0 111.211 -161.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -13.65 66.12 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.579 2.037 . . . . 0.0 116.235 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.36 174.68 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.2 2.0 . . . . 0.0 111.01 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 m -141.12 163.9 39.2 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.536 1.134 . . . . 0.0 110.792 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.57 168.77 1.42 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 124.255 3.304 . . . . 0.0 114.668 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.8 m -44.46 100.11 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.402 2.281 . . . . 0.0 114.258 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.26 -1.62 84.58 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.722 1.153 . . . . 0.0 115.191 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -80.5 161.58 24.77 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.749 1.275 . . . . 0.0 110.966 168.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.9 m -138.2 156.12 48.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.383 1.473 . . . . 0.0 110.862 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -89.01 114.06 25.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.745 1.218 . . . . 0.0 111.379 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 4.8 t -70.73 168.22 17.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 113.233 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 . . . . . 0 CA--C 1.544 0.746 0 C-N-CA 126.359 1.864 . . . . 0.0 115.43 -176.587 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.269 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -123.51 149.46 45.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.195 1.798 . . . . 0.0 111.538 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -94.97 149.98 20.65 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.14 -165.16 37.79 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.564 1.078 . . . . 0.0 112.081 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -135.0 167.43 20.95 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.514 1.526 . . . . 0.0 111.591 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.62 -174.65 48.56 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.807 0.718 . . . . 0.0 113.101 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.9 -36.12 26.23 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.025 3.817 . . . . 0.0 116.151 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.61 -9.35 58.48 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 88.3 m-85 -139.25 -44.85 0.46 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -170.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 . . . . . 0 CA--C 1.542 0.662 0 N-CA-C 111.356 0.132 . . . . 0.0 111.356 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.8 m -50.39 154.19 1.34 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.517 1.127 . . . . 0.0 113.852 -163.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.05 70.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 123.573 1.654 . . . . 0.0 108.756 172.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? 33.33 50.23 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 1 C-N-CA 132.41 4.284 . . . . 0.0 112.559 -172.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.18 -17.92 10.44 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 127.295 2.379 . . . . 0.0 114.943 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.52 164.7 12.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.274 1.537 . . . . 0.0 111.493 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.1 m -144.7 168.11 13.09 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.364 1.466 . . . . 0.0 111.34 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.69 156.8 8.41 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.966 3.111 . . . . 0.0 114.211 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -52.85 97.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.746 2.018 . . . . 0.0 113.302 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.36 39.65 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.916 1.245 . . . . 0.0 114.85 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -94.07 167.79 11.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.801 1.301 . . . . 0.0 111.506 168.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.4 143.5 48.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.453 1.501 . . . . 0.0 110.681 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -83.08 109.02 16.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.449 0.7 . . . . 0.0 110.199 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.0 p -70.6 164.32 25.14 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 125.173 1.389 . . . . 0.0 114.582 175.432 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.11 0 CA-C-O 119.716 -0.491 . . . . 0.0 112.935 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -114.49 131.67 56.55 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.856 1.663 . . . . 0.0 110.228 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.8 m -73.57 152.67 40.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.965 1.306 . . . . 0.0 112.63 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.62 -167.18 40.23 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.098 0.856 . . . . 0.0 111.987 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.41 167.28 21.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 110.905 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.86 -172.96 54.6 Favored Glycine 0 CA--C 1.54 1.595 0 O-C-N 121.9 -0.5 . . . . 0.0 113.565 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -42.4 -48.05 7.01 Favored 'Trans proline' 0 C--N 1.351 0.689 1 C-N-CA 125.925 4.417 . . . . 0.0 116.915 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -70.94 -9.36 57.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -134.71 -60.73 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.915 0.886 . . . . 0.0 112.178 -168.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 96.8 m . . . . . 0 CA--C 1.545 0.762 0 C-N-CA 126.313 1.845 . . . . 0.0 112.907 -172.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 CA--C 1.55 0.979 0 CA-C-O 121.557 0.694 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 58.8 m -87.09 126.24 34.64 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 138.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.71 92.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.585 2.354 . . . . 0.0 110.664 -168.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 37.74 46.04 0.7 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.32 1.848 . . . . 0.0 112.266 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.08 -10.29 65.7 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.0 2.238 . . . . 0.0 115.554 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -103.19 179.14 4.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.457 1.629 . . . . 0.0 112.669 -173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 m -138.8 158.9 69.19 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.342 1.857 . . . . 0.0 110.423 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.96 163.05 39.86 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.562 2.175 . . . . 0.0 111.485 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.4 p -56.77 93.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.519 1.928 . . . . 0.0 112.78 -173.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.6 -11.91 10.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.499 1.523 . . . . 0.0 114.604 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -91.31 169.39 10.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.793 1.796 . . . . 0.0 111.883 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 p -142.8 164.56 29.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.514 1.526 . . . . 0.0 111.762 -174.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.0 t -120.36 111.12 17.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.359 1.064 . . . . 0.0 112.352 -157.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -69.73 161.95 28.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 113.917 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 . . . . . 0 N--CA 1.472 0.642 0 C-N-CA 124.209 1.004 . . . . 0.0 113.625 -173.453 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.658 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.83 114.78 17.67 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.475 1.51 . . . . 0.0 110.636 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 4' ' ' CYS . 43.4 t -78.74 148.32 33.07 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.463 0.705 . . . . 0.0 111.682 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.61 -152.26 13.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.992 1.758 . . . . 0.0 110.641 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -138.9 160.09 40.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.833 0.853 . . . . 0.0 110.915 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.31 172.2 13.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.044 1.783 . . . . 0.0 111.515 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.56 -34.27 75.62 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.882 2.388 . . . . 0.0 112.409 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -11.11 60.66 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -106.5 -45.36 4.27 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.995 1.318 . . . . 0.0 110.997 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.0 m . . . . . 0 CA--C 1.54 0.579 0 C-N-CA 124.618 1.167 . . . . 0.0 112.886 -177.341 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 . . . . . 0 CA--C 1.551 0.997 0 CA-C-O 121.817 0.818 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.4 m -94.26 110.08 21.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.909 1.684 . . . . 0.0 106.51 136.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.79 101.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.773 1.629 . . . . 0.0 111.373 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 48.51 27.05 1.32 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.405 1.482 . . . . 0.0 112.917 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.51 -15.74 14.7 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.37 2.414 . . . . 0.0 116.644 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.46 171.22 14.44 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.074 2.437 . . . . 0.0 112.917 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -146.86 156.17 47.82 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 123.105 0.562 . . . . 0.0 112.338 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.98 177.94 8.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.041 3.161 . . . . 0.0 112.996 -172.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.8 p 59.68 24.54 13.41 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.86 96.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.489 1.043 . . . . 0.0 112.704 -169.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.6 mtt -69.47 169.95 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.224 1.012 . . . . 0.0 110.739 160.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -140.4 155.43 46.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.143 1.777 . . . . 0.0 110.744 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -94.13 121.77 35.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.11 1.364 . . . . 0.0 113.212 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p -72.14 152.39 42.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.423 -0.798 . . . . 0.0 111.504 166.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 pm0 . . . . . 0 CA--C 1.541 0.634 0 C-N-CA 126.345 1.858 . . . . 0.0 114.187 175.605 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.98 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.318 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -121.17 122.33 39.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.154 1.781 . . . . 0.0 109.426 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.97 164.52 19.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.72 -151.11 10.08 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.8 2.143 . . . . 0.0 110.435 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -137.37 156.61 48.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.943 1.297 . . . . 0.0 110.335 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.45 -167.4 23.47 Favored Glycine 0 CA--C 1.542 1.76 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.49 4.94 2.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.857 3.705 . . . . 0.0 115.675 -164.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 4.49 9.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.697 1.999 . . . . 0.0 112.608 176.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.8 -44.03 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.122 1.769 . . . . 0.0 111.878 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 125.841 1.656 . . . . 0.0 107.927 171.328 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 CA--C 1.542 0.666 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -60.11 101.73 0.14 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -57.28 96.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 128.281 2.632 . . . . 0.0 110.865 -164.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? 48.79 29.55 2.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -167.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.46 -2.61 67.93 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.222 2.344 . . . . 0.0 116.23 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 165.91 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.272 2.036 . . . . 0.0 111.887 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m -141.57 130.83 12.5 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.999 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -80.6 168.79 17.59 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.635 2.89 . . . . 0.0 112.779 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p 55.06 28.13 10.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.21 35.55 60.44 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.92 1.248 . . . . 0.0 113.32 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -67.99 167.11 14.44 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.387 1.093 . . . . 0.0 110.501 162.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.41 135.22 54.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.96 2.104 . . . . 0.0 108.874 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 t -75.56 137.33 40.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.04 0.536 . . . . 0.0 110.558 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -117.68 163.93 15.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 113.969 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 125.622 1.569 . . . . 0.0 113.063 178.201 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.908 0 CA-C-O 119.391 -0.672 . . . . 0.0 113.39 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -121.84 155.71 34.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.94 1.696 . . . . 0.0 110.692 -168.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -86.62 156.03 20.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.824 0.85 . . . . 0.0 111.794 170.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.01 -174.12 41.38 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.832 1.206 . . . . 0.0 110.162 159.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -124.51 149.46 46.88 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.721 1.261 . . . . 0.0 110.557 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 179.12 52.17 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 123.523 0.582 . . . . 0.0 113.422 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.44 -20.13 61.12 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 114.444 -166.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.51 -21.41 16.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.992 1.317 . . . . 0.0 113.183 170.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -133.15 -42.76 0.87 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.426 1.49 . . . . 0.0 111.451 -173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m . . . . . 0 CA--C 1.541 0.617 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.626 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 . . . . . 0 CA--C 1.546 0.798 0 CA-C-O 121.277 0.561 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 61.7 m -100.86 109.95 21.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.759 1.624 . . . . 0.0 107.361 139.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -53.39 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.831 2.452 . . . . 0.0 110.747 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 48.85 27.08 1.47 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.815 2.046 . . . . 0.0 113.549 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.23 -11.03 33.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.946 2.212 . . . . 0.0 115.008 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 170.8 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.096 1.948 . . . . 0.0 112.657 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.6 m -136.4 167.68 20.5 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.967 1.307 . . . . 0.0 110.493 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.96 146.15 17.48 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.706 2.938 . . . . 0.0 112.568 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.7 m -66.31 82.28 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.137 1.375 . . . . 0.0 112.177 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.26 -17.57 2.7 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.326 1.917 . . . . 0.0 113.674 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mmt -80.29 177.04 9.24 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.658 1.229 . . . . 0.0 111.457 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.9 m -127.0 163.83 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.177 2.191 . . . . 0.0 110.124 169.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.51 118.88 37.81 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.73 1.212 . . . . 0.0 110.55 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.7 p -71.21 166.94 20.45 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 . . . . . 0 CA--C 1.544 0.725 0 C-N-CA 128.22 2.608 . . . . 0.0 115.297 162.85 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.173 0 CA-C-O 119.704 -0.498 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -120.59 133.97 55.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.237 2.615 . . . . 0.0 110.397 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 71.1 m -65.59 155.79 34.71 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.01 -160.13 29.84 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.139 1.828 . . . . 0.0 111.534 170.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.29 174.06 10.89 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.486 1.143 . . . . 0.0 111.207 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.93 169.98 42.3 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 124.656 1.122 . . . . 0.0 112.05 -166.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.37 -36.95 85.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.979 2.453 . . . . 0.0 112.358 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -55.6 -24.06 30.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.323 1.849 . . . . 0.0 114.16 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.9 -1.25 12.61 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.902 1.281 . . . . 0.0 113.502 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.544 0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.542 0.65 0 N-CA-C 111.559 0.207 . . . . 0.0 111.559 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.5 m -65.45 90.48 0.11 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 157.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.7 t -55.49 93.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 128.457 2.703 . . . . 0.0 111.068 -160.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 46.36 36.88 3.68 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.879 1.672 . . . . 0.0 112.796 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.69 -6.83 11.28 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.212 2.339 . . . . 0.0 117.516 171.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.24 167.42 20.4 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.998 2.399 . . . . 0.0 114.793 -170.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.6 m -132.12 161.79 60.68 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.419 . . . . 0.0 110.584 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.9 154.89 15.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.731 2.954 . . . . 0.0 113.364 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -49.91 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.98 2.112 . . . . 0.0 114.032 -173.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.17 -7.77 58.74 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.049 1.309 . . . . 0.0 114.85 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.1 mtp -76.77 161.61 28.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.52 1.66 . . . . 0.0 110.383 166.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.3 m -126.43 121.01 31.22 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.898 0.879 . . . . 0.0 110.511 -161.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.71 107.13 3.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.121 0.968 . . . . 0.0 110.748 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -73.26 156.1 38.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.297 0.57 . . . . 0.0 112.247 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.0 pm0 . . . . . 0 CA--C 1.539 0.542 0 C-N-CA 126.575 1.95 . . . . 0.0 114.329 -178.339 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.229 0 CA-C-O 119.44 -0.645 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -129.41 136.25 49.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.455 1.102 . . . . 0.0 112.124 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.9 m -71.76 157.69 37.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.915 1.686 . . . . 0.0 112.541 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.65 -163.63 33.48 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.106 0.86 . . . . 0.0 112.927 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -141.7 170.73 15.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.911 2.084 . . . . 0.0 108.445 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.83 -171.59 50.19 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 118.565 0.621 . . . . 0.0 113.879 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.49 -38.64 72.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.316 2.678 . . . . 0.0 114.825 -161.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.507 ' HE3' ' CZ ' ' A' ' 27' ' ' TYR . 3.3 ttpp -73.45 -2.57 23.02 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.507 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 72.5 m-85 -140.26 -34.56 0.53 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -171.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 m -69.87 95.04 0.88 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -62.63 89.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.863 2.065 . . . . 0.0 111.366 -161.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? 57.69 26.58 13.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.188 1.795 . . . . 0.0 113.336 -166.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.01 -13.68 5.76 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.197 1.38 . . . . 0.0 116.44 166.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.31 170.53 14.94 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.795 1.797 . . . . 0.0 113.685 -171.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.2 m -128.1 161.75 54.24 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.287 1.835 . . . . 0.0 110.991 -173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.59 159.37 53.0 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.822 2.348 . . . . 0.0 112.184 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.6 p -60.14 92.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.822 . . . . 0.0 112.104 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -15.86 4.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.44 1.495 . . . . 0.0 113.725 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -112.49 164.66 13.03 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.739 1.27 . . . . 0.0 111.293 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.2 m -132.13 148.82 52.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.919 1.688 . . . . 0.0 109.92 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -82.58 148.44 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.148 0.579 . . . . 0.0 111.654 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.3 p -118.26 163.09 17.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.718 1.207 . . . . 0.0 113.313 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 . . . . . 0 N--CA 1.47 0.545 0 C-N-CA 125.551 1.54 . . . . 0.0 113.819 176.969 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.155 0 CA-C-O 119.472 -0.626 . . . . 0.0 113.353 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -124.02 144.86 49.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.608 1.163 . . . . 0.0 112.121 -169.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -82.32 156.24 24.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.963 1.305 . . . . 0.0 112.429 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.54 -164.6 36.3 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.63 0.634 . . . . 0.0 113.349 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -136.36 172.05 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.425 1.89 . . . . 0.0 110.695 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.55 -177.67 53.46 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 123.9 0.762 . . . . 0.0 113.554 -168.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.08 -48.59 14.31 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.261 3.974 . . . . 0.0 115.096 -172.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.75 -13.68 11.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.091 1.756 . . . . 0.0 115.632 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -135.07 -37.15 0.8 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.424 1.011 . . . . 0.0 113.317 -168.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? . . . . . 0 CA--C 1.543 0.698 0 N-CA-C 111.44 0.163 . . . . 0.0 111.44 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -72.19 93.38 1.45 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.724 -0.61 . . . . 0.0 110.905 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.0 89.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 128.346 2.658 . . . . 0.0 111.215 -168.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.504 ' CZ ' ' H ' ' A' ' 6' ' ' ARG . 7.9 mmp_? 38.06 41.74 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.699 2.8 . . . . 0.0 112.21 -163.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.27 34.23 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 128.211 2.815 . . . . 0.0 116.095 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -89.74 160.03 16.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.2 2.0 . . . . 0.0 112.031 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.3 m -140.77 161.7 52.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.577 1.151 . . . . 0.0 111.164 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.44 168.36 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.373 3.382 . . . . 0.0 115.057 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.7 m -43.79 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.889 2.476 . . . . 0.0 114.059 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.38 7.41 87.9 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.049 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.8 mtt -84.22 166.13 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.059 1.429 . . . . 0.0 111.964 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.1 m -123.99 152.7 42.24 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.762 1.625 . . . . 0.0 109.823 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.42 154.37 38.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.932 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 p -133.92 174.78 10.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 . . . . . 0 N--CA 1.47 0.533 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -154.998 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.046 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.73 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -129.17 139.77 51.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.392 1.096 . . . . 0.0 112.651 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.2 m -79.63 159.44 26.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.381 2.272 . . . . 0.0 113.629 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.62 -166.83 39.25 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 123.938 0.78 . . . . 0.0 113.977 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -129.29 165.57 21.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.32 1.848 . . . . 0.0 111.139 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.75 -178.51 53.24 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 123.536 0.589 . . . . 0.0 113.707 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.64 -33.26 58.26 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.65 3.566 . . . . 0.0 116.297 -171.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -14.89 63.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 113.406 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -137.58 -48.88 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.02 0.827 . . . . 0.0 113.222 -171.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.4 t . . . . . 0 CA--C 1.537 0.463 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -156.511 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 . . . . . 0 CA--C 1.543 0.695 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.86 99.59 9.12 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 143.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -57.94 93.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.319 1.847 . . . . 0.0 111.454 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 42.73 36.98 0.92 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.148 1.779 . . . . 0.0 112.452 -164.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.11 66.22 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.407 2.432 . . . . 0.0 116.01 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.98 170.87 9.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.219 2.009 . . . . 0.0 112.685 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.99 152.47 55.14 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.414 2.286 . . . . 0.0 109.327 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.6 166.04 6.96 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.731 2.954 . . . . 0.0 113.858 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -47.35 105.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.149 2.18 . . . . 0.0 113.591 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.23 4.28 89.74 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.968 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.2 mtt -90.42 163.95 14.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.885 1.342 . . . . 0.0 111.417 170.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -133.42 133.45 42.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.139 1.375 . . . . 0.0 111.137 -165.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.52 140.67 44.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.528 . . . . 0.0 110.53 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.0 p -117.04 163.36 16.35 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.543 1.137 . . . . 0.0 113.472 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 . . . . . 0 N--CA 1.471 0.585 0 C-N-CA 126.066 1.746 . . . . 0.0 113.825 178.451 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.12 0 CA-C-O 120.051 -0.305 . . . . 0.0 113.132 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -126.18 136.02 52.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.264 1.826 . . . . 0.0 111.101 -168.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.53 150.98 32.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.149 0.98 . . . . 0.0 112.481 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.48 -162.14 31.41 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.336 0.97 . . . . 0.0 113.248 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -138.35 167.26 22.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.233 1.413 . . . . 0.0 112.546 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.15 -174.89 40.11 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.428 0.537 . . . . 0.0 113.442 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.6 -32.18 27.05 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.91 3.74 . . . . 0.0 116.523 -172.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -6.98 50.35 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 116.85 -1.548 . . . . 0.0 115.118 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -144.38 -38.57 0.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -169.867 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.2 m -64.88 96.2 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 158.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.1 t -51.89 93.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.99 2.516 . . . . 0.0 111.794 -159.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 38.44 36.18 0.12 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.722 2.009 . . . . 0.0 113.156 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -4.39 31.14 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 128.531 2.967 . . . . 0.0 116.751 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 167.56 12.69 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 121.214 2.507 . . . . 0.0 113.592 176.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.35 152.0 52.65 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 126.773 2.029 . . . . 0.0 108.356 166.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.42 168.53 2.85 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.98 3.12 . . . . 0.0 114.321 169.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -47.74 99.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.454 2.302 . . . . 0.0 113.886 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.99 84.06 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.795 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -83.8 169.54 15.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.982 1.391 . . . . 0.0 110.919 163.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.11 164.12 31.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.032 1.733 . . . . 0.0 111.572 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -117.57 112.5 20.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 112.307 -162.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.5 p -68.51 160.17 30.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.384 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pm0 . . . . . 0 CA--C 1.54 0.591 0 C-N-CA 125.528 1.531 . . . . 0.0 114.264 176.291 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.011 0 CA-C-O 119.613 -0.548 . . . . 0.0 112.871 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -106.06 130.91 53.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 0.0 110.007 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -78.04 159.85 28.48 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.336 1.455 . . . . 0.0 111.118 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.74 -160.91 32.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.698 1.618 . . . . 0.0 110.852 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -138.67 156.34 47.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.686 -0.891 . . . . 0.0 110.057 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.03 -175.82 41.83 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 123.522 0.582 . . . . 0.0 114.121 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.5 -47.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.046 3.831 . . . . 0.0 115.482 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -74.56 -0.27 17.19 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -125.31 -35.67 2.58 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.89 1.276 . . . . 0.0 112.706 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 m . . . . . 0 CA--C 1.543 0.681 0 C-N-CA 124.949 1.3 . . . . 0.0 111.956 178.867 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 CA--C 1.551 0.994 0 CA-C-O 121.526 0.679 . . . . 0.0 111.1 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 59.4 m -95.15 107.66 19.75 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 137.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -55.63 96.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.555 1.942 . . . . 0.0 111.325 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 39.18 43.02 0.82 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 111.896 -167.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.45 56.13 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.846 2.165 . . . . 0.0 116.506 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -118.12 167.62 11.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.853 2.326 . . . . 0.0 114.047 -170.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.1 m -131.11 164.12 44.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.003 1.321 . . . . 0.0 111.595 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.16 160.37 4.59 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.167 3.245 . . . . 0.0 114.469 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.14 100.04 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.144 2.178 . . . . 0.0 113.382 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.06 2.25 66.52 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.086 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -77.95 172.6 13.25 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.433 1.617 . . . . 0.0 111.844 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.81 159.86 36.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.048 2.139 . . . . 0.0 111.154 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -108.51 114.46 28.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.615 1.566 . . . . 0.0 110.56 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.9 p -67.51 153.19 44.26 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.779 0.799 . . . . 0.0 112.841 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 CA--C 1.542 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 113.791 168.091 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.035 0 CA-C-O 119.43 -0.65 . . . . 0.0 113.988 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -123.41 126.84 47.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.684 1.994 . . . . 0.0 110.528 -177.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 61.4 m -74.18 158.8 33.5 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.63 -160.71 31.04 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.748 2.118 . . . . 0.0 110.334 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -138.17 143.56 40.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 1.469 . . . . 0.0 111.266 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.37 177.12 20.35 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.291 1.424 . . . . 0.0 112.053 -170.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.5 -38.69 81.48 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.931 2.421 . . . . 0.0 112.628 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -59.96 -10.24 3.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.338 1.455 . . . . 0.0 114.564 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -122.31 -29.54 4.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.188 1.395 . . . . 0.0 113.009 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 36.1 m . . . . . 0 CA--C 1.546 0.821 0 C-N-CA 124.108 0.963 . . . . 0.0 112.92 176.637 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 . . . . . 0 CA--C 1.543 0.684 0 CA-C-O 121.518 0.675 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -66.24 117.17 8.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 152.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.07 94.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.322 2.249 . . . . 0.0 110.721 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? 42.64 35.7 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.052 0.941 . . . . 0.0 112.458 -161.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.32 -6.05 63.23 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 126.4 1.953 . . . . 0.0 116.384 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.71 170.78 9.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.418 2.109 . . . . 0.0 112.96 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.5 m -139.14 157.45 71.15 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.472 1.909 . . . . 0.0 108.701 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.5 162.87 37.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.662 2.241 . . . . 0.0 112.263 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -55.34 89.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.695 2.398 . . . . 0.0 113.522 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.96 -8.31 7.65 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.212 1.386 . . . . 0.0 114.715 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 99.2 mtp -98.97 169.6 9.32 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.152 1.476 . . . . 0.0 111.265 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.74 136.5 51.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.773 1.629 . . . . 0.0 111.606 -175.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.8 t -89.19 116.24 27.29 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.106 1.362 . . . . 0.0 109.694 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -73.32 156.09 38.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.232 1.015 . . . . 0.0 113.339 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 . . . . . 0 CA--C 1.541 0.606 0 C-N-CA 126.862 2.065 . . . . 0.0 113.474 170.253 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.134 0 CA-C-O 119.381 -0.677 . . . . 0.0 114.428 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -116.6 141.1 48.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.534 1.134 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.69 153.35 20.79 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.017 1.327 . . . . 0.0 110.877 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.58 -159.75 26.8 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.666 -0.646 . . . . 0.0 112.534 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 0.0 110.179 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.04 178.34 49.95 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.918 0.77 . . . . 0.0 112.863 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.4 -21.69 66.34 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.468 2.779 . . . . 0.0 114.359 -167.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -58.57 -21.55 53.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.137 0.975 . . . . 0.0 113.136 171.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -132.56 -36.64 1.08 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.132 0.973 . . . . 0.0 113.479 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m . . . . . 0 CA--C 1.543 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 112.072 174.896 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.979 0.895 . . . . 0.0 112.965 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.03 106.16 1.2 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 150.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -52.03 97.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 128.517 2.727 . . . . 0.0 109.913 -168.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 41.9 39.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.74 2.016 . . . . 0.0 112.513 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.96 -6.59 40.53 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 127.029 2.252 . . . . 0.0 115.637 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.33 176.24 5.57 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.962 1.881 . . . . 0.0 113.829 -168.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.1 m -137.51 152.33 72.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 110.742 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.7 169.32 22.52 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 112.12 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.2 t -45.97 110.49 0.27 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.862 1.665 . . . . 0.0 113.257 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 -12.0 68.09 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.57 -1.683 . . . . 0.0 115.671 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -75.4 170.93 15.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.595 2.198 . . . . 0.0 111.38 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -130.35 148.23 52.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.535 1.534 . . . . 0.0 111.106 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -92.92 114.98 27.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.777 1.231 . . . . 0.0 110.438 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.8 p -67.54 163.12 21.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.826 1.298 . . . . 0.0 114.258 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 . . . . . 0 CA--C 1.547 0.835 0 C-N-CA 128.686 2.794 . . . . 0.0 115.545 161.401 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.289 0 CA-C-O 120.091 -0.283 . . . . 0.0 113.778 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -107.0 149.99 26.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.382 1.473 . . . . 0.0 109.929 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.8 t -118.61 133.74 55.63 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.746 0.818 . . . . 0.0 112.145 -168.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.16 -154.16 10.21 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.527 1.537 . . . . 0.0 111.289 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.29 169.84 16.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.229 1.014 . . . . 0.0 111.594 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.14 169.89 44.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.093 1.33 . . . . 0.0 111.457 -167.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.62 -34.46 92.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.617 2.211 . . . . 0.0 112.121 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -52.72 -33.95 50.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 113.271 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.49 -14.16 15.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.007 1.723 . . . . 0.0 113.712 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.632 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -175.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? . . . . . 0 CA--C 1.54 0.563 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.64 104.55 2.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.992 0.517 . . . . 0.0 110.915 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.25 91.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.557 2.343 . . . . 0.0 110.542 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.579 ' H ' ' NH1' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 43.58 34.63 0.84 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.592 2.357 . . . . 0.0 112.341 -164.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 -10.27 56.68 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.324 2.392 . . . . 0.0 116.347 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 160.81 19.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.877 2.339 . . . . 0.0 111.724 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -140.1 134.24 15.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.685 1.194 . . . . 0.0 110.275 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.52 178.38 7.63 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.444 2.763 . . . . 0.0 112.634 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 m 45.42 41.36 6.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.277 2.231 . . . . 0.0 115.423 170.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.53 58.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 113.795 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 79.1 mtm -84.56 164.48 18.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.621 1.211 . . . . 0.0 111.062 168.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 m -112.34 147.31 36.63 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.486 1.914 . . . . 0.0 109.556 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -80.3 112.04 17.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.385 0.674 . . . . 0.0 110.778 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.8 p -66.26 162.64 19.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.867 1.318 . . . . 0.0 113.974 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 . . . . . 0 CA--C 1.545 0.774 0 C-N-CA 128.41 2.684 . . . . 0.0 115.558 161.797 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 1.254 0 CA-C-O 119.845 -0.42 . . . . 0.0 114.057 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.59 143.05 50.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.211 1.405 . . . . 0.0 111.652 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -76.46 147.16 38.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.388 1.075 . . . . 0.0 112.675 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.68 -162.15 27.72 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.532 1.063 . . . . 0.0 112.175 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -132.14 166.29 22.14 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.187 0.994 . . . . 0.0 111.51 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.53 175.28 37.23 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.527 1.061 . . . . 0.0 113.601 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -47.87 -43.5 29.35 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.298 3.332 . . . . 0.0 114.273 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -58.1 -26.22 62.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.276 1.43 . . . . 0.0 113.91 -176.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -114.31 -14.65 12.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.602 1.561 . . . . 0.0 113.528 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.001 0 CA-C-O 122.573 1.177 . . . . 0.0 111.29 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.419 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 40.7 m -74.44 179.74 4.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.575 -1.328 . . . . 0.0 110.491 147.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.32 79.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.208 -1.557 . . . . 0.0 107.613 164.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 45.36 47.04 10.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.246 1.418 . . . . 0.0 112.28 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.26 76.61 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.734 1.159 . . . . 0.0 115.463 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.77 172.6 11.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.659 1.984 . . . . 0.0 109.924 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -141.88 154.8 65.88 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 118.973 0.806 . . . . 0.0 112.894 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.17 173.61 11.61 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.903 3.069 . . . . 0.0 111.773 169.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m 36.0 43.18 0.19 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 129.128 2.971 . . . . 0.0 117.086 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.19 31.08 61.71 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.854 1.216 . . . . 0.0 114.253 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -73.87 165.04 25.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.701 1.75 . . . . 0.0 109.561 159.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.3 m -118.32 115.6 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.462 1.505 . . . . 0.0 109.48 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -74.15 89.16 1.98 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.15 164.79 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.776 1.63 . . . . 0.0 114.275 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 . . . . . 0 N--CA 1.468 0.471 0 C-N-CA 125.4 1.48 . . . . 0.0 113.361 176.854 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.12 0 CA-C-O 119.488 -0.618 . . . . 0.0 113.505 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.53 126.52 37.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.952 1.301 . . . . 0.0 111.252 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 69.3 m -67.21 135.91 54.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.252 0.478 . . . . 0.0 111.456 167.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.55 -163.33 17.39 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.622 1.106 . . . . 0.0 112.108 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -132.59 167.0 20.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.443 1.497 . . . . 0.0 110.483 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.43 179.13 34.01 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.683 0.658 . . . . 0.0 113.383 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.51 -28.66 70.57 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.993 2.462 . . . . 0.0 113.442 -171.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -12.01 20.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.842 -1.551 . . . . 0.0 114.505 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.73 -25.93 1.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.541 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 113.633 175.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 . . . . . 0 N--CA 1.475 0.808 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -61.56 101.65 0.2 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.26 95.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.488 2.315 . . . . 0.0 110.0 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? 47.05 34.41 2.81 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.893 1.277 . . . . 0.0 111.729 -167.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.2 68.46 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 126.982 2.229 . . . . 0.0 116.276 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.27 163.95 15.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.448 2.124 . . . . 0.0 111.682 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -138.38 158.29 70.92 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.804 1.241 . . . . 0.0 110.772 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.66 168.24 25.27 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.872 2.382 . . . . 0.0 112.687 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -43.71 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.249 2.619 . . . . 0.0 114.586 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -7.15 59.48 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.196 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -79.0 170.4 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.791 1.795 . . . . 0.0 111.875 170.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -139.14 163.29 32.82 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.892 2.077 . . . . 0.0 110.542 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -109.54 114.96 29.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.823 1.249 . . . . 0.0 112.091 -166.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.55 157.95 34.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.002 1.321 . . . . 0.0 112.862 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pm0 . . . . . 0 CA--C 1.539 0.53 0 C-N-CA 124.599 1.16 . . . . 0.0 113.484 169.923 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.996 0 CA-C-O 119.503 -0.61 . . . . 0.0 113.798 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -114.84 143.76 44.6 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 112.684 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.65 157.56 31.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.551 1.141 . . . . 0.0 112.066 167.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.51 -160.89 34.66 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.281 1.896 . . . . 0.0 109.77 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -142.93 163.06 33.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.514 0.657 . . . . 0.0 110.803 169.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.71 179.11 25.72 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.696 1.141 . . . . 0.0 112.928 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.87 -8.46 23.55 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.902 3.068 . . . . 0.0 114.867 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.21 -2.12 50.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.7 1.6 . . . . 0.0 113.661 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.37 -44.91 1.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.873 1.669 . . . . 0.0 111.767 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.5 m . . . . . 0 CA--C 1.544 0.736 0 C-N-CA 125.88 1.672 . . . . 0.0 111.913 175.081 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? . . . . . 0 CA--C 1.541 0.598 0 N-CA-C 114.075 1.139 . . . . 0.0 114.075 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.5 m -68.49 103.33 1.64 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.324 0.649 . . . . 0.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -54.54 89.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 128.73 2.812 . . . . 0.0 111.524 -172.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.58 ' H ' ' NH1' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 37.66 40.09 0.23 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.726 2.81 . . . . 0.0 112.785 -162.432 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.68 -7.46 27.93 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 126.429 1.966 . . . . 0.0 116.559 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -112.45 166.55 11.21 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.573 2.187 . . . . 0.0 113.574 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -142.17 167.07 17.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.331 1.852 . . . . 0.0 110.828 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -54.04 155.53 14.88 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.729 2.953 . . . . 0.0 114.223 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.9 t -62.28 74.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.392 2.277 . . . . 0.0 113.914 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.04 -10.41 2.55 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.026 1.774 . . . . 0.0 114.533 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.0 171.76 10.06 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.261 1.425 . . . . 0.0 111.31 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -123.01 149.69 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.102 1.761 . . . . 0.0 110.101 169.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.94 118.46 21.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.846 0.859 . . . . 0.0 109.974 166.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -78.88 159.22 27.87 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.863 0.839 . . . . 0.0 112.795 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 125.791 1.637 . . . . 0.0 113.872 173.569 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.117 0 CA-C-O 119.491 -0.616 . . . . 0.0 113.743 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.7 140.03 50.58 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.439 1.096 . . . . 0.0 111.823 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m -73.17 153.15 40.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.624 1.569 . . . . 0.0 112.53 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 -170.5 43.64 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.62 0.629 . . . . 0.0 113.953 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -128.45 165.78 20.0 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.323 2.249 . . . . 0.0 110.299 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.89 179.98 52.79 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.069 0.842 . . . . 0.0 113.295 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.67 -26.8 39.35 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 124.585 3.523 . . . . 0.0 116.235 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -71.61 -10.93 60.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -143.95 -52.02 0.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.542 0.648 0 C-N-CA 125.729 1.612 . . . . 0.0 114.142 -159.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 . . . . . 0 CA--C 1.549 0.916 0 CA-C-O 121.656 0.741 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 20.2 m -99.66 146.7 26.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.459 1.504 . . . . 0.0 110.802 141.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -69.09 91.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.47 1.508 . . . . 0.0 110.016 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.421 ' H ' ' NH1' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 48.68 25.84 1.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.814 -168.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.89 39.97 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.588 1.566 . . . . 0.0 116.54 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.29 166.19 11.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.22 2.01 . . . . 0.0 112.16 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -145.49 163.56 31.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.935 -173.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.18 156.46 10.23 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.356 3.37 . . . . 0.0 115.443 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -51.68 102.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.201 2.201 . . . . 0.0 112.59 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.38 -3.75 47.23 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.682 -1.065 . . . . 0.0 114.831 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.46 -175.59 2.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.926 1.863 . . . . 0.0 112.354 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.63 137.86 52.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.081 2.152 . . . . 0.0 109.818 160.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.36 107.81 13.46 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 158.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -77.04 165.77 24.19 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -174.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 125.418 1.487 . . . . 0.0 113.525 171.03 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.05 0 CA-C-O 119.786 -0.452 . . . . 0.0 113.109 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -122.35 133.12 54.66 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.243 2.217 . . . . 0.0 110.261 -173.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 98.5 m -65.99 146.03 55.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 165.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.5 -167.38 39.28 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.091 0.853 . . . . 0.0 113.659 165.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -131.13 169.68 15.56 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.739 2.016 . . . . 0.0 111.539 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.33 178.87 33.14 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.139 0.876 . . . . 0.0 113.76 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.31 -35.66 35.53 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.717 3.612 . . . . 0.0 116.288 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -5.67 40.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -144.01 -30.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -157.309 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 . . . . . 0 CA--C 1.55 0.96 0 CA-C-O 122.211 1.005 . . . . 0.0 111.862 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 47.7 m -95.95 128.11 42.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.352 1.861 . . . . 0.0 109.006 145.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.2 90.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 129.163 2.985 . . . . 0.0 111.456 -171.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? 44.96 29.81 0.5 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.195 0.998 . . . . 0.0 113.42 -165.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.21 8.22 63.16 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.075 1.322 . . . . 0.0 115.437 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -105.53 174.02 6.06 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.814 2.445 . . . . 0.0 110.654 171.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.1 m -140.1 133.26 15.09 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.85 166.48 17.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.807 3.005 . . . . 0.0 111.874 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p 53.97 27.85 7.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.44 34.37 54.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.081 1.324 . . . . 0.0 113.61 -170.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.2 mtt -67.17 170.47 6.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 110.687 163.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 m -130.34 148.83 52.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.386 1.474 . . . . 0.0 110.341 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 t -91.96 109.41 20.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.35 1.06 . . . . 0.0 111.856 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 87.2 p -66.43 165.8 13.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.703 1.201 . . . . 0.0 113.811 177.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 . . . . . 0 CA--C 1.538 0.487 0 C-N-CA 127.212 2.205 . . . . 0.0 114.447 170.357 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.96 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.044 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -120.16 126.13 49.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.276 2.231 . . . . 0.0 109.93 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 86.9 m -68.06 149.4 49.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 170.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.48 -159.25 21.14 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.773 1.654 . . . . 0.0 111.846 173.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.14 157.2 40.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.842 1.257 . . . . 0.0 110.981 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.31 -175.96 49.88 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.414 0.925 . . . . 0.0 115.414 171.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.01 -22.25 38.04 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.918 3.745 . . . . 0.0 117.284 -170.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.39 1.22 57.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.776 1.23 . . . . 0.0 113.319 176.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 86.6 m-85 -129.6 -44.34 1.23 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.636 1.174 . . . . 0.0 112.403 -176.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.541 0.608 0 C-N-CA 123.591 0.756 . . . . 0.0 113.028 170.861 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 . . . . . 0 CA--C 1.543 0.676 0 N-CA-C 110.44 -0.207 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m -65.49 108.35 1.97 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.706 -0.621 . . . . 0.0 111.713 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.71 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.862 2.065 . . . . 0.0 110.639 -174.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.518 ' CZ ' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 40.59 43.81 1.65 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.739 2.016 . . . . 0.0 111.405 -162.556 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.04 70.88 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.982 1.753 . . . . 0.0 116.089 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.0 20.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.441 2.121 . . . . 0.0 111.433 176.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.8 m -142.37 154.61 64.04 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.036 1.334 . . . . 0.0 111.469 174.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -77.27 174.32 12.95 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.613 2.875 . . . . 0.0 111.95 175.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m 37.34 45.66 0.55 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.191 2.596 . . . . 0.0 116.137 167.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.86 30.78 22.8 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.746 1.641 . . . . 0.0 114.125 -176.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.8 mtt -74.37 159.94 31.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.622 1.211 . . . . 0.0 111.579 177.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.4 m -87.63 120.97 29.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.445 1.498 . . . . 0.0 109.448 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.0 t -67.67 101.14 0.98 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 160.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -75.31 163.6 27.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -174.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 . . . . . 0 CA--C 1.54 0.586 0 C-N-CA 125.521 1.529 . . . . 0.0 113.504 173.541 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.206 0 N-CA-C 114.074 0.39 . . . . 0.0 114.074 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -128.58 146.9 50.71 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.287 1.035 . . . . 0.0 112.02 -172.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.76 147.81 37.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.882 2.073 . . . . 0.0 112.438 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.86 -169.69 42.83 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.38 0.514 . . . . 0.0 113.77 163.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -130.12 159.97 35.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.491 1.916 . . . . 0.0 108.993 170.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.87 173.67 47.85 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 123.903 0.763 . . . . 0.0 112.744 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -45.9 34.13 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.155 3.237 . . . . 0.0 115.53 -167.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 0.28 1.23 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -137.61 -38.62 0.59 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 CA--C 1.542 0.644 0 C-N-CA 125.281 1.432 . . . . 0.0 113.702 -176.129 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 CA--C 1.546 0.826 0 CA-C-O 123.134 1.445 . . . . 0.0 113.78 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.5 m -82.17 132.59 35.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 144.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.36 86.2 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.872 1.269 . . . . 0.0 111.479 -161.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.16 42.89 25.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.673 1.189 . . . . 0.0 111.22 -159.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.15 -10.04 65.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.012 1.768 . . . . 0.0 115.03 177.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -103.01 172.38 6.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.83 1.315 . . . . 0.0 113.328 -167.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.75 157.61 64.45 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.909 2.084 . . . . 0.0 110.784 176.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.64 161.09 42.79 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.877 2.385 . . . . 0.0 111.893 165.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -55.27 92.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.238 2.215 . . . . 0.0 113.48 -173.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.76 -10.83 10.3 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.219 1.39 . . . . 0.0 114.5 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.3 mtt -88.62 167.12 13.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.868 1.334 . . . . 0.0 111.228 166.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 m -137.44 142.01 41.61 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.944 1.698 . . . . 0.0 110.858 -172.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.4 t -83.93 108.18 16.76 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.467 1.107 . . . . 0.0 110.128 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.1 p -71.44 161.72 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.823 0.82 . . . . 0.0 113.034 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 . . . . . 0 CA--C 1.541 0.602 0 C-N-CA 125.843 1.657 . . . . 0.0 113.864 174.255 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.025 0 CA-C-O 119.623 -0.543 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.18 127.88 49.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.838 1.655 . . . . 0.0 110.661 -173.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.0 t -83.51 144.76 29.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.875 0.87 . . . . 0.0 112.387 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.48 -165.2 33.21 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.319 0.961 . . . . 0.0 112.644 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -136.41 162.59 32.62 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.397 1.079 . . . . 0.0 111.864 176.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.68 -173.68 42.12 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.161 0.886 . . . . 0.0 112.953 -173.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -44.31 -47.98 10.26 Favored 'Trans proline' 0 C--N 1.35 0.652 1 C-N-CA 125.407 4.072 . . . . 0.0 115.612 -172.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -65.69 -6.53 11.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.891 1.676 . . . . 0.0 115.522 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -139.64 -56.0 0.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.005 0.922 . . . . 0.0 113.033 -171.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m . . . . . 0 CA--C 1.537 0.475 0 C-N-CA 126.567 1.947 . . . . 0.0 113.553 -170.881 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 . . . . . 0 CA--C 1.549 0.937 0 CA-C-O 121.386 0.612 . . . . 0.0 111.027 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.2 m -85.76 107.44 17.61 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 139.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -55.43 95.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.964 1.706 . . . . 0.0 111.524 -158.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? 45.28 36.06 2.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.085 1.754 . . . . 0.0 112.335 -169.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.92 -4.65 59.23 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 127.697 2.57 . . . . 0.0 115.873 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.76 8.5 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.264 2.032 . . . . 0.0 113.087 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.34 152.02 74.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.148 . . . . 0.0 109.661 169.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.65 165.96 4.16 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.783 2.989 . . . . 0.0 113.257 162.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.64 98.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.703 2.401 . . . . 0.0 114.07 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.53 4.61 89.11 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.466 176.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt -77.6 172.91 12.64 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.797 1.798 . . . . 0.0 112.105 171.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 m -128.61 133.96 48.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.376 1.87 . . . . 0.0 110.62 -169.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.5 t -81.99 125.97 31.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.909 -0.494 . . . . 0.0 110.672 173.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -79.2 154.32 29.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 173.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 . . . . . 0 CA--C 1.541 0.618 0 O-C-N 121.46 -0.775 . . . . 0.0 112.845 169.725 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.916 0 CA-C-O 119.204 -0.776 . . . . 0.0 114.177 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -115.41 131.08 57.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.41 1.484 . . . . 0.0 109.864 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.44 149.89 36.79 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.491 0.316 . . . . 0.0 111.791 169.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.46 -159.17 23.03 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.871 1.224 . . . . 0.0 112.001 175.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -139.31 154.48 47.92 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.991 0.916 . . . . 0.0 110.079 175.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.41 176.92 28.73 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.857 1.218 . . . . 0.0 112.799 -173.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.88 -53.06 6.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.546 3.498 . . . . 0.0 114.467 -174.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -56.62 -12.19 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.337 1.855 . . . . 0.0 114.888 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.07 -39.11 2.85 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.882 1.673 . . . . 0.0 112.943 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.7 m . . . . . 0 CA--C 1.545 0.761 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.091 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 . . . . . 0 CA--C 1.554 1.097 0 CA-C-O 121.074 0.464 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.49 107.52 15.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 130.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.01 101.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 126.693 1.997 . . . . 0.0 110.425 -170.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 48.9 33.2 4.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.586 1.155 . . . . 0.0 112.379 -170.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.78 68.33 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.898 2.189 . . . . 0.0 115.269 -178.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -121.38 164.21 17.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.774 1.787 . . . . 0.0 112.597 -174.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.35 173.83 4.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.441 2.297 . . . . 0.0 108.878 163.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.58 136.07 16.15 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.75 2.966 . . . . 0.0 113.755 173.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.8 p -58.31 97.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.107 1.763 . . . . 0.0 112.254 -174.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.31 -19.88 4.51 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.441 1.496 . . . . 0.0 112.969 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.3 mtp -82.37 158.95 23.15 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.211 1.005 . . . . 0.0 109.645 159.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.6 m -143.29 139.6 30.21 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.834 1.254 . . . . 0.0 110.156 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -70.93 155.3 40.98 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 177.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -126.83 166.38 17.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.879 1.271 . . . . 0.0 113.219 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 . . . . . 0 CA--C 1.541 0.611 0 C-N-CA 124.951 1.3 . . . . 0.0 114.067 174.95 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 CA-C-O 119.648 -0.529 . . . . 0.0 113.38 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.64 137.0 50.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.45 1.5 . . . . 0.0 110.033 -171.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 151.71 30.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 166.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.5 -162.22 26.82 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.918 1.246 . . . . 0.0 112.015 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -138.25 163.98 30.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.819 1.648 . . . . 0.0 110.714 172.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.45 -175.66 46.01 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 123.609 0.623 . . . . 0.0 113.232 -176.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.53 -36.38 31.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 125.178 3.919 . . . . 0.0 116.77 -171.038 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.94 -9.65 58.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 178.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.74 -47.84 0.5 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -168.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.54 0.578 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -174.127 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 . . . . . 0 CA--C 1.547 0.836 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.8 m -95.27 112.94 24.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.684 1.994 . . . . 0.0 107.268 151.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.0 103.07 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.536 1.134 . . . . 0.0 110.44 -163.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.26 30.5 4.44 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.366 1.066 . . . . 0.0 112.156 -165.124 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.26 -7.69 81.51 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.184 1.85 . . . . 0.0 115.198 -174.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.8 171.93 8.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.584 1.692 . . . . 0.0 112.016 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.0 m -143.14 149.17 47.79 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.363 1.865 . . . . 0.0 111.521 -172.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.02 -178.27 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 125.261 3.974 . . . . 0.0 114.991 165.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -38.96 92.3 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.644 3.178 . . . . 0.0 115.311 -177.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.38 30.13 61.24 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.62 1.105 . . . . 0.0 113.588 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.4 mtt -85.71 170.04 12.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 110.813 170.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.16 142.32 35.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.22 1.808 . . . . 0.0 110.734 -164.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.6 113.13 23.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.564 1.145 . . . . 0.0 110.555 -177.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.9 p -71.58 165.87 23.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.148 0.975 . . . . 0.0 113.504 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 127.347 2.259 . . . . 0.0 114.683 170.906 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.073 0 CA-C-O 119.748 -0.473 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -111.65 123.04 49.4 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.43 1.892 . . . . 0.0 108.906 -178.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.77 142.69 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.246 0.476 . . . . 0.0 112.02 178.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.91 -161.47 19.21 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.951 1.739 . . . . 0.0 110.33 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -132.59 150.0 52.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.769 1.285 . . . . 0.0 110.779 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 -160.64 30.33 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 115.406 0.923 . . . . 0.0 115.406 172.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.88 4.29 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 125.109 3.873 . . . . 0.0 116.151 -160.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.32 5.44 9.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.053 1.741 . . . . 0.0 112.737 174.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -129.24 -57.44 1.15 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.487 1.515 . . . . 0.0 110.378 177.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 m . . . . . 0 CA--C 1.534 0.354 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.029 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 52.6 mp0 . . . . . 0 CA--C 1.542 0.668 0 CA-C-O 119.787 -0.149 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.1 m -57.92 160.07 5.01 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -74.9 56.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.983 1.713 . . . . 0.0 109.293 168.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 52.82 38.36 26.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.915 3.286 . . . . 0.0 112.417 -179.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.39 -12.55 7.94 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.578 2.037 . . . . 0.0 115.058 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 mtm-85 -115.36 168.52 9.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.614 1.566 . . . . 0.0 111.012 177.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -144.98 167.17 15.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.367 1.067 . . . . 0.0 112.798 -172.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.07 166.13 1.71 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 124.512 3.474 . . . . 0.0 114.59 168.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -39.16 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 128.531 2.733 . . . . 0.0 114.749 -174.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.35 3.16 81.81 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.49 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.9 mmt -80.03 161.95 25.13 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.368 1.584 . . . . 0.0 110.722 173.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.54 129.51 54.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.85 1.26 . . . . 0.0 110.639 -172.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.28 107.92 8.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.305 0.642 . . . . 0.0 109.979 174.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -57.71 148.73 23.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.673 1.189 . . . . 0.0 111.123 170.161 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 . . . . . 0 CA--C 1.542 0.662 0 C-N-CA 127.238 2.215 . . . . 0.0 114.197 169.91 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 1.149 0 N-CA-C 115.405 0.922 . . . . 0.0 115.405 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -126.69 140.44 52.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.891 1.276 . . . . 0.0 112.897 -170.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.6 m -84.09 142.76 30.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.513 1.525 . . . . 0.0 113.257 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.57 -163.66 36.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.863 0.744 . . . . 0.0 113.269 172.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -137.47 166.7 23.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.941 1.696 . . . . 0.0 110.773 174.097 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.19 -176.62 51.72 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 123.704 0.668 . . . . 0.0 113.257 -174.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.06 -39.92 41.18 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.037 3.825 . . . . 0.0 116.109 -170.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -11.09 58.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.889 1.276 . . . . 0.0 113.501 179.478 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -138.85 -45.61 0.48 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -168.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.542 0.663 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -169.031 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 . . . . . 0 CA--C 1.55 0.977 0 CA-C-O 121.658 0.742 . . . . 0.0 110.976 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.459 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 30.5 m -92.83 114.85 27.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.839 1.256 . . . . 0.0 108.034 133.111 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.56 95.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.733 2.013 . . . . 0.0 110.877 -166.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? 48.14 30.86 2.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.075 0.95 . . . . 0.0 112.244 -166.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -6.47 77.66 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 126.856 2.17 . . . . 0.0 116.01 -175.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 167.9 12.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.232 2.016 . . . . 0.0 111.094 175.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -139.93 141.76 28.39 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.785 0.834 . . . . 0.0 112.545 175.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.57 172.92 9.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.985 3.124 . . . . 0.0 112.171 177.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t 43.66 39.57 2.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.943 2.097 . . . . 0.0 116.245 165.041 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.66 31.68 60.76 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.919 1.247 . . . . 0.0 113.95 -176.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.2 mtt -76.82 163.64 26.58 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.817 1.308 . . . . 0.0 110.39 164.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.0 m -115.42 145.95 42.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.615 1.966 . . . . 0.0 109.814 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -80.32 110.93 16.22 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.284 0.634 . . . . 0.0 111.105 177.118 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.7 p -71.37 166.3 21.95 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -176.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 CA--C 1.544 0.716 0 C-N-CA 128.22 2.608 . . . . 0.0 115.433 163.899 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.183 0 CA-C-O 119.894 -0.392 . . . . 0.0 113.242 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -123.03 131.25 53.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.332 2.253 . . . . 0.0 110.274 -179.637 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m -62.63 143.23 57.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.534 0.606 . . . . 0.0 112.508 168.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.67 -159.95 15.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.121 1.82 . . . . 0.0 111.538 168.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -133.89 166.3 23.0 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.167 1.483 . . . . 0.0 112.355 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.5 170.95 29.14 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.312 1.434 . . . . 0.0 113.352 -175.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -48.37 -41.17 36.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.155 3.236 . . . . 0.0 113.888 -178.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -27.06 16.85 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.991 2.116 . . . . 0.0 114.208 177.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -119.15 -8.81 10.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.317 1.447 . . . . 0.0 113.459 177.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.543 0.697 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.568 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? . . . . . 0 CA--C 1.542 0.637 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.1 m -65.64 100.88 0.56 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.008 -0.433 . . . . 0.0 110.93 178.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.14 89.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 128.527 2.731 . . . . 0.0 110.004 -170.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.448 ' H ' ' NH1' ' A' ' 6' ' ' ARG . 7.3 mmp_? 40.38 46.68 2.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.669 1.988 . . . . 0.0 111.242 -164.37 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.06 -10.84 71.53 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.848 2.166 . . . . 0.0 115.453 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -96.69 163.75 12.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.747 1.774 . . . . 0.0 111.432 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.4 m -144.15 162.59 39.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.045 1.338 . . . . 0.0 110.541 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -54.5 157.06 12.69 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 124.084 3.19 . . . . 0.0 114.723 175.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.17 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.034 2.134 . . . . 0.0 113.379 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.04 64.08 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.668 -1.074 . . . . 0.0 114.845 178.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 44.0 mtt -83.33 166.48 18.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.077 1.438 . . . . 0.0 111.553 165.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.73 140.33 50.1 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.481 1.512 . . . . 0.0 110.313 173.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.21 109.06 6.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 163.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.8 p -75.81 160.52 29.88 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.776 0.798 . . . . 0.0 112.944 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 . . . . . 0 CA--C 1.539 0.554 0 C-N-CA 125.971 1.709 . . . . 0.0 113.947 175.743 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 1.186 0 CA-C-O 119.31 -0.717 . . . . 0.0 114.038 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -127.94 145.94 50.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.278 1.039 . . . . 0.0 112.485 -174.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.5 m -76.88 151.77 35.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.923 1.689 . . . . 0.0 112.536 176.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.48 -167.38 40.52 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.604 0.621 . . . . 0.0 113.544 168.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -132.4 169.0 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.897 1.679 . . . . 0.0 112.142 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.55 -179.02 34.32 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 123.849 0.738 . . . . 0.0 113.651 -178.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.45 -29.52 31.65 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.535 3.49 . . . . 0.0 116.157 -173.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.29 -8.16 54.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 116.737 -1.601 . . . . 0.0 115.157 177.117 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -147.15 -39.32 0.2 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.6 t . . . . . 0 CA--C 1.538 0.498 0 C-N-CA 125.439 1.496 . . . . 0.0 114.47 -159.658 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 . . . . . 0 CA--C 1.555 1.164 0 CA-C-O 121.83 0.824 . . . . 0.0 110.473 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.96 107.94 12.07 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 124.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.75 99.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.623 2.369 . . . . 0.0 110.717 -169.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 41.39 43.04 2.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.345 1.458 . . . . 0.0 112.791 -170.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.16 -3.45 60.11 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.45 2.452 . . . . 0.0 115.262 178.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -128.41 -175.53 3.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.175 1.487 . . . . 0.0 112.516 -165.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.56 169.95 8.51 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.427 1.891 . . . . 0.0 107.551 160.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.5 164.61 15.08 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.84 2.36 . . . . 0.0 114.08 173.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -54.76 104.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.217 1.807 . . . . 0.0 111.648 177.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.94 -2.85 24.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.753 1.168 . . . . 0.0 114.296 -177.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -113.43 169.41 8.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.912 1.356 . . . . 0.0 109.938 170.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -141.58 157.11 45.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 0.0 112.337 -172.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.46 112.15 24.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.619 1.568 . . . . 0.0 111.663 -172.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.5 p -67.31 164.19 18.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -173.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 CA--C 1.547 0.843 0 C-N-CA 129.159 2.983 . . . . 0.0 115.706 162.648 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 1.297 0 CA-C-O 119.528 -0.596 . . . . 0.0 113.598 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.4 130.02 53.36 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.52 1.928 . . . . 0.0 109.649 177.682 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.5 p -93.38 159.83 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -176.378 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.2 -149.33 9.78 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.368 1.937 . . . . 0.0 111.488 -167.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -135.72 159.4 41.75 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 118.971 1.385 . . . . 0.0 112.526 -176.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.44 174.86 46.67 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.592 1.091 . . . . 0.0 113.626 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -45.49 -46.53 14.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.686 3.591 . . . . 0.0 114.673 -172.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -55.56 -24.4 32.23 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.511 1.924 . . . . 0.0 114.295 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -109.6 -27.54 9.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.362 1.865 . . . . 0.0 113.089 175.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m . . . . . 0 CA--C 1.544 0.727 0 C-N-CA 124.79 1.236 . . . . 0.0 113.87 -176.155 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.67 -102.47 1.3 Allowed Glycine 0 C--O 1.221 -0.676 0 N-CA-C 105.586 -3.006 . . . . 0.0 105.586 -149.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -65.56 148.37 51.84 Favored 'General case' 0 CA--C 1.552 1.024 0 CA-C-N 119.292 1.546 . . . . 0.0 112.247 167.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.8 m -75.55 101.37 4.87 Favored 'General case' 0 CA--C 1.541 0.623 0 O-C-N 121.239 -0.913 . . . . 0.0 108.943 155.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.39 105.63 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 C-N-CA 124.306 1.042 . . . . 0.0 110.179 -169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.9 27.2 4.12 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.167 0.987 . . . . 0.0 111.231 -169.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 90.88 -4.52 81.74 Favored Glycine 0 CA--C 1.538 1.527 0 C-N-CA 126.412 1.958 . . . . 0.0 115.65 -174.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.61 167.29 13.51 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 120.207 2.004 . . . . 0.0 112.488 178.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.1 m -134.23 154.89 80.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 126.813 2.045 . . . . 0.0 110.448 175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -76.36 176.68 9.76 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.151 2.567 . . . . 0.0 111.646 170.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.6 m -29.7 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 129.431 3.092 . . . . 0.0 115.416 -174.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.12 3.57 81.78 Favored Glycine 0 CA--C 1.533 1.196 0 CA-C-O 118.047 -1.418 . . . . 0.0 116.02 173.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -77.0 169.16 18.85 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 120.139 1.969 . . . . 0.0 112.173 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 26.8 m -132.62 157.92 43.56 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 125.811 1.645 . . . . 0.0 111.192 -170.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.8 t -112.14 116.2 30.1 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.673 1.189 . . . . 0.0 112.403 -171.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.1 p -68.98 163.48 24.49 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 125.359 1.464 . . . . 0.0 113.624 176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.8 pm0 -57.75 -18.24 20.27 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 126.061 1.744 . . . . 0.0 113.944 174.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.5 19.15 78.85 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-N 118.497 0.589 . . . . 0.0 112.663 -175.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.48 135.62 51.79 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.653 1.181 . . . . 0.0 110.654 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 33.4 t -109.68 137.62 47.22 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 127.434 2.294 . . . . 0.0 111.409 -169.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.8 -160.88 24.13 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 125.321 1.439 . . . . 0.0 111.478 -176.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -133.17 126.31 31.37 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 123.772 0.829 . . . . 0.0 109.665 175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 146.94 178.09 22.0 Favored Glycine 0 CA--C 1.538 1.475 0 C-N-CA 124.579 1.085 . . . . 0.0 112.754 -176.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -48.04 -53.93 5.96 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 124.839 3.693 . . . . 0.0 114.521 -175.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.4 mptp? -71.69 -8.69 55.67 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -100.24 -51.69 3.59 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 124.041 0.937 . . . . 0.0 111.124 178.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 59.1 m -95.71 -22.46 17.53 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.254 1.022 . . . . 0.0 113.689 -175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -98.97 -132.38 7.66 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 108.353 -1.899 . . . . 0.0 108.353 158.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.294 0 C-N-CA 125.741 1.616 . . . . 0.0 110.066 176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . 0.268 12.3 p . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 118.622 -0.704 . . . . 0.0 111.971 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.17 35.9 0.93 Allowed Glycine 0 CA--C 1.535 1.315 0 C-N-CA 126.034 1.778 . . . . 0.0 113.343 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 154.2 139.42 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.631 1 C-N-CA 133.881 4.872 . . . . 0.0 107.841 -157.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 79.5 m -72.21 117.83 14.34 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 120.587 -1.321 . . . . 0.0 109.287 169.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.7 t -59.26 85.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 129.205 3.002 . . . . 0.0 110.307 -171.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.585 ' H ' ' NH1' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 40.39 42.75 1.33 Allowed 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 127.194 2.198 . . . . 0.0 111.211 -161.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.61 -13.65 66.12 Favored Glycine 0 CA--C 1.539 1.531 0 C-N-CA 126.579 2.037 . . . . 0.0 116.235 -177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.36 174.68 9.38 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 120.2 2.0 . . . . 0.0 111.01 173.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 48.8 m -141.12 163.9 39.2 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 124.536 1.134 . . . . 0.0 110.792 170.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.57 168.77 1.42 Allowed 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 124.255 3.304 . . . . 0.0 114.668 174.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.8 m -44.46 100.11 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 127.402 2.281 . . . . 0.0 114.258 -176.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 81.26 -1.62 84.58 Favored Glycine 0 CA--C 1.535 1.312 0 C-N-CA 124.722 1.153 . . . . 0.0 115.191 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.8 mtt -80.5 161.58 24.77 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 118.749 1.275 . . . . 0.0 110.966 168.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 66.9 m -138.2 156.12 48.01 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 125.383 1.473 . . . . 0.0 110.862 -172.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 24.9 t -89.01 114.06 25.21 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.745 1.218 . . . . 0.0 111.379 -173.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.476 ' HB2' ' CD2' ' A' ' 27' ' ' TYR . 4.8 t -70.73 168.22 17.06 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.562 1.145 . . . . 0.0 113.233 177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -62.73 -4.81 2.26 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.359 1.864 . . . . 0.0 115.43 -176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.23 33.87 27.79 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.966 -0.908 . . . . 0.0 114.269 174.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -123.51 149.46 45.15 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 126.195 1.798 . . . . 0.0 111.538 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 75.8 m -94.97 149.98 20.65 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.14 -165.16 37.79 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 124.564 1.078 . . . . 0.0 112.081 176.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.8 mtpp -135.0 167.43 20.95 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.514 1.526 . . . . 0.0 111.591 176.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.62 -174.65 48.56 Favored Glycine 0 CA--C 1.538 1.509 0 C-N-CA 123.807 0.718 . . . . 0.0 113.101 -178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -47.9 -36.12 26.23 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.025 3.817 . . . . 0.0 116.151 -173.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.7 mmmp? -72.61 -9.35 58.48 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 178.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.476 ' CD2' ' HB2' ' A' ' 16' ' ' SER . 88.3 m-85 -139.25 -44.85 0.46 Allowed 'General case' 0 N--CA 1.469 0.524 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 -170.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.65 4.05 0.87 Allowed 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -173.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.91 -45.06 2.67 Favored Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.628 -1.295 . . . . 0.0 112.346 -166.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.226 0 CA-C-O 115.803 -2.046 . . . . 0.0 113.907 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.5 p . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.51 10.41 73.6 Favored Glycine 0 CA--C 1.534 1.222 0 CA-C-O 118.464 -1.186 . . . . 0.0 114.931 -179.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 49.1 mp0 -48.0 106.58 0.1 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.697 1.999 . . . . 0.0 111.356 173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.8 m -50.39 154.19 1.34 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 124.517 1.127 . . . . 0.0 113.852 -163.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.0 t -73.05 70.98 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 CA-C-O 123.573 1.654 . . . . 0.0 108.756 172.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.0 mmp_? 33.33 50.23 0.25 Allowed 'General case' 0 CA--C 1.538 0.501 1 C-N-CA 132.41 4.284 . . . . 0.0 112.559 -172.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 119.18 -17.92 10.44 Favored Glycine 0 CA--C 1.539 1.561 0 C-N-CA 127.295 2.379 . . . . 0.0 114.943 -177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.3 mtt85 -110.52 164.7 12.45 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 119.274 1.537 . . . . 0.0 111.493 -173.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.1 m -144.7 168.11 13.09 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.364 1.466 . . . . 0.0 111.34 -175.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -52.69 156.8 8.41 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.966 3.111 . . . . 0.0 114.211 172.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.9 m -52.85 97.34 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.746 2.018 . . . . 0.0 113.302 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.54 -3.36 39.65 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 124.916 1.245 . . . . 0.0 114.85 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 63.0 mtt -94.07 167.79 11.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.801 1.301 . . . . 0.0 111.506 168.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 58.1 m -133.4 143.5 48.95 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.453 1.501 . . . . 0.0 110.681 -175.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 33.8 t -83.08 109.02 16.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.449 0.7 . . . . 0.0 110.199 176.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.0 p -70.6 164.32 25.14 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 176.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -57.56 -17.4 13.84 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.173 1.389 . . . . 0.0 114.582 175.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.11 17.59 80.22 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 123.84 0.733 . . . . 0.0 112.935 -172.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.0 m-30 -114.49 131.67 56.55 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.856 1.663 . . . . 0.0 110.228 -173.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 93.8 m -73.57 152.67 40.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.965 1.306 . . . . 0.0 112.63 170.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.62 -167.18 40.23 Favored Glycine 0 CA--C 1.528 0.881 0 C-N-CA 124.098 0.856 . . . . 0.0 111.987 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 8.1 tttm -136.41 167.28 21.64 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.081 1.352 . . . . 0.0 110.905 175.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.86 -172.96 54.6 Favored Glycine 0 CA--C 1.54 1.595 0 O-C-N 121.9 -0.5 . . . . 0.0 113.565 -175.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_exo -42.4 -48.05 7.01 Favored 'Trans proline' 0 C--N 1.351 0.689 1 C-N-CA 125.925 4.417 . . . . 0.0 116.915 -168.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 29.6 mtpp -70.94 -9.36 57.7 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -134.71 -60.73 0.78 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.915 0.886 . . . . 0.0 112.178 -168.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 96.8 m -117.36 -1.15 11.82 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 126.313 1.845 . . . . 0.0 112.907 -172.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.39 -42.46 1.95 Allowed Glycine 0 CA--C 1.537 1.467 0 O-C-N 120.886 -1.134 . . . . 0.0 113.154 -170.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.197 0 C-N-CA 127.426 2.29 . . . . 0.0 111.754 176.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.3 m . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.23 -52.47 1.41 Allowed Glycine 0 CA--C 1.535 1.283 0 N-CA-C 111.117 -0.793 . . . . 0.0 111.117 -156.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -155.62 -176.29 5.88 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 127.665 2.386 . . . . 0.0 111.101 175.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HB2' ' A' ' 21' ' ' CYS . 58.8 m -87.09 126.24 34.64 Favored 'General case' 0 N--CA 1.463 0.202 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 138.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -55.71 92.43 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 C-N-CA 127.585 2.354 . . . . 0.0 110.664 -168.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 37.74 46.04 0.7 Allowed 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.32 1.848 . . . . 0.0 112.266 -162.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.08 -10.29 65.7 Favored Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.0 2.238 . . . . 0.0 115.554 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -103.19 179.14 4.36 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 119.457 1.629 . . . . 0.0 112.669 -173.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 15.0 m -138.8 158.9 69.19 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 126.342 1.857 . . . . 0.0 110.423 175.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -69.96 163.05 39.86 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.562 2.175 . . . . 0.0 111.485 167.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 92.4 p -56.77 93.63 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.519 1.928 . . . . 0.0 112.78 -173.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.6 -11.91 10.27 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 125.499 1.523 . . . . 0.0 114.604 177.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 58.1 mtt -91.31 169.39 10.85 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 119.793 1.796 . . . . 0.0 111.883 172.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 3.9 p -142.8 164.56 29.77 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.514 1.526 . . . . 0.0 111.762 -174.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.0 t -120.36 111.12 17.35 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.359 1.064 . . . . 0.0 112.352 -157.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 89.8 p -69.73 161.95 28.75 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.291 1.436 . . . . 0.0 113.917 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.1 pm0 -61.88 -22.11 65.28 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.209 1.004 . . . . 0.0 113.625 -173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.42 40.46 39.86 Favored Glycine 0 C--N 1.341 0.861 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -172.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -127.83 114.78 17.67 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.475 1.51 . . . . 0.0 110.636 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.44 ' HB2' ' HA ' ' A' ' 4' ' ' CYS . 43.4 t -78.74 148.32 33.07 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.463 0.705 . . . . 0.0 111.682 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.61 -152.26 13.01 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.992 1.758 . . . . 0.0 110.641 -177.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -138.9 160.09 40.57 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.833 0.853 . . . . 0.0 110.915 167.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 127.31 172.2 13.2 Favored Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.044 1.783 . . . . 0.0 111.515 -175.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -62.56 -34.27 75.62 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.882 2.388 . . . . 0.0 112.409 -174.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -11.11 60.66 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -106.5 -45.36 4.27 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.995 1.318 . . . . 0.0 110.997 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 16.0 m -91.13 -16.98 26.88 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.618 1.167 . . . . 0.0 112.886 -177.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -101.89 165.64 17.61 Favored Glycine 0 CA--C 1.534 1.233 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 152.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.7 tpm_? . . . . . 0 C--O 1.245 0.831 0 O-C-N 122.363 -0.492 . . . . 0.0 112.019 -175.378 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.1 -50.83 2.37 Favored Glycine 0 CA--C 1.533 1.197 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 -161.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -150.73 -176.7 5.62 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 126.251 1.82 . . . . 0.0 110.622 166.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 16.4 m -94.26 110.08 21.85 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.909 1.684 . . . . 0.0 106.51 136.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.0 t -54.79 101.1 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 125.773 1.629 . . . . 0.0 111.373 -167.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.5 mmp_? 48.51 27.05 1.32 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 125.405 1.482 . . . . 0.0 112.917 -170.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 116.51 -15.74 14.7 Favored Glycine 0 CA--C 1.539 1.564 0 C-N-CA 127.37 2.414 . . . . 0.0 116.644 179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -140.46 171.22 14.44 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 121.074 2.437 . . . . 0.0 112.917 -171.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.4 m -146.86 156.17 47.82 Favored Pre-proline 0 CA--C 1.544 0.733 0 C-N-CA 123.105 0.562 . . . . 0.0 112.338 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -76.98 177.94 8.26 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 124.041 3.161 . . . . 0.0 112.996 -172.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 70.8 p 59.68 24.54 13.41 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.642 1.719 . . . . 0.0 115.642 175.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 59.47 40.86 96.73 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.489 1.043 . . . . 0.0 112.704 -169.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 62.6 mtt -69.47 169.95 11.49 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 118.224 1.012 . . . . 0.0 110.739 160.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.2 p -140.4 155.43 46.74 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.143 1.777 . . . . 0.0 110.744 -177.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 34.6 t -94.13 121.77 35.96 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.11 1.364 . . . . 0.0 113.212 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 76.2 p -72.14 152.39 42.35 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 121.423 -0.798 . . . . 0.0 111.504 166.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.6 pm0 -58.0 -14.42 6.48 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.345 1.858 . . . . 0.0 114.187 175.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.73 18.93 69.22 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 119.234 -0.759 . . . . 0.0 113.318 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -121.17 122.33 39.76 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 126.154 1.781 . . . . 0.0 109.426 -178.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.97 164.52 19.3 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 178.72 -151.11 10.08 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 126.8 2.143 . . . . 0.0 110.435 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.1 mttm -137.37 156.61 48.01 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.943 1.297 . . . . 0.0 110.335 173.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 97.45 -167.4 23.47 Favored Glycine 0 CA--C 1.542 1.76 0 N-CA-C 115.164 0.826 . . . . 0.0 115.164 170.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.49 4.94 2.62 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.857 3.705 . . . . 0.0 115.675 -164.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.41 4.49 9.06 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 126.697 1.999 . . . . 0.0 112.608 176.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -131.8 -44.03 0.98 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 126.122 1.769 . . . . 0.0 111.878 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.8 m -90.6 -59.44 2.18 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.841 1.656 . . . . 0.0 107.927 171.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.48 168.94 34.09 Favored Glycine 0 CA--C 1.535 1.317 0 N-CA-C 110.959 -0.856 . . . . 0.0 110.959 157.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 8.6 mmm180 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 116.399 -1.762 . . . . 0.0 111.442 -171.656 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 81.5 t . . . . . 0 N--CA 1.485 1.31 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -50.49 114.37 2.58 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 108.015 -2.034 . . . . 0.0 108.015 131.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 68.52 132.28 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.594 2.357 . . . . 0.0 112.842 -160.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 48.2 m -60.11 101.73 0.14 Allowed 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 151.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 36.3 t -57.28 96.5 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 C-N-CA 128.281 2.632 . . . . 0.0 110.865 -164.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.9 mmp_? 48.79 29.55 2.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.818 0.847 . . . . 0.0 112.301 -167.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.46 -2.61 67.93 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 127.222 2.344 . . . . 0.0 116.23 -175.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.17 165.91 11.49 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 120.272 2.036 . . . . 0.0 111.887 177.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.3 m -141.57 130.83 12.5 Favored Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 124.25 1.02 . . . . 0.0 110.999 174.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -80.6 168.79 17.59 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 123.635 2.89 . . . . 0.0 112.779 -174.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 96.9 p 55.06 28.13 10.38 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 115.541 1.682 . . . . 0.0 115.541 174.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.21 35.55 60.44 Favored Glycine 0 CA--C 1.534 1.256 0 C-N-CA 124.92 1.248 . . . . 0.0 113.32 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 64.6 mtt -67.99 167.11 14.44 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 118.387 1.093 . . . . 0.0 110.501 162.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -117.41 135.22 54.04 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 126.96 2.104 . . . . 0.0 108.874 -176.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.5 t -75.56 137.33 40.75 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.04 0.536 . . . . 0.0 110.558 173.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.4 p -117.68 163.93 15.74 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.775 1.23 . . . . 0.0 113.969 -173.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -57.88 -23.9 55.18 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.622 1.569 . . . . 0.0 113.063 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.07 11.04 85.11 Favored Glycine 0 C--N 1.343 0.945 0 C-N-CA 125.478 1.513 . . . . 0.0 113.39 -178.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -121.84 155.71 34.8 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.94 1.696 . . . . 0.0 110.692 -168.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 63.7 m -86.62 156.03 20.19 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 123.824 0.85 . . . . 0.0 111.794 170.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.01 -174.12 41.38 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.832 1.206 . . . . 0.0 110.162 159.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.2 tttp -124.51 149.46 46.88 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.721 1.261 . . . . 0.0 110.557 -176.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 83.54 179.12 52.17 Favored Glycine 0 CA--C 1.543 1.799 0 C-N-CA 123.523 0.582 . . . . 0.0 113.422 -172.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -65.44 -20.13 61.12 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 114.444 -166.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -55.51 -21.41 16.55 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.992 1.317 . . . . 0.0 113.183 170.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 50.4 m-85 -133.15 -42.76 0.87 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.426 1.49 . . . . 0.0 111.451 -173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.9 m -69.93 -12.38 61.57 Favored 'General case' 0 CA--C 1.541 0.617 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 171.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.04 -0.6 76.81 Favored Glycine 0 CA--C 1.537 1.454 0 CA-C-O 118.355 -1.247 . . . . 0.0 113.987 163.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.264 0.8 OUTLIER . . . . . 0 C--O 1.248 1.025 0 C-N-CA 129.473 3.109 . . . . 0.0 113.174 -175.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.48 1.045 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.55 -45.89 2.73 Favored Glycine 0 CA--C 1.532 1.129 0 C-N-CA 124.156 0.884 . . . . 0.0 113.029 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -158.76 169.02 25.3 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.016 1.326 . . . . 0.0 111.169 176.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.416 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 61.7 m -100.86 109.95 21.97 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.759 1.624 . . . . 0.0 107.361 139.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.4 t -53.39 97.29 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 127.831 2.452 . . . . 0.0 110.747 -167.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? 48.85 27.08 1.47 Allowed 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.815 2.046 . . . . 0.0 113.549 -171.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.23 -11.03 33.81 Favored Glycine 0 CA--C 1.536 1.392 0 C-N-CA 126.946 2.212 . . . . 0.0 115.008 -176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.01 170.8 7.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 120.096 1.948 . . . . 0.0 112.657 -177.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.6 m -136.4 167.68 20.5 Favored Pre-proline 0 CA--C 1.539 0.537 0 C-N-CA 124.967 1.307 . . . . 0.0 110.493 171.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -49.96 146.15 17.48 Favored 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 123.706 2.938 . . . . 0.0 112.568 170.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 54.7 m -66.31 82.28 0.09 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.137 1.375 . . . . 0.0 112.177 -174.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 141.26 -17.57 2.7 Favored Glycine 0 CA--C 1.536 1.4 0 C-N-CA 126.326 1.917 . . . . 0.0 113.674 -174.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 25.1 mmt -80.29 177.04 9.24 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 118.658 1.229 . . . . 0.0 111.457 169.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 62.9 m -127.0 163.83 22.86 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.177 2.191 . . . . 0.0 110.124 169.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 49.1 t -102.51 118.88 37.81 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.73 1.212 . . . . 0.0 110.55 175.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.7 p -71.21 166.94 20.45 Favored 'General case' 0 N--CA 1.465 0.298 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -175.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -51.75 -8.82 0.07 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 128.22 2.608 . . . . 0.0 115.297 162.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.82 23.98 77.27 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.02 0.827 . . . . 0.0 113.235 -172.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -120.59 133.97 55.33 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 128.237 2.615 . . . . 0.0 110.397 179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.416 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 71.1 m -65.59 155.79 34.71 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.5 1.296 . . . . 0.0 114.5 175.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.01 -160.13 29.84 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.139 1.828 . . . . 0.0 111.534 170.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.29 174.06 10.89 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 118.486 1.143 . . . . 0.0 111.207 172.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 80.93 169.98 42.3 Favored Glycine 0 CA--C 1.541 1.689 0 C-N-CA 124.656 1.122 . . . . 0.0 112.05 -166.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -60.37 -36.95 85.14 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.979 2.453 . . . . 0.0 112.358 -172.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 18.3 mmtm -55.6 -24.06 30.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 126.323 1.849 . . . . 0.0 114.16 175.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -115.9 -1.25 12.61 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.902 1.281 . . . . 0.0 113.502 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.08 -4.42 6.25 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.275 1.213 . . . . 0.0 114.275 -176.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -171.57 -49.54 0.04 OUTLIER Glycine 0 CA--C 1.534 1.259 0 N-CA-C 115.68 1.032 . . . . 0.0 115.68 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.381 0 CA-C-N 119.083 1.441 . . . . 0.0 112.957 -169.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 N--CA 1.483 1.207 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.07 113.34 0.83 Allowed Glycine 0 CA--C 1.529 0.968 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -151.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 -42.04 144.59 0.43 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.818 1.647 . . . . 0.0 111.559 170.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.5 m -65.45 90.48 0.11 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 157.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.7 t -55.49 93.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 128.457 2.703 . . . . 0.0 111.068 -160.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.3 mmt85 46.36 36.88 3.68 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.879 1.672 . . . . 0.0 112.796 -167.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 120.69 -6.83 11.28 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 127.212 2.339 . . . . 0.0 117.516 171.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.24 167.42 20.4 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 120.998 2.399 . . . . 0.0 114.793 -170.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 98.6 m -132.12 161.79 60.68 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.246 1.419 . . . . 0.0 110.584 178.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -53.9 154.89 15.86 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.731 2.954 . . . . 0.0 113.364 170.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.5 m -49.91 96.2 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 126.98 2.112 . . . . 0.0 114.032 -173.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 100.17 -7.77 58.74 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.049 1.309 . . . . 0.0 114.85 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 92.1 mtp -76.77 161.61 28.34 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 119.52 1.66 . . . . 0.0 110.383 166.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 32.3 m -126.43 121.01 31.22 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.898 0.879 . . . . 0.0 110.511 -161.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.71 107.13 3.8 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.121 0.968 . . . . 0.0 110.748 176.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -73.26 156.1 38.83 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.297 0.57 . . . . 0.0 112.247 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.0 pm0 -56.89 -17.97 11.46 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.575 1.95 . . . . 0.0 114.329 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 91.2 16.66 53.15 Favored Glycine 0 CA--C 1.534 1.229 0 C-N-CA 124.658 1.123 . . . . 0.0 113.969 -176.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 87.8 m-85 -129.41 136.25 49.71 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.455 1.102 . . . . 0.0 112.124 -172.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 83.9 m -71.76 157.69 37.46 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.915 1.686 . . . . 0.0 112.541 176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.65 -163.63 33.48 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 124.106 0.86 . . . . 0.0 112.927 168.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.9 tptp -141.7 170.73 15.16 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.911 2.084 . . . . 0.0 108.445 172.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.83 -171.59 50.19 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 118.565 0.621 . . . . 0.0 113.879 -176.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -60.49 -38.64 72.04 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.316 2.678 . . . . 0.0 114.825 -161.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.507 ' HE3' ' CZ ' ' A' ' 27' ' ' TYR . 3.3 ttpp -73.45 -2.57 23.02 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.507 ' CZ ' ' HE3' ' A' ' 26' ' ' LYS . 72.5 m-85 -140.26 -34.56 0.53 Allowed 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -171.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -146.85 1.77 0.79 Allowed 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -172.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.91 -61.3 2.55 Favored Glycine 0 CA--C 1.534 1.223 0 O-C-N 121.053 -1.029 . . . . 0.0 111.16 -164.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.2 tpm_? . . . . . 0 C--O 1.257 1.466 0 C-N-CA 126.673 1.989 . . . . 0.0 110.948 179.128 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 34.4 m . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 117.451 -1.261 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.23 81.95 0.19 Allowed Glycine 0 CA--C 1.532 1.108 0 CA-C-N 120.48 1.491 . . . . 0.0 113.421 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -53.26 154.84 3.01 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.994 1.317 . . . . 0.0 113.976 176.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.8 m -69.87 95.04 0.88 Allowed 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 162.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.6 t -62.63 89.33 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 126.863 2.065 . . . . 0.0 111.366 -161.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 10.3 mmp_? 57.69 26.58 13.16 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.188 1.795 . . . . 0.0 113.336 -166.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.01 -13.68 5.76 Favored Glycine 0 CA--C 1.534 1.268 0 C-N-CA 125.197 1.38 . . . . 0.0 116.44 166.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.31 170.53 14.94 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 119.795 1.797 . . . . 0.0 113.685 -171.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 95.2 m -128.1 161.75 54.24 Favored Pre-proline 0 CA--C 1.539 0.556 0 C-N-CA 126.287 1.835 . . . . 0.0 110.991 -173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.59 159.37 53.0 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 122.822 2.348 . . . . 0.0 112.184 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.6 p -60.14 92.37 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 126.254 1.822 . . . . 0.0 112.104 -177.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.63 -15.86 4.35 Favored Glycine 0 CA--C 1.533 1.187 0 C-N-CA 125.44 1.495 . . . . 0.0 113.725 -175.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.5 mmt -112.49 164.66 13.03 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 118.739 1.27 . . . . 0.0 111.293 174.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.2 m -132.13 148.82 52.5 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.919 1.688 . . . . 0.0 109.92 -176.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.9 t -82.58 148.44 28.03 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.148 0.579 . . . . 0.0 111.654 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 92.3 p -118.26 163.09 17.2 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.718 1.207 . . . . 0.0 113.313 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.2 pm0 -59.15 -17.76 29.99 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 125.551 1.54 . . . . 0.0 113.819 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.71 12.68 81.19 Favored Glycine 0 CA--C 1.532 1.155 0 C-N-CA 124.415 1.007 . . . . 0.0 113.353 -175.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -124.02 144.86 49.58 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.608 1.163 . . . . 0.0 112.121 -169.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.6 m -82.32 156.24 24.37 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.963 1.305 . . . . 0.0 112.429 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.54 -164.6 36.3 Favored Glycine 0 CA--C 1.53 0.991 0 C-N-CA 123.63 0.634 . . . . 0.0 113.349 172.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.0 mmtt -136.36 172.05 13.57 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.425 1.89 . . . . 0.0 110.695 170.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 82.55 -177.67 53.46 Favored Glycine 0 CA--C 1.541 1.679 0 C-N-CA 123.9 0.762 . . . . 0.0 113.554 -168.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -47.08 -48.59 14.31 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 125.261 3.974 . . . . 0.0 115.096 -172.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -59.75 -13.68 11.2 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.091 1.756 . . . . 0.0 115.632 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -135.07 -37.15 0.8 Allowed 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 119.424 1.011 . . . . 0.0 113.317 -168.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.98 9.2 0.87 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 -174.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 76.44 -57.97 3.32 Favored Glycine 0 CA--C 1.533 1.219 0 O-C-N 120.936 -1.103 . . . . 0.0 111.051 -165.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.4 tpt85 . . . . . 0 C--O 1.251 1.142 0 CA-C-O 116.089 -1.91 . . . . 0.0 111.873 168.39 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 31.1 m . . . . . 0 N--CA 1.484 1.267 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.323 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.87 108.13 0.64 Allowed Glycine 0 CA--C 1.528 0.862 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 -156.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.9 pp20? -58.67 146.83 34.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 117.44 0.62 . . . . 0.0 111.44 173.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -72.19 93.38 1.45 Allowed 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.724 -0.61 . . . . 0.0 110.905 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.0 t -56.0 89.25 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 128.346 2.658 . . . . 0.0 111.215 -168.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.504 ' CZ ' ' H ' ' A' ' 6' ' ' ARG . 7.9 mmp_? 38.06 41.74 0.41 Allowed 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 128.699 2.8 . . . . 0.0 112.21 -163.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.05 -13.27 34.23 Favored Glycine 0 CA--C 1.539 1.562 0 C-N-CA 128.211 2.815 . . . . 0.0 116.095 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 20.3 mtt85 -89.74 160.03 16.76 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.2 2.0 . . . . 0.0 112.031 -176.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.3 m -140.77 161.7 52.78 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.577 1.151 . . . . 0.0 111.164 175.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.44 168.36 3.0 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 124.373 3.382 . . . . 0.0 115.057 175.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.7 m -43.79 102.84 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.889 2.476 . . . . 0.0 114.059 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.38 7.41 87.9 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.708 -1.051 . . . . 0.0 115.049 177.189 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 39.8 mtt -84.22 166.13 17.79 Favored 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 119.059 1.429 . . . . 0.0 111.964 170.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 85.1 m -123.99 152.7 42.24 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 125.762 1.625 . . . . 0.0 109.823 170.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.5 t -74.42 154.37 38.81 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.34 0.656 . . . . 0.0 110.932 170.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 57.3 p -133.92 174.78 10.1 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.3 pm0 -64.35 -17.62 63.89 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 115.44 1.645 . . . . 0.0 115.44 -154.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.12 22.33 38.65 Favored Glycine 0 CA--C 1.531 1.046 0 CA-C-O 118.937 -0.924 . . . . 0.0 113.73 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -129.17 139.77 51.77 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 118.392 1.096 . . . . 0.0 112.651 -175.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 85.2 m -79.63 159.44 26.76 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 127.381 2.272 . . . . 0.0 113.629 -176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.62 -166.83 39.25 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 123.938 0.78 . . . . 0.0 113.977 169.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.1 mtpp -129.29 165.57 21.17 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.32 1.848 . . . . 0.0 111.139 178.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 78.75 -178.51 53.24 Favored Glycine 0 CA--C 1.542 1.765 0 C-N-CA 123.536 0.589 . . . . 0.0 113.707 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -52.64 -33.26 58.26 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.65 3.566 . . . . 0.0 116.297 -171.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.9 -14.89 63.25 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 124.247 1.019 . . . . 0.0 113.406 178.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 74.7 m-85 -137.58 -48.88 0.58 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.02 0.827 . . . . 0.0 113.222 -171.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.4 t -138.15 -4.74 1.69 Allowed 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -156.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.04 -63.07 3.59 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.563 1.078 . . . . 0.0 110.701 -166.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . 0.261 0.0 OUTLIER . . . . . 0 C--O 1.251 1.149 0 C-N-CA 126.32 1.848 . . . . 0.0 110.999 168.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.478 0.928 0 CA-C-O 119.06 -0.495 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 70.25 -75.14 0.51 Allowed Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.061 1.315 . . . . 0.0 114.686 172.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.7 tt0 -170.03 164.12 9.39 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 127.238 2.215 . . . . 0.0 108.957 -176.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 60.6 m -81.86 99.59 9.12 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 106.666 -1.605 . . . . 0.0 106.666 143.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 43.9 t -57.94 93.97 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 126.319 1.847 . . . . 0.0 111.454 -160.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.0 mmt85 42.73 36.98 0.92 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.148 1.779 . . . . 0.0 112.452 -164.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.57 -4.11 66.22 Favored Glycine 0 CA--C 1.539 1.536 0 C-N-CA 127.407 2.432 . . . . 0.0 116.01 -176.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.98 170.87 9.22 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 120.219 2.009 . . . . 0.0 112.685 178.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.4 m -143.99 152.47 55.14 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 127.414 2.286 . . . . 0.0 109.327 171.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_exo -58.6 166.04 6.96 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 123.731 2.954 . . . . 0.0 113.858 165.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -47.35 105.63 0.07 Allowed 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 127.149 2.18 . . . . 0.0 113.591 -178.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.23 4.28 89.74 Favored Glycine 0 CA--C 1.533 1.19 0 CA-C-O 118.661 -1.077 . . . . 0.0 114.968 177.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 38.2 mtt -90.42 163.95 14.48 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.885 1.342 . . . . 0.0 111.417 170.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.8 m -133.42 133.45 42.37 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 125.139 1.375 . . . . 0.0 111.137 -165.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 52.9 t -74.52 140.67 44.67 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 123.021 0.528 . . . . 0.0 110.53 172.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 86.0 p -117.04 163.36 16.35 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.543 1.137 . . . . 0.0 113.472 -179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.7 pm0 -58.15 -18.25 24.24 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.066 1.746 . . . . 0.0 113.825 178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 76.88 17.84 79.43 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.11 0.862 . . . . 0.0 113.132 -176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.6 m-30 -126.18 136.02 52.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.264 1.826 . . . . 0.0 111.101 -168.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 26.1 t -78.53 150.98 32.75 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.149 0.98 . . . . 0.0 112.481 171.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.48 -162.14 31.41 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.336 0.97 . . . . 0.0 113.248 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -138.35 167.26 22.26 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.233 1.413 . . . . 0.0 112.546 179.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.15 -174.89 40.11 Favored Glycine 0 CA--C 1.539 1.566 0 C-N-CA 123.428 0.537 . . . . 0.0 113.442 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -49.6 -32.18 27.05 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 124.91 3.74 . . . . 0.0 116.523 -172.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -73.79 -6.98 50.35 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 116.85 -1.548 . . . . 0.0 115.118 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -144.38 -38.57 0.29 Allowed 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 114.292 1.219 . . . . 0.0 114.292 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.7 t -138.52 -24.05 0.96 Allowed 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 -169.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 68.42 6.44 48.46 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-O 119.331 -0.705 . . . . 0.0 113.952 -159.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.473 0 CA-C-O 116.079 -1.915 . . . . 0.0 113.347 -163.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 59.1 t . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.22 114.54 3.67 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 108.336 -1.906 . . . . 0.0 108.336 -154.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -37.35 136.86 0.44 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 126.977 2.111 . . . . 0.0 113.949 175.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.2 m -64.88 96.2 0.18 Allowed 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 158.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.1 t -51.89 93.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.813 0 C-N-CA 127.99 2.516 . . . . 0.0 111.794 -159.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.8 mmt85 38.44 36.18 0.12 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 126.722 2.009 . . . . 0.0 113.156 -166.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 109.48 -4.39 31.14 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 128.531 2.967 . . . . 0.0 116.751 -178.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.98 167.56 12.69 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 121.214 2.507 . . . . 0.0 113.592 176.463 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.35 152.0 52.65 Favored Pre-proline 0 CA--C 1.545 0.757 0 C-N-CA 126.773 2.029 . . . . 0.0 108.356 166.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.42 168.53 2.85 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.98 3.12 . . . . 0.0 114.321 169.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.5 m -47.74 99.89 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 127.454 2.302 . . . . 0.0 113.886 -177.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.3 12.99 84.06 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.831 -0.983 . . . . 0.0 114.795 178.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.8 mtt -83.8 169.54 15.07 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 118.982 1.391 . . . . 0.0 110.919 163.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -142.11 164.12 31.03 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.032 1.733 . . . . 0.0 111.572 -172.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 41.8 t -117.57 112.5 20.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.451 1.1 . . . . 0.0 112.307 -162.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 97.5 p -68.51 160.17 30.37 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.353 1.061 . . . . 0.0 113.384 177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pm0 -58.92 -17.0 20.42 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.528 1.531 . . . . 0.0 114.264 176.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.21 16.49 80.57 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-N 118.552 0.615 . . . . 0.0 112.871 -171.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.8 m-30 -106.06 130.91 53.88 Favored 'General case' 0 C--O 1.236 0.342 0 C-N-CA 124.647 1.179 . . . . 0.0 110.007 178.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 14.7 t -78.04 159.85 28.48 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.336 1.455 . . . . 0.0 111.118 175.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.74 -160.91 32.12 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.698 1.618 . . . . 0.0 110.852 178.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.2 tttp -138.67 156.34 47.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.686 -0.891 . . . . 0.0 110.057 176.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 90.03 -175.82 41.83 Favored Glycine 0 CA--C 1.539 1.567 0 C-N-CA 123.522 0.582 . . . . 0.0 114.121 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -46.5 -47.58 15.22 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 125.046 3.831 . . . . 0.0 115.482 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 24.5 mmmt -74.56 -0.27 17.19 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.951 1.463 . . . . 0.0 114.951 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -125.31 -35.67 2.58 Favored 'General case' 0 N--CA 1.466 0.344 0 C-N-CA 124.89 1.276 . . . . 0.0 112.706 177.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 49.6 m -93.87 -25.68 17.22 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.949 1.3 . . . . 0.0 111.956 178.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -105.05 -159.75 23.47 Favored Glycine 0 CA--C 1.535 1.292 0 C-N-CA 126.638 2.066 . . . . 0.0 109.338 157.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.4 mmp_? . . . . . 0 C--O 1.254 1.306 0 C-N-CA 125.428 1.491 . . . . 0.0 111.411 176.415 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.416 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 11.7 m . . . . . 0 N--CA 1.481 1.096 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.93 -49.51 1.43 Allowed Glycine 0 CA--C 1.535 1.325 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -159.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -153.07 178.68 9.44 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 126.641 1.976 . . . . 0.0 111.1 177.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 59.4 m -95.15 107.66 19.75 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 137.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.3 t -55.63 96.95 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 C-N-CA 126.555 1.942 . . . . 0.0 111.325 -163.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.6 mmt85 39.18 43.02 0.82 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.043 1.737 . . . . 0.0 111.896 -167.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.83 -11.45 56.13 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 126.846 2.165 . . . . 0.0 116.506 178.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -118.12 167.62 11.32 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.853 2.326 . . . . 0.0 114.047 -170.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 29.1 m -131.11 164.12 44.48 Favored Pre-proline 0 CA--C 1.543 0.673 0 C-N-CA 125.003 1.321 . . . . 0.0 111.595 -176.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -53.16 160.37 4.59 Favored 'Trans proline' 0 CA--C 1.539 0.726 0 C-N-CA 124.167 3.245 . . . . 0.0 114.469 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.14 100.04 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.144 2.178 . . . . 0.0 113.382 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 93.06 2.25 66.52 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-O 118.405 -1.219 . . . . 0.0 115.086 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -77.95 172.6 13.25 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-N 119.433 1.617 . . . . 0.0 111.844 166.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.81 159.86 36.11 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.048 2.139 . . . . 0.0 111.154 176.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 40.1 t -108.51 114.46 28.31 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 125.615 1.566 . . . . 0.0 110.56 -175.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.9 p -67.51 153.19 44.26 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.779 0.799 . . . . 0.0 112.841 177.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -58.8 -14.25 8.31 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.928 1.291 . . . . 0.0 113.791 168.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.48 17.46 66.32 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.082 0.848 . . . . 0.0 113.988 174.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.416 ' CD2' ' HA ' ' A' ' 1' ' ' VAL . 2.0 m-85 -123.41 126.84 47.52 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.684 1.994 . . . . 0.0 110.528 -177.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 61.4 m -74.18 158.8 33.5 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 169.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.63 -160.71 31.04 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 126.748 2.118 . . . . 0.0 110.334 174.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 tttp -138.17 143.56 40.31 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.138 1.469 . . . . 0.0 111.266 174.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 111.37 177.12 20.35 Favored Glycine 0 CA--C 1.538 1.482 0 C-N-CA 125.291 1.424 . . . . 0.0 112.053 -170.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -59.5 -38.69 81.48 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.931 2.421 . . . . 0.0 112.628 -172.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 17.4 mmmt -59.96 -10.24 3.9 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.338 1.455 . . . . 0.0 114.564 176.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -122.31 -29.54 4.13 Favored 'General case' 0 C--O 1.224 -0.286 0 C-N-CA 125.188 1.395 . . . . 0.0 113.009 177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 36.1 m -87.06 -6.72 58.61 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.108 0.963 . . . . 0.0 112.92 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 142.84 1.19 1.18 Allowed Glycine 0 CA--C 1.537 1.453 0 N-CA-C 117.746 1.858 . . . . 0.0 117.746 153.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.882 0 CA-C-N 120.316 2.058 . . . . 0.0 112.846 -168.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.106 0 CA-C-O 119.226 -0.416 . . . . 0.0 110.396 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -72.37 -148.94 0.86 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 130.191 3.758 . . . . 0.0 113.574 -8.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -51.67 164.81 0.21 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.868 0.867 . . . . 0.0 112.504 168.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -66.24 117.17 8.13 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 152.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.2 t -58.07 94.5 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 127.322 2.249 . . . . 0.0 110.721 -170.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 8.3 mmp_? 42.64 35.7 0.72 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.052 0.941 . . . . 0.0 112.458 -161.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.32 -6.05 63.23 Favored Glycine 0 CA--C 1.539 1.586 0 C-N-CA 126.4 1.953 . . . . 0.0 116.384 -176.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.71 170.78 9.32 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 120.418 2.109 . . . . 0.0 112.96 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 16.5 m -139.14 157.45 71.15 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 126.472 1.909 . . . . 0.0 108.701 162.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.5 162.87 37.28 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.662 2.241 . . . . 0.0 112.263 175.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.3 m -55.34 89.53 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 127.695 2.398 . . . . 0.0 113.522 -174.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 125.96 -8.31 7.65 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 125.212 1.386 . . . . 0.0 114.715 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 99.2 mtp -98.97 169.6 9.32 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.152 1.476 . . . . 0.0 111.265 171.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.74 136.5 51.61 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.773 1.629 . . . . 0.0 111.606 -175.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 37.8 t -89.19 116.24 27.29 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.106 1.362 . . . . 0.0 109.694 175.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -73.32 156.09 38.77 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 122.232 1.015 . . . . 0.0 113.339 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -58.73 -16.7 17.81 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.862 2.065 . . . . 0.0 113.474 170.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 87.91 10.68 69.04 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.215 0.912 . . . . 0.0 114.428 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -116.6 141.1 48.64 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 124.534 1.134 . . . . 0.0 111.696 -177.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.69 153.35 20.79 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.017 1.327 . . . . 0.0 110.877 -178.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.58 -159.75 26.8 Favored Glycine 0 CA--C 1.526 0.742 0 O-C-N 121.666 -0.646 . . . . 0.0 112.534 175.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.9 tttp -141.51 156.12 45.76 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 124.069 0.948 . . . . 0.0 110.179 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 86.04 178.34 49.95 Favored Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.918 0.77 . . . . 0.0 112.863 -171.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -64.4 -21.69 66.34 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 C-N-CA 123.468 2.779 . . . . 0.0 114.359 -167.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.422 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -58.57 -21.55 53.24 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.137 0.975 . . . . 0.0 113.136 171.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -132.56 -36.64 1.08 Allowed 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.132 0.973 . . . . 0.0 113.479 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.3 m -85.77 -12.07 51.91 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.723 1.209 . . . . 0.0 112.072 174.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -76.6 62.5 3.14 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.504 1.049 . . . . 0.0 110.901 169.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.363 0 C-N-CA 127.236 2.214 . . . . 0.0 110.368 -167.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 14.9 p . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.71 -119.1 9.62 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 106.512 -2.635 . . . . 0.0 106.512 -137.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -58.05 160.9 4.46 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 118.502 1.151 . . . . 0.0 112.965 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 33.8 m -65.03 106.16 1.2 Allowed 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 150.147 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.0 t -52.03 97.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 C-N-CA 128.517 2.727 . . . . 0.0 109.913 -168.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? 41.9 39.74 1.35 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.74 2.016 . . . . 0.0 112.513 -169.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.96 -6.59 40.53 Favored Glycine 0 CA--C 1.537 1.449 0 C-N-CA 127.029 2.252 . . . . 0.0 115.637 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.33 176.24 5.57 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 119.962 1.881 . . . . 0.0 113.829 -168.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.1 m -137.51 152.33 72.78 Favored Pre-proline 0 CA--C 1.538 0.498 0 C-N-CA 125.036 1.334 . . . . 0.0 110.742 175.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -75.7 169.32 22.52 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 122.839 2.359 . . . . 0.0 112.12 172.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.2 t -45.97 110.49 0.27 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.862 1.665 . . . . 0.0 113.257 -171.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.4 -12.0 68.09 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 117.57 -1.683 . . . . 0.0 115.671 175.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.3 mmt -75.4 170.93 15.15 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 120.595 2.198 . . . . 0.0 111.38 174.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.3 m -130.35 148.23 52.15 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.535 1.534 . . . . 0.0 111.106 179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 45.7 t -92.92 114.98 27.69 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.777 1.231 . . . . 0.0 110.438 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 91.8 p -67.54 163.12 21.85 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 122.826 1.298 . . . . 0.0 114.258 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -52.07 -3.04 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.686 2.794 . . . . 0.0 115.545 161.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 74.7 14.24 81.49 Favored Glycine 0 CA--C 1.535 1.289 0 CA-C-N 119.153 0.888 . . . . 0.0 113.778 -172.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -107.0 149.99 26.97 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 125.382 1.473 . . . . 0.0 109.929 174.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 38.8 t -118.61 133.74 55.63 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 123.746 0.818 . . . . 0.0 112.145 -168.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -173.16 -154.16 10.21 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.527 1.537 . . . . 0.0 111.289 -171.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 37.7 tptt -141.29 169.84 16.85 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.229 1.014 . . . . 0.0 111.594 177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 89.14 169.89 44.74 Favored Glycine 0 CA--C 1.538 1.469 0 C-N-CA 125.093 1.33 . . . . 0.0 111.457 -167.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -60.62 -34.46 92.27 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.617 2.211 . . . . 0.0 112.121 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.0 mmmt -52.72 -33.95 50.24 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 125.982 1.713 . . . . 0.0 113.271 177.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -104.49 -14.16 15.79 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 126.007 1.723 . . . . 0.0 113.712 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.26 -4.83 14.25 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 165.98 -17.39 0.09 OUTLIER Glycine 0 CA--C 1.536 1.362 0 N-CA-C 117.252 1.661 . . . . 0.0 117.252 163.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.273 0 CA-C-N 119.713 1.757 . . . . 0.0 114.86 -175.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.533 HG22 ' H ' ' A' ' 2' ' ' GLY . 7.1 p . . . . . 0 N--CA 1.485 1.306 0 CA-C-O 116.969 -1.491 . . . . 0.0 108.556 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.533 ' H ' HG22 ' A' ' 1' ' ' VAL . . . -67.36 91.39 0.2 Allowed Glycine 0 CA--C 1.53 0.999 0 CA-C-N 121.307 1.867 . . . . 0.0 112.214 176.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -55.8 147.9 17.92 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.683 1.193 . . . . 0.0 113.108 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 37.9 m -68.64 104.55 2.0 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 122.992 0.517 . . . . 0.0 110.915 179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.8 t -59.25 91.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 127.557 2.343 . . . . 0.0 110.542 -171.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.579 ' H ' ' NH1' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 43.58 34.63 0.84 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.592 2.357 . . . . 0.0 112.341 -164.043 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 102.17 -10.27 56.68 Favored Glycine 0 CA--C 1.54 1.62 0 C-N-CA 127.324 2.392 . . . . 0.0 116.347 -177.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.0 160.81 19.96 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 120.877 2.339 . . . . 0.0 111.724 175.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 62.4 m -140.1 134.24 15.59 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.685 1.194 . . . . 0.0 110.275 171.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -78.52 178.38 7.63 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.444 2.763 . . . . 0.0 112.634 179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.4 m 45.42 41.36 6.45 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 127.277 2.231 . . . . 0.0 115.423 170.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 55.36 33.53 58.53 Favored Glycine 0 CA--C 1.533 1.197 0 C-N-CA 125.016 1.293 . . . . 0.0 113.795 -177.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 79.1 mtm -84.56 164.48 18.71 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 118.621 1.211 . . . . 0.0 111.062 168.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 34.1 m -112.34 147.31 36.63 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.486 1.914 . . . . 0.0 109.556 177.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.7 t -80.3 112.04 17.25 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.385 0.674 . . . . 0.0 110.778 174.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 88.8 p -66.26 162.64 19.62 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 122.867 1.318 . . . . 0.0 113.974 178.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -52.49 -2.74 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 128.41 2.684 . . . . 0.0 115.558 161.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 80.39 14.67 79.82 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 119.124 0.874 . . . . 0.0 114.057 -177.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -122.59 143.05 50.0 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 125.211 1.405 . . . . 0.0 111.652 -178.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.8 m -76.46 147.16 38.07 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.388 1.075 . . . . 0.0 112.675 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -178.68 -162.15 27.72 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 124.532 1.063 . . . . 0.0 112.175 172.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.7 mttm -132.14 166.29 22.14 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 118.187 0.994 . . . . 0.0 111.51 -178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.53 175.28 37.23 Favored Glycine 0 CA--C 1.54 1.654 0 C-N-CA 124.527 1.061 . . . . 0.0 113.601 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -47.87 -43.5 29.35 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 124.298 3.332 . . . . 0.0 114.273 -175.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 13.9 mmmt -58.1 -26.22 62.31 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.276 1.43 . . . . 0.0 113.91 -176.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -114.31 -14.65 12.22 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.602 1.561 . . . . 0.0 113.528 179.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.98 -2.66 9.18 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -172.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -159.89 -73.21 0.02 OUTLIER Glycine 0 CA--C 1.532 1.097 0 CA-C-N 119.299 0.954 . . . . 0.0 113.842 178.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.454 ' CZ ' ' HA ' ' A' ' 30' ' ' ARG . 3.3 mmp_? . . . . . 0 C--O 1.252 1.196 0 C-N-CA 126.87 2.068 . . . . 0.0 112.457 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 19.0 m . . . . . 0 N--CA 1.481 1.116 0 CA-C-O 116.86 -1.543 . . . . 0.0 106.964 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.27 93.12 0.51 Allowed Glycine 0 CA--C 1.529 0.943 0 CA-C-N 121.46 1.936 . . . . 0.0 108.621 154.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 68.38 -170.05 0.19 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.333 1.453 . . . . 0.0 111.29 -166.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.419 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 40.7 m -74.44 179.74 4.45 Favored 'General case' 0 CA--C 1.543 0.697 0 O-C-N 120.575 -1.328 . . . . 0.0 110.491 147.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 23.8 t -77.32 79.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.208 -1.557 . . . . 0.0 107.613 164.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 14.7 mmm180 45.36 47.04 10.62 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.246 1.418 . . . . 0.0 112.28 -175.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 85.7 10.26 76.61 Favored Glycine 0 CA--C 1.536 1.396 0 C-N-CA 124.734 1.159 . . . . 0.0 115.463 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -129.77 172.6 11.47 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.659 1.984 . . . . 0.0 109.924 175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 76.0 m -141.88 154.8 65.88 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 118.973 0.806 . . . . 0.0 112.894 178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -81.17 173.61 11.61 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.903 3.069 . . . . 0.0 111.773 169.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.2 m 36.0 43.18 0.19 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 129.128 2.971 . . . . 0.0 117.086 163.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.19 31.08 61.71 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.854 1.216 . . . . 0.0 114.253 -177.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -73.87 165.04 25.83 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.701 1.75 . . . . 0.0 109.561 159.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.3 m -118.32 115.6 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.462 1.505 . . . . 0.0 109.48 -167.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.3 t -74.15 89.16 1.98 Allowed 'General case' 0 C--O 1.234 0.267 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 175.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -59.15 164.79 2.88 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.776 1.63 . . . . 0.0 114.275 -172.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.0 pm0 -58.51 -21.67 52.82 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.4 1.48 . . . . 0.0 113.361 176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.3 30.1 25.95 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.056 0.836 . . . . 0.0 113.505 -173.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 32.4 m-85 -130.53 126.52 37.01 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.952 1.301 . . . . 0.0 111.252 -175.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.419 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 69.3 m -67.21 135.91 54.18 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 118.252 0.478 . . . . 0.0 111.456 167.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.55 -163.33 17.39 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 124.622 1.106 . . . . 0.0 112.108 165.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.7 mttp -132.59 167.0 20.82 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 125.443 1.497 . . . . 0.0 110.483 175.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.43 179.13 34.01 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 123.683 0.658 . . . . 0.0 113.383 -176.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -63.51 -28.66 70.57 Favored 'Trans proline' 0 CA--C 1.534 0.488 0 C-N-CA 122.993 2.462 . . . . 0.0 113.442 -171.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.6 -12.01 20.37 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 116.842 -1.551 . . . . 0.0 114.505 173.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -134.73 -25.93 1.41 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 176.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -97.77 -11.44 23.37 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.155 0.982 . . . . 0.0 113.633 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -78.04 72.11 2.32 Favored Glycine 0 C--N 1.342 0.909 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 166.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.236 0 CA-C-O 115.788 -2.053 . . . . 0.0 113.09 -163.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 57.9 t . . . . . 0 N--CA 1.486 1.346 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.21 107.74 3.0 Favored Glycine 0 CA--C 1.528 0.876 0 N-CA-C 108.877 -1.689 . . . . 0.0 108.877 -160.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -35.31 133.03 0.36 Allowed 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 126.975 2.11 . . . . 0.0 114.682 -177.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 30.4 m -61.56 101.65 0.2 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 158.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.6 t -58.26 95.56 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 127.488 2.315 . . . . 0.0 110.0 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.8 mmp_? 47.05 34.41 2.81 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 124.893 1.277 . . . . 0.0 111.729 -167.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 95.27 -6.2 68.46 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 126.982 2.229 . . . . 0.0 116.276 -176.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.27 163.95 15.15 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 120.448 2.124 . . . . 0.0 111.682 176.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -138.38 158.29 70.92 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.804 1.241 . . . . 0.0 110.772 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -73.66 168.24 25.27 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 122.872 2.382 . . . . 0.0 112.687 -178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.1 m -43.71 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.249 2.619 . . . . 0.0 114.586 -171.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 99.54 -7.15 59.48 Favored Glycine 0 CA--C 1.533 1.2 0 CA-C-O 118.122 -1.377 . . . . 0.0 115.196 175.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 46.5 mtt -79.0 170.4 16.75 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 119.791 1.795 . . . . 0.0 111.875 170.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.3 p -139.14 163.29 32.82 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.892 2.077 . . . . 0.0 110.542 178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 48.3 t -109.54 114.96 29.03 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.823 1.249 . . . . 0.0 112.091 -166.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 6.5 t -68.55 157.95 34.94 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.002 1.321 . . . . 0.0 112.862 177.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.2 pm0 -54.27 -24.69 19.87 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.599 1.16 . . . . 0.0 113.484 169.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.83 17.62 74.61 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 118.736 0.698 . . . . 0.0 113.798 175.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -114.84 143.76 44.6 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 125.105 1.362 . . . . 0.0 112.684 -178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.65 157.56 31.74 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.551 1.141 . . . . 0.0 112.066 167.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 167.51 -160.89 34.66 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 126.281 1.896 . . . . 0.0 109.77 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 35.5 tttp -142.93 163.06 33.8 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.514 0.657 . . . . 0.0 110.803 169.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.71 179.11 25.72 Favored Glycine 0 CA--C 1.538 1.49 0 C-N-CA 124.696 1.141 . . . . 0.0 112.928 -174.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -68.87 -8.46 23.55 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 123.902 3.068 . . . . 0.0 114.867 -168.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 10.0 mmpt? -95.21 -2.12 50.29 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.7 1.6 . . . . 0.0 113.661 172.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.37 -44.91 1.98 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 125.873 1.669 . . . . 0.0 111.767 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 45.5 m -93.46 -7.17 45.2 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.88 1.672 . . . . 0.0 111.913 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -132.51 -173.71 13.4 Favored Glycine 0 CA--C 1.534 1.276 0 C-N-CA 127.742 2.592 . . . . 0.0 109.254 165.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HA ' ' HE ' ' A' ' 30' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.178 0 C-N-CA 124.778 1.231 . . . . 0.0 110.295 175.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 60.9 t . . . . . 0 N--CA 1.486 1.351 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.9 99.04 2.32 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 108.297 -1.921 . . . . 0.0 108.297 -159.4 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -51.13 139.76 17.52 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.89 1.276 . . . . 0.0 114.075 -175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 46.5 m -68.49 103.33 1.64 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.324 0.649 . . . . 0.0 111.611 -179.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -54.54 89.18 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 128.73 2.812 . . . . 0.0 111.524 -172.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.58 ' H ' ' NH1' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 37.66 40.09 0.23 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 128.726 2.81 . . . . 0.0 112.785 -162.432 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 111.68 -7.46 27.93 Favored Glycine 0 CA--C 1.54 1.611 0 C-N-CA 126.429 1.966 . . . . 0.0 116.559 178.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -112.45 166.55 11.21 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 120.573 2.187 . . . . 0.0 113.574 -176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 92.4 m -142.17 167.07 17.69 Favored Pre-proline 0 CA--C 1.542 0.651 0 C-N-CA 126.331 1.852 . . . . 0.0 110.828 -174.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 65.0 Cg_exo -54.04 155.53 14.88 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.729 2.953 . . . . 0.0 114.223 174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.9 t -62.28 74.91 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.392 2.277 . . . . 0.0 113.914 -175.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.04 -10.41 2.55 Favored Glycine 0 CA--C 1.534 1.232 0 C-N-CA 126.026 1.774 . . . . 0.0 114.533 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -88.0 171.76 10.06 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.261 1.425 . . . . 0.0 111.31 173.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.6 m -123.01 149.69 44.0 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 126.102 1.761 . . . . 0.0 110.101 169.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 42.1 t -79.94 118.46 21.72 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 123.846 0.859 . . . . 0.0 109.974 166.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.6 p -78.88 159.22 27.87 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.863 0.839 . . . . 0.0 112.795 172.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.5 pm0 -58.83 -16.41 17.07 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.791 1.637 . . . . 0.0 113.872 173.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.66 9.88 82.38 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.554 1.073 . . . . 0.0 113.743 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -118.7 140.03 50.58 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 124.439 1.096 . . . . 0.0 111.823 -174.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 72.7 m -73.17 153.15 40.83 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 125.624 1.569 . . . . 0.0 112.53 170.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 173.35 -170.5 43.64 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 123.62 0.629 . . . . 0.0 113.953 170.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.8 mtpp -128.45 165.78 20.0 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 127.323 2.249 . . . . 0.0 110.299 178.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.89 179.98 52.79 Favored Glycine 0 CA--C 1.538 1.522 0 C-N-CA 124.069 0.842 . . . . 0.0 113.295 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -53.67 -26.8 39.35 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 124.585 3.523 . . . . 0.0 116.235 -172.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.5 mmpt? -71.61 -10.93 60.52 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 175.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -143.95 -52.02 0.32 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -172.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -142.08 7.09 1.79 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.729 1.612 . . . . 0.0 114.142 -159.135 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 75.94 -53.97 3.0 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.867 1.222 . . . . 0.0 112.79 -175.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.921 0 C-N-CA 126.747 2.019 . . . . 0.0 113.459 176.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.411 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 17.7 m . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.96 -48.84 1.72 Allowed Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -162.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 pt-20 -154.07 -177.15 6.22 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 126.259 1.824 . . . . 0.0 112.547 171.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.447 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 20.2 m -99.66 146.7 26.2 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.459 1.504 . . . . 0.0 110.802 141.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 t -69.09 91.4 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 125.47 1.508 . . . . 0.0 110.016 -177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.421 ' H ' ' NH1' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 48.68 25.84 1.09 Allowed 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 126.119 1.767 . . . . 0.0 112.814 -168.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 105.51 -3.89 39.97 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 125.588 1.566 . . . . 0.0 116.54 -173.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.29 166.19 11.5 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 120.22 2.01 . . . . 0.0 112.16 -179.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.7 m -145.49 163.56 31.1 Favored Pre-proline 0 CA--C 1.541 0.631 0 C-N-CA 124.804 1.242 . . . . 0.0 111.935 -173.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -53.18 156.46 10.23 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 124.356 3.37 . . . . 0.0 115.443 172.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.1 m -51.68 102.85 0.05 Allowed 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 127.201 2.201 . . . . 0.0 112.59 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.38 -3.75 47.23 Favored Glycine 0 CA--C 1.531 1.072 0 CA-C-O 118.682 -1.065 . . . . 0.0 114.831 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 26.2 mmt -74.46 -175.59 2.42 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.926 1.863 . . . . 0.0 112.354 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.9 m -127.63 137.86 52.66 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 127.081 2.152 . . . . 0.0 109.818 160.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.7 t -80.36 107.81 13.46 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 158.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 93.6 p -77.04 165.77 24.19 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 -174.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.1 pm0 -58.98 -18.1 30.89 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.418 1.487 . . . . 0.0 113.525 171.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.44 19.27 78.82 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 124.056 0.836 . . . . 0.0 113.109 -176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.411 ' CD2' ' HA ' ' A' ' 1' ' ' VAL . 3.2 m-30 -122.35 133.12 54.66 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 127.243 2.217 . . . . 0.0 110.261 -173.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.447 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 98.5 m -65.99 146.03 55.17 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 165.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 175.5 -167.38 39.28 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.091 0.853 . . . . 0.0 113.659 165.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.4 mtpp -131.13 169.68 15.56 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 126.739 2.016 . . . . 0.0 111.539 174.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 72.33 178.87 33.14 Favored Glycine 0 CA--C 1.539 1.571 0 C-N-CA 124.139 0.876 . . . . 0.0 113.76 -178.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_exo -49.31 -35.66 35.53 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 124.717 3.612 . . . . 0.0 116.288 -173.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.03 -5.67 40.42 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 -179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -144.01 -30.49 0.48 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 115.692 1.738 . . . . 0.0 115.692 179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.5 t -147.64 -21.49 0.37 Allowed 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 115.195 1.554 . . . . 0.0 115.195 -157.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 69.7 -56.77 0.72 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 123.944 0.783 . . . . 0.0 111.794 -159.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.254 1.317 0 C-N-CA 128.053 2.541 . . . . 0.0 113.427 -176.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.482 1.158 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.58 -52.78 2.77 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.866 -0.894 . . . . 0.0 110.866 -163.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -152.55 -171.7 4.01 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 126.013 1.725 . . . . 0.0 111.862 162.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.492 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 47.7 m -95.95 128.11 42.55 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.352 1.861 . . . . 0.0 109.006 145.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 92.2 t -52.2 90.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.87 0 C-N-CA 129.163 2.985 . . . . 0.0 111.456 -171.512 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 7.9 mmp_? 44.96 29.81 0.5 Allowed 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.195 0.998 . . . . 0.0 113.42 -165.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.21 8.22 63.16 Favored Glycine 0 CA--C 1.54 1.63 0 C-N-CA 125.075 1.322 . . . . 0.0 115.437 -174.531 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.9 mmp_? -105.53 174.02 6.06 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 127.814 2.445 . . . . 0.0 110.654 171.669 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.1 m -140.1 133.26 15.09 Favored Pre-proline 0 CA--C 1.543 0.675 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 176.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -81.85 166.48 17.06 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.807 3.005 . . . . 0.0 111.874 177.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 90.7 p 53.97 27.85 7.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 174.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.44 34.37 54.67 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.081 1.324 . . . . 0.0 113.61 -170.043 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 65.2 mtt -67.17 170.47 6.97 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 118.954 1.377 . . . . 0.0 110.687 163.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.7 m -130.34 148.83 52.2 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.386 1.474 . . . . 0.0 110.341 -178.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 26.6 t -91.96 109.41 20.76 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.35 1.06 . . . . 0.0 111.856 -169.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.429 ' HB3' ' CD2' ' A' ' 27' ' ' TYR . 87.2 p -66.43 165.8 13.61 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.703 1.201 . . . . 0.0 113.811 177.1 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 12.5 pm0 -52.15 -22.16 3.99 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.212 2.205 . . . . 0.0 114.447 170.357 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.15 29.89 73.55 Favored Glycine 0 CA--C 1.529 0.96 0 CA-C-O 119.302 -0.721 . . . . 0.0 112.044 -172.141 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -120.16 126.13 49.92 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 127.276 2.231 . . . . 0.0 109.93 -179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.492 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 86.9 m -68.06 149.4 49.71 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 170.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.48 -159.25 21.14 Favored Glycine 0 CA--C 1.534 1.241 0 C-N-CA 125.773 1.654 . . . . 0.0 111.846 173.423 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -127.14 157.2 40.34 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.842 1.257 . . . . 0.0 110.981 -178.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 85.31 -175.96 49.88 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 115.414 0.925 . . . . 0.0 115.414 171.887 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -56.01 -22.25 38.04 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 124.918 3.745 . . . . 0.0 117.284 -170.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -92.39 1.22 57.36 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.776 1.23 . . . . 0.0 113.319 176.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 16' ' ' SER . 86.6 m-85 -129.6 -44.34 1.23 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.636 1.174 . . . . 0.0 112.403 -176.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -96.57 -15.23 21.71 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 123.591 0.756 . . . . 0.0 113.028 170.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -103.93 -154.22 23.51 Favored Glycine 0 CA--C 1.535 1.306 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 154.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.232 0 C-N-CA 125.24 1.416 . . . . 0.0 109.158 175.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 29.5 m . . . . . 0 N--CA 1.483 1.186 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.02 106.2 0.96 Allowed Glycine 0 CA--C 1.529 0.926 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -159.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 tm-20 -54.99 142.71 28.99 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.985 0.914 . . . . 0.0 110.44 167.596 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.8 m -65.49 108.35 1.97 Allowed 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.706 -0.621 . . . . 0.0 111.713 -175.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.1 t -59.71 88.22 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 126.862 2.065 . . . . 0.0 110.639 -174.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.518 ' CZ ' ' H ' ' A' ' 6' ' ' ARG . 0.0 OUTLIER 40.59 43.81 1.65 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.739 2.016 . . . . 0.0 111.405 -162.556 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.36 -11.04 70.88 Favored Glycine 0 CA--C 1.538 1.523 0 C-N-CA 125.982 1.753 . . . . 0.0 116.089 -178.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.16 160.0 20.94 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 120.441 2.121 . . . . 0.0 111.433 176.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 88.8 m -142.37 154.61 64.04 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 125.036 1.334 . . . . 0.0 111.469 174.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -77.27 174.32 12.95 Favored 'Trans proline' 0 CA--C 1.54 0.802 0 C-N-CA 123.613 2.875 . . . . 0.0 111.95 175.409 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.0 m 37.34 45.66 0.55 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 128.191 2.596 . . . . 0.0 116.137 167.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 50.86 30.78 22.8 Favored Glycine 0 CA--C 1.535 1.291 0 C-N-CA 125.746 1.641 . . . . 0.0 114.125 -176.329 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 68.8 mtt -74.37 159.94 31.7 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.622 1.211 . . . . 0.0 111.579 177.779 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 78.4 m -87.63 120.97 29.47 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 125.445 1.498 . . . . 0.0 109.448 177.992 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 51.0 t -67.67 101.14 0.98 Allowed 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 108.77 -0.826 . . . . 0.0 108.77 160.52 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 85.5 p -75.31 163.6 27.31 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -174.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.5 pm0 -58.25 -17.12 16.98 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.521 1.529 . . . . 0.0 113.504 173.541 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.33 10.51 74.02 Favored Glycine 0 CA--C 1.533 1.206 0 C-N-CA 124.796 1.189 . . . . 0.0 114.074 -178.108 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 30.5 m-85 -128.58 146.9 50.71 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.287 1.035 . . . . 0.0 112.02 -172.155 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 84.5 m -76.76 147.81 37.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 126.882 2.073 . . . . 0.0 112.438 177.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 172.86 -169.69 42.83 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 123.38 0.514 . . . . 0.0 113.77 163.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -130.12 159.97 35.17 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.491 1.916 . . . . 0.0 108.993 170.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.87 173.67 47.85 Favored Glycine 0 CA--C 1.541 1.701 0 C-N-CA 123.903 0.763 . . . . 0.0 112.744 -173.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -51.14 -45.9 34.13 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 124.155 3.237 . . . . 0.0 115.53 -167.679 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.81 0.28 1.23 Allowed 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 177.615 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -137.61 -38.62 0.59 Allowed 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 114.259 1.207 . . . . 0.0 114.259 176.239 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 84.5 m -115.17 -1.68 12.92 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.281 1.432 . . . . 0.0 113.702 -176.129 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 73.77 -48.84 1.66 Allowed Glycine 0 CA--C 1.536 1.376 0 CA-C-N 119.847 1.203 . . . . 0.0 112.861 -171.355 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.1 tpm_? . . . . . 0 C--O 1.248 1.003 0 C-N-CA 125.519 1.528 . . . . 0.0 110.506 160.691 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.476 0.838 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.9 67.5 1.93 Allowed Glycine 0 CA--C 1.53 0.984 0 N-CA-C 108.346 -1.902 . . . . 0.0 108.346 -145.173 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 59.82 -172.58 0.12 Allowed 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 126.278 1.831 . . . . 0.0 113.78 -170.66 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.5 m -82.17 132.59 35.24 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 144.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.36 86.2 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.825 0 C-N-CA 124.872 1.269 . . . . 0.0 111.479 -161.248 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.16 42.89 25.85 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.673 1.189 . . . . 0.0 111.22 -159.462 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 97.15 -10.04 65.5 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 126.012 1.768 . . . . 0.0 115.03 177.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 -103.01 172.38 6.85 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 118.83 1.315 . . . . 0.0 113.328 -167.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 23.2 m -141.75 157.61 64.45 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 126.909 2.084 . . . . 0.0 110.784 176.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -73.64 161.09 42.79 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 122.877 2.385 . . . . 0.0 111.893 165.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.0 m -55.27 92.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.238 2.215 . . . . 0.0 113.48 -173.746 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.76 -10.83 10.3 Favored Glycine 0 CA--C 1.532 1.101 0 C-N-CA 125.219 1.39 . . . . 0.0 114.5 177.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.3 mtt -88.62 167.12 13.65 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 118.868 1.334 . . . . 0.0 111.228 166.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.3 m -137.44 142.01 41.61 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 125.944 1.698 . . . . 0.0 110.858 -172.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.4 t -83.93 108.18 16.76 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.467 1.107 . . . . 0.0 110.128 177.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 90.1 p -71.44 161.72 30.58 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.823 0.82 . . . . 0.0 113.034 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.4 pm0 -58.59 -16.38 15.62 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.843 1.657 . . . . 0.0 113.864 174.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.63 18.81 79.59 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 123.898 0.761 . . . . 0.0 113.056 -177.469 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.18 127.88 49.27 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.838 1.655 . . . . 0.0 110.661 -173.401 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.0 t -83.51 144.76 29.31 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.875 0.87 . . . . 0.0 112.387 177.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.48 -165.2 33.21 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.319 0.961 . . . . 0.0 112.644 176.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.8 tttp -136.41 162.59 32.62 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.397 1.079 . . . . 0.0 111.864 176.962 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.68 -173.68 42.12 Favored Glycine 0 CA--C 1.538 1.53 0 C-N-CA 124.161 0.886 . . . . 0.0 112.953 -173.815 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_exo -44.31 -47.98 10.26 Favored 'Trans proline' 0 C--N 1.35 0.652 1 C-N-CA 125.407 4.072 . . . . 0.0 115.612 -172.605 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 9.0 tptp -65.69 -6.53 11.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.891 1.676 . . . . 0.0 115.522 -179.079 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -139.64 -56.0 0.57 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.005 0.922 . . . . 0.0 113.033 -171.748 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 88.5 m -117.86 -5.76 11.04 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.567 1.947 . . . . 0.0 113.553 -170.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.43 -49.84 3.08 Favored Glycine 0 CA--C 1.535 1.3 0 O-C-N 120.999 -1.063 . . . . 0.0 111.894 -160.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.22 0 CA-C-O 115.862 -2.018 . . . . 0.0 113.248 -178.752 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 43.0 t . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.16 -47.23 2.58 Favored Glycine 0 CA--C 1.532 1.156 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -161.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -152.78 176.5 11.72 Favored 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 125.776 1.63 . . . . 0.0 111.027 169.665 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 36.2 m -85.76 107.44 17.61 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 106.339 -1.726 . . . . 0.0 106.339 139.433 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.5 t -55.43 95.78 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 125.964 1.706 . . . . 0.0 111.524 -158.211 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? 45.28 36.06 2.08 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.085 1.754 . . . . 0.0 112.335 -169.545 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.92 -4.65 59.23 Favored Glycine 0 CA--C 1.538 1.493 0 C-N-CA 127.697 2.57 . . . . 0.0 115.873 -176.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.76 8.5 Favored 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.264 2.032 . . . . 0.0 113.087 -179.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 m -136.34 152.02 74.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 127.069 2.148 . . . . 0.0 109.661 169.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -56.65 165.96 4.16 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 123.783 2.989 . . . . 0.0 113.257 162.473 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.6 m -44.64 98.35 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.703 2.401 . . . . 0.0 114.07 -175.649 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.53 4.61 89.11 Favored Glycine 0 CA--C 1.534 1.225 0 CA-C-O 118.275 -1.292 . . . . 0.0 115.466 176.483 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 56.1 mtt -77.6 172.91 12.64 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.797 1.798 . . . . 0.0 112.105 171.923 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 47.2 m -128.61 133.96 48.45 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.376 1.87 . . . . 0.0 110.62 -169.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 47.5 t -81.99 125.97 31.41 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 121.909 -0.494 . . . . 0.0 110.672 173.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.0 p -79.2 154.32 29.33 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 173.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.49 ' H ' ' HD3' ' A' ' 30' ' ' ARG . 9.5 pt20 -59.19 -21.6 59.71 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 121.46 -0.775 . . . . 0.0 112.845 169.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.9 10.29 83.23 Favored Glycine 0 C--N 1.343 0.946 0 C-N-CA 124.397 0.998 . . . . 0.0 114.177 172.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -115.41 131.08 57.04 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 125.41 1.484 . . . . 0.0 109.864 -179.761 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 49.7 t -76.44 149.89 36.79 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.491 0.316 . . . . 0.0 111.791 169.243 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.46 -159.17 23.03 Favored Glycine 0 CA--C 1.532 1.109 0 C-N-CA 124.871 1.224 . . . . 0.0 112.001 175.47 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.0 tptt -139.31 154.48 47.92 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.991 0.916 . . . . 0.0 110.079 175.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 101.41 176.92 28.73 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 124.857 1.218 . . . . 0.0 112.799 -173.788 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -46.88 -53.06 6.72 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 124.546 3.498 . . . . 0.0 114.467 -174.042 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.0 mmpt? -56.62 -12.19 1.69 Allowed 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.337 1.855 . . . . 0.0 114.888 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -120.07 -39.11 2.85 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 125.882 1.673 . . . . 0.0 112.943 -178.48 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 52.7 m -110.23 -14.53 14.16 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 -173.091 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -136.53 66.56 0.55 Allowed Glycine 0 N--CA 1.469 0.898 0 C-N-CA 125.695 1.617 . . . . 0.0 110.222 -176.052 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.49 ' HD3' ' H ' ' A' ' 17' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 C-N-CA 127.251 2.22 . . . . 0.0 110.954 -157.588 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 40.7 t . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 -45.9 2.43 Favored Glycine 0 CA--C 1.533 1.214 0 N-CA-C 111.253 -0.739 . . . . 0.0 111.253 -163.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -154.45 179.84 8.64 Favored 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 126.776 2.03 . . . . 0.0 109.88 168.904 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -82.49 107.52 15.21 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 130.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 45.9 t -55.01 101.89 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 126.693 1.997 . . . . 0.0 110.425 -170.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.9 mmp_? 48.9 33.2 4.28 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 124.586 1.155 . . . . 0.0 112.379 -170.313 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 91.18 4.78 68.33 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 126.898 2.189 . . . . 0.0 115.269 -178.298 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? -121.38 164.21 17.46 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 119.774 1.787 . . . . 0.0 112.597 -174.622 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.2 m -160.35 173.83 4.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 127.441 2.297 . . . . 0.0 108.878 163.881 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -46.58 136.07 16.15 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.75 2.966 . . . . 0.0 113.755 173.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 89.8 p -58.31 97.03 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.107 1.763 . . . . 0.0 112.254 -174.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.31 -19.88 4.51 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 125.441 1.496 . . . . 0.0 112.969 -174.357 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 75.3 mtp -82.37 158.95 23.15 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.211 1.005 . . . . 0.0 109.645 159.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 60.6 m -143.29 139.6 30.21 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.834 1.254 . . . . 0.0 110.156 -165.405 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.2 m -70.93 155.3 40.98 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 123.565 0.746 . . . . 0.0 111.859 177.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 94.2 p -126.83 166.38 17.55 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.879 1.271 . . . . 0.0 113.219 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 21.9 pt20 -57.97 -18.17 21.93 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.951 1.3 . . . . 0.0 114.067 174.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.24 9.93 84.27 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.624 1.107 . . . . 0.0 113.38 -174.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -111.64 137.0 50.1 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.45 1.5 . . . . 0.0 110.033 -171.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.8 151.71 30.15 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 166.509 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -176.5 -162.22 26.82 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 124.918 1.246 . . . . 0.0 112.015 177.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 18.4 mtpp -138.25 163.98 30.38 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.819 1.648 . . . . 0.0 110.714 172.683 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 87.45 -175.66 46.01 Favored Glycine 0 CA--C 1.538 1.505 0 C-N-CA 123.609 0.623 . . . . 0.0 113.232 -176.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -48.53 -36.38 31.37 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 125.178 3.919 . . . . 0.0 116.77 -171.038 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.94 -9.65 58.95 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.506 1.298 . . . . 0.0 114.506 178.742 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.74 -47.84 0.5 Allowed 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.812 1.041 . . . . 0.0 113.812 -168.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -144.55 5.17 1.21 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -174.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 78.18 -46.62 2.75 Favored Glycine 0 CA--C 1.533 1.178 0 O-C-N 120.652 -1.28 . . . . 0.0 112.38 -167.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.25 0 C-N-CA 126.546 1.938 . . . . 0.0 113.416 -179.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 117.157 -1.402 . . . . 0.0 107.41 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.59 19.44 0.53 Allowed Glycine 0 CA--C 1.54 1.651 0 CA-C-N 120.823 1.647 . . . . 0.0 114.811 169.727 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 tt0 -171.77 165.14 6.59 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 129.441 3.097 . . . . 0.0 108.797 -179.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 20.8 m -95.27 112.94 24.57 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.684 1.994 . . . . 0.0 107.268 151.109 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 49.3 t -67.0 103.07 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 124.536 1.134 . . . . 0.0 110.44 -163.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.26 30.5 4.44 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.366 1.066 . . . . 0.0 112.156 -165.124 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.26 -7.69 81.51 Favored Glycine 0 CA--C 1.535 1.343 0 C-N-CA 126.184 1.85 . . . . 0.0 115.198 -174.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.8 171.93 8.99 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 119.584 1.692 . . . . 0.0 112.016 -176.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 4.0 m -143.14 149.17 47.79 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 126.363 1.865 . . . . 0.0 111.521 -172.519 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.02 -178.27 0.13 Allowed 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 125.261 3.974 . . . . 0.0 114.991 165.09 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 15.4 m -38.96 92.3 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 129.644 3.178 . . . . 0.0 115.311 -177.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.38 30.13 61.24 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.62 1.105 . . . . 0.0 113.588 -177.597 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 40.4 mtt -85.71 170.04 12.86 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.21 1.004 . . . . 0.0 110.813 170.212 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.16 142.32 35.97 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.22 1.808 . . . . 0.0 110.734 -164.306 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 35.0 t -88.6 113.13 23.85 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.564 1.145 . . . . 0.0 110.555 -177.355 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 99.9 p -71.58 165.87 23.01 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 122.148 0.975 . . . . 0.0 113.504 179.225 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.7 pm0 -53.25 -17.68 1.9 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 127.347 2.259 . . . . 0.0 114.683 170.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.34 19.59 78.85 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-N 118.727 0.694 . . . . 0.0 112.747 -170.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -111.65 123.04 49.4 Favored 'General case' 0 N--CA 1.465 0.295 0 C-N-CA 126.43 1.892 . . . . 0.0 108.906 -178.114 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.77 142.69 30.5 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 118.246 0.476 . . . . 0.0 112.02 178.183 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.91 -161.47 19.21 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.951 1.739 . . . . 0.0 110.33 177.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.3 tttp -132.59 150.0 52.22 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 118.769 1.285 . . . . 0.0 110.779 -175.405 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 88.66 -160.64 30.33 Favored Glycine 0 CA--C 1.544 1.863 0 N-CA-C 115.406 0.923 . . . . 0.0 115.406 172.657 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -72.88 4.29 3.76 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 125.109 3.873 . . . . 0.0 116.151 -160.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.32 5.44 9.68 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.053 1.741 . . . . 0.0 112.737 174.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -129.24 -57.44 1.15 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 125.487 1.515 . . . . 0.0 110.378 177.936 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 41.9 m -73.85 -62.23 1.57 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.029 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.36 162.76 43.51 Favored Glycine 0 CA--C 1.533 1.204 0 N-CA-C 111.454 -0.658 . . . . 0.0 111.454 164.358 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.137 0 C-N-CA 124.094 0.957 . . . . 0.0 112.321 -169.698 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.412 ' H2 ' ' CD ' ' A' ' 3' ' ' GLU . 12.0 p . . . . . 0 N--CA 1.481 1.083 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.67 7.7 68.6 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 118.842 -0.977 . . . . 0.0 114.71 -178.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.412 ' CD ' ' H2 ' ' A' ' 1' ' ' VAL . 52.6 mp0 -51.17 124.88 12.55 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.806 1.642 . . . . 0.0 110.819 172.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.1 m -57.92 160.07 5.01 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -171.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -74.9 56.79 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 125.983 1.713 . . . . 0.0 109.293 168.782 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? 52.82 38.36 26.43 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 129.915 3.286 . . . . 0.0 112.417 -179.577 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 124.39 -12.55 7.94 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 126.578 2.037 . . . . 0.0 115.058 179.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 12.0 mtm-85 -115.36 168.52 9.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.614 1.566 . . . . 0.0 111.012 177.697 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.4 m -144.98 167.17 15.32 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.367 1.067 . . . . 0.0 112.798 -172.433 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -54.07 166.13 1.71 Allowed 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 124.512 3.474 . . . . 0.0 114.59 168.765 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.9 m -39.16 98.15 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 128.531 2.733 . . . . 0.0 114.749 -174.149 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.35 3.16 81.81 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.447 -1.196 . . . . 0.0 115.49 176.031 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 32.9 mmt -80.03 161.95 25.13 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 119.368 1.584 . . . . 0.0 110.722 173.096 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 55.9 m -119.54 129.51 54.71 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.85 1.26 . . . . 0.0 110.639 -172.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.1 t -76.28 107.92 8.86 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.305 0.642 . . . . 0.0 109.979 174.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 17.5 t -57.71 148.73 23.82 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.673 1.189 . . . . 0.0 111.123 170.161 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.2 pm0 -51.01 -20.75 1.48 Allowed 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.238 2.215 . . . . 0.0 114.197 169.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 98.49 16.85 30.57 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.538 1.066 . . . . 0.0 115.405 172.316 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -126.69 140.44 52.4 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.891 1.276 . . . . 0.0 112.897 -170.781 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 91.6 m -84.09 142.76 30.17 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.513 1.525 . . . . 0.0 113.257 177.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.57 -163.66 36.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 123.863 0.744 . . . . 0.0 113.269 172.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.2 mmmt -137.47 166.7 23.22 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.941 1.696 . . . . 0.0 110.773 174.097 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 84.19 -176.62 51.72 Favored Glycine 0 CA--C 1.541 1.668 0 C-N-CA 123.704 0.668 . . . . 0.0 113.257 -174.455 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -49.06 -39.92 41.18 Favored 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 125.037 3.825 . . . . 0.0 116.109 -170.236 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.14 -11.09 58.55 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.889 1.276 . . . . 0.0 113.501 179.478 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -138.85 -45.61 0.48 Allowed 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -168.094 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -144.99 6.72 1.17 Allowed 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 -169.031 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.35 -52.49 3.42 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 121.009 -1.057 . . . . 0.0 112.487 -169.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 50.4 tpt85 . . . . . 0 C--O 1.253 1.276 0 C-N-CA 126.932 2.093 . . . . 0.0 112.3 179.065 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . 0.446 ' HA ' ' CD2' ' A' ' 20' ' ' TYR . 42.8 t . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.13 -53.08 3.41 Favored Glycine 0 CA--C 1.532 1.115 0 N-CA-C 111.155 -0.778 . . . . 0.0 111.155 -165.948 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -153.03 -177.59 6.39 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.648 1.579 . . . . 0.0 110.976 170.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.459 ' HA ' ' SG ' ' A' ' 21' ' ' CYS . 30.5 m -92.83 114.85 27.52 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.839 1.256 . . . . 0.0 108.034 133.111 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 44.6 t -58.56 95.65 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 C-N-CA 126.733 2.013 . . . . 0.0 110.877 -166.723 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? 48.14 30.86 2.29 Favored 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 124.075 0.95 . . . . 0.0 112.244 -166.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 92.53 -6.47 77.66 Favored Glycine 0 CA--C 1.539 1.581 0 C-N-CA 126.856 2.17 . . . . 0.0 116.01 -175.377 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.44 167.9 12.63 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 120.232 2.016 . . . . 0.0 111.094 175.187 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -139.93 141.76 28.39 Favored Pre-proline 0 CA--C 1.542 0.636 0 C-N-CA 123.785 0.834 . . . . 0.0 112.545 175.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -83.57 172.92 9.91 Favored 'Trans proline' 0 CA--C 1.539 0.771 0 C-N-CA 123.985 3.124 . . . . 0.0 112.171 177.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 32.3 t 43.66 39.57 2.49 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 126.943 2.097 . . . . 0.0 116.245 165.041 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 56.66 31.68 60.76 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.919 1.247 . . . . 0.0 113.95 -176.163 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 66.2 mtt -76.82 163.64 26.58 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 118.817 1.308 . . . . 0.0 110.39 164.969 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.0 m -115.42 145.95 42.07 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.615 1.966 . . . . 0.0 109.814 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -80.32 110.93 16.22 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.284 0.634 . . . . 0.0 111.105 177.118 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 98.7 p -71.37 166.3 21.95 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -176.653 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -53.47 -5.1 0.05 OUTLIER 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.22 2.608 . . . . 0.0 115.433 163.899 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.51 23.08 78.52 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-N 119.038 0.836 . . . . 0.0 113.242 -174.44 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.446 ' CD2' ' HA ' ' A' ' 1' ' ' VAL . 1.7 m-85 -123.03 131.25 53.63 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 127.332 2.253 . . . . 0.0 110.274 -179.637 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.459 ' SG ' ' HA ' ' A' ' 4' ' ' CYS . 82.4 m -62.63 143.23 57.55 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 118.534 0.606 . . . . 0.0 112.508 168.524 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -168.67 -159.95 15.5 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 126.121 1.82 . . . . 0.0 111.538 168.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -133.89 166.3 23.0 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.167 1.483 . . . . 0.0 112.355 -179.518 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.5 170.95 29.14 Favored Glycine 0 CA--C 1.541 1.662 0 C-N-CA 125.312 1.434 . . . . 0.0 113.352 -175.037 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -48.37 -41.17 36.05 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.155 3.236 . . . . 0.0 113.888 -178.121 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.88 -27.06 16.85 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.991 2.116 . . . . 0.0 114.208 177.903 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -119.15 -8.81 10.1 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.317 1.447 . . . . 0.0 113.459 177.178 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -117.78 -4.56 11.15 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -175.568 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -162.45 -63.32 0.02 OUTLIER Glycine 0 CA--C 1.534 1.247 0 CA-C-N 119.191 0.905 . . . . 0.0 114.307 179.113 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.148 0 C-N-CA 125.954 1.702 . . . . 0.0 112.767 -177.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.485 1.281 0 CA-C-O 119.269 -0.396 . . . . 0.0 109.953 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.83 107.99 0.64 Allowed Glycine 0 CA--C 1.528 0.852 0 N-CA-C 108.566 -1.813 . . . . 0.0 108.566 -153.251 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -56.49 152.65 11.28 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.632 0.773 . . . . 0.0 112.284 177.608 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 63.1 m -65.64 100.88 0.56 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.008 -0.433 . . . . 0.0 110.93 178.581 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 40.0 t -58.14 89.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 128.527 2.731 . . . . 0.0 110.004 -170.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.448 ' H ' ' NH1' ' A' ' 6' ' ' ARG . 7.3 mmp_? 40.38 46.68 2.07 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.669 1.988 . . . . 0.0 111.242 -164.37 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 94.06 -10.84 71.53 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 126.848 2.166 . . . . 0.0 115.453 179.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 10.5 mpt_? -96.69 163.75 12.88 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 119.747 1.774 . . . . 0.0 111.432 -176.257 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.4 m -144.15 162.59 39.5 Favored Pre-proline 0 CA--C 1.544 0.727 0 C-N-CA 125.045 1.338 . . . . 0.0 110.541 176.553 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_exo -54.5 157.06 12.69 Favored 'Trans proline' 0 CA--C 1.536 0.592 0 C-N-CA 124.084 3.19 . . . . 0.0 114.723 175.02 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -50.17 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.034 2.134 . . . . 0.0 113.379 -177.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 95.35 -1.04 64.08 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-O 118.668 -1.074 . . . . 0.0 114.845 178.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 44.0 mtt -83.33 166.48 18.43 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.077 1.438 . . . . 0.0 111.553 165.893 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 59.1 m -118.73 140.33 50.1 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.481 1.512 . . . . 0.0 110.313 173.485 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 46.8 t -73.21 109.06 6.45 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 163.177 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 95.8 p -75.81 160.52 29.88 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.776 0.798 . . . . 0.0 112.944 176.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 11.4 pm0 -58.02 -17.78 19.83 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.971 1.709 . . . . 0.0 113.947 175.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 89.01 14.03 61.32 Favored Glycine 0 CA--C 1.533 1.186 0 C-N-CA 124.374 0.988 . . . . 0.0 114.038 -177.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -127.94 145.94 50.8 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 118.278 1.039 . . . . 0.0 112.485 -174.175 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 77.5 m -76.88 151.77 35.68 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.923 1.689 . . . . 0.0 112.536 176.405 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 170.48 -167.38 40.52 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 123.604 0.621 . . . . 0.0 113.544 168.719 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.7 mtpp -132.4 169.0 17.15 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 125.897 1.679 . . . . 0.0 112.142 -179.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 71.55 -179.02 34.32 Favored Glycine 0 CA--C 1.541 1.67 0 C-N-CA 123.849 0.738 . . . . 0.0 113.651 -178.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -51.45 -29.52 31.65 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 124.535 3.49 . . . . 0.0 116.157 -173.46 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.29 -8.16 54.66 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-O 116.737 -1.601 . . . . 0.0 115.157 177.117 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -147.15 -39.32 0.2 Allowed 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 114.938 1.458 . . . . 0.0 114.938 -178.705 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.6 t -140.81 -5.03 1.18 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.439 1.496 . . . . 0.0 114.47 -159.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.01 -52.89 2.13 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 121.225 -0.922 . . . . 0.0 112.323 -167.805 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.378 0 C-N-CA 126.38 1.872 . . . . 0.0 112.238 -173.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.4 -52.08 2.62 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -159.776 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -141.71 177.98 7.79 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 128.26 2.624 . . . . 0.0 110.473 169.809 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 71.9 m -78.96 107.94 12.07 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 124.568 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.6 t -47.75 99.4 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 127.623 2.369 . . . . 0.0 110.717 -169.665 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.7 mmt85 41.39 43.04 2.03 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.345 1.458 . . . . 0.0 112.791 -170.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 98.16 -3.45 60.11 Favored Glycine 0 CA--C 1.538 1.479 0 C-N-CA 127.45 2.452 . . . . 0.0 115.262 178.874 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -128.41 -175.53 3.54 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 119.175 1.487 . . . . 0.0 112.516 -165.409 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.56 169.95 8.51 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 126.427 1.891 . . . . 0.0 107.551 160.753 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -61.5 164.61 15.08 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.84 2.36 . . . . 0.0 114.08 173.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.4 p -54.76 104.73 0.12 Allowed 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.217 1.807 . . . . 0.0 111.648 177.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.94 -2.85 24.27 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.753 1.168 . . . . 0.0 114.296 -177.95 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.7 mpp? -113.43 169.41 8.98 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.912 1.356 . . . . 0.0 109.938 170.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -141.58 157.11 45.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.825 1.65 . . . . 0.0 112.337 -172.417 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.46 112.15 24.6 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.619 1.568 . . . . 0.0 111.663 -172.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 96.5 p -67.31 164.19 18.96 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 -173.777 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -51.54 -3.24 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 129.159 2.983 . . . . 0.0 115.706 162.648 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' NAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.86 19.42 78.89 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 119.008 0.822 . . . . 0.0 113.598 -174.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -121.4 130.02 53.36 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.52 1.928 . . . . 0.0 109.649 177.682 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 12.5 p -93.38 159.83 15.08 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -176.378 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.2 -149.33 9.78 Favored Glycine 0 CA--C 1.538 1.491 0 C-N-CA 126.368 1.937 . . . . 0.0 111.488 -167.37 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -135.72 159.4 41.75 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 118.971 1.385 . . . . 0.0 112.526 -176.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 79.44 174.86 46.67 Favored Glycine 0 CA--C 1.538 1.5 0 C-N-CA 124.592 1.091 . . . . 0.0 113.626 176.458 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_exo -45.49 -46.53 14.4 Favored 'Trans proline' 0 C--N 1.35 0.643 0 C-N-CA 124.686 3.591 . . . . 0.0 114.673 -172.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.7 mmtm -55.56 -24.4 32.23 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 126.511 1.924 . . . . 0.0 114.295 -179.193 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -109.6 -27.54 9.34 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.362 1.865 . . . . 0.0 113.089 175.544 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 55.7 m -91.86 -8.98 44.98 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.79 1.236 . . . . 0.0 113.87 -176.155 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.05 -26.14 0.12 Allowed Glycine 0 CA--C 1.537 1.422 0 N-CA-C 117.038 1.575 . . . . 0.0 117.038 166.118 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.432 ' CZ ' ' HA ' ' A' ' 30' ' ' ARG . 1.7 tpm_? . . . . . 0 C--O 1.256 1.395 0 CA-C-N 119.561 1.681 . . . . 0.0 114.784 -178.467 . . . . . . . . 1 1 . 1 stop_ save_